Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACP2	LAP	ENSG00000134575	"Acid phosphatase 2, lysosomal"	P11117	11	47239302-47248906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 30.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		8100				"unprognostic (5.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.57e-1)"	15.7	23.6	13.1	13.9	13.6	3.6	13.0	12.5	19.5	11.3	15.4	11.7	15.4	26.9	10.5	20.0	8.9	9.3	12.4	18.1	14.4	18.2	18.7	65.4	13.3	40.7	11.8	12.7	8.1	36.2	13.6	13.8	31.3	12.2	15.3	11.7	16.4	32.3	18.5	10.1	7.0	24.4	10.8	11.0	18.9	14.2	14.6	7.1	10.0	12.4	9.6	9.7	14.3	8.0	1.0	6.6	4.6	30.3	3.8	5.6	4.2	6.8	14.2	13.8	12.2	12.4	6.2	10.7	11.3	20.2	20.7	21.6	9.8	11.2	1.8	9.3	14.4	6.2	10.1	7.2	10.4	10.0	35.2	12.4	4.6	20.9	10.2	17.2	6.8	11.8	15.1	6.6	10.7	6.3	12.5	14.9	6.2	8.3	14.8	13.5	11.1	5.6	6.1	9.5	10.4	8.6	4.4	18.7	14.9	15.5	16.0	7.3	11.4	15.6	34.8	8.0	7.5	21.2	6.0	8.8	10.5	8.8	13.7	16.1	12.4	16.0	1.5	15.5	3.4	16.1	4.6	7.2	3.0	5.6	30.3	4.4	1.0	3.5	5.0	6.6	0.7	3.1	2.7	1.2	3.8	19.5	0.2	3.6	4.2	13.1	13.6	12.5	19.5	14.4	18.2	11.8	12.7	12.2	7.1	17.9	18.1	4.5	10.0	3.7	13.1	7.3	20.4	10.7	7.9	17.4	5.9	36.5	8.3	47.8	1.4	13.9	43.0	0.0	52.7	28.2	10.4	9.4	11.5	74.2	103.8	11.1	14.5	48.5	51.1	1.7	4.6	17.1	23.6	43.3	23.6	21.3	29.5	28.1	9.9	23.4	11.5	19.4	7.5	9.7	17.0	2.0	24.5	7.5	10.9	5.1
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 90.2;Leydig cells: 39.1;monocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"JURKAT: 61.5;MOLT-4: 198.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		650000	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	4.0	2.0	1.4	3.9	5.5	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.9	2.7	0.2	1.4	5.9	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.2	26.2	2.5	0.5	0.9	1.3	5.4	61.5	2.0	3.3	0.6	3.4	198.0	2.9	0.5	1.8	1.4	10.7	2.8	9.9	0.2	0.0	0.0	0.9	2.1	0.4	2.5	2.7	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1	0.0	3.4	12.7	3.0	11.4	0.0	1.9	0.0	2.7	0.0	1.8	0.0	2.3	0.0	3.7	0.1	16.2	0.5	0.0	17.9	90.2	16.7	0.9	0.0	2.9	27.6	0.0	0.0	6.7	13.4	1.5	39.1	14.4	8.5	49.5	1.4	2.9	8.2	0.0	2.5	2.1	0.0	12.9	16.1	0.4	1.3	12.2	3.1	30.5	3.3	2.4
ADK	AK	ENSG00000156110	"Adenosine kinase"	P55263	10	74151185-74709303	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Purine salvage"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 71.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032876, HPA038391, HPA038409, HPA075222"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		320000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: "	"unprognostic (1.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.93e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.95e-2)"	13.8	10.7	11.8	13.6	25.4	12.1	14.5	11.2	11.8	9.5	9.3	9.0	9.6	8.8	6.6	10.6	29.4	8.9	6.3	15.7	9.8	11.1	19.0	71.9	15.1	17.9	12.3	9.3	5.2	12.6	15.1	23.5	43.2	11.6	8.7	10.8	8.5	13.1	11.4	18.1	20.8	6.4	8.3	13.2	11.3	7.4	11.9	10.3	13.4	20.8	24.1	21.9	12.6	14.7	49.3	23.0	5.4	21.6	6.5	15.7	9.8	38.1	8.6	9.1	12.2	9.2	14.2	21.0	33.2	26.3	25.7	28.9	24.1	39.8	20.0	8.3	13.3	12.1	34.9	10.7	35.3	41.2	13.4	12.3	12.7	14.1	25.9	10.5	20.3	5.2	13.0	23.3	18.7	46.6	19.0	22.3	9.3	10.1	6.5	19.3	21.3	23.9	27.5	2.6	17.8	60.9	23.1	15.8	17.2	28.1	21.0	7.2	8.5	14.6	56.7	11.0	8.5	37.7	15.4	19.1	8.5	15.7	22.7	27.3	9.4	10.6	22.6	16.1	29.3	5.2	1.3	10.1	1.4	4.5	18.0	10.0	29.7	9.5	8.2	23.0	49.3	7.9	6.5	5.4	6.5	21.6	16.7	15.7	9.8	11.8	25.4	11.2	11.8	9.8	11.1	12.3	9.3	11.6	10.3	77.4	57.2	37.1	62.9	83.7	14.5	53.3	35.7	34.8	76.2	29.6	53.0	120.6	77.9	60.0	55.9	14.7	5.9	0.0	58.9	113.1	27.2	33.9	19.8	112.8	36.3	11.1	10.4	14.7	21.4	22.9	15.5	40.6	45.5	31.5	11.5	10.0	45.7	14.0	11.3	48.3	27.9	6.5	32.8	13.3	12.2	84.8	89.7	20.3	19.9	57.0
ADPRM	"C17orf48, MDS006"	ENSG00000170222	"ADP-ribose/CDP-alcohol diphosphatase, manganese dependent"	Q3LIE5	17	10697594-10711233	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023265, HPA023820"	Approved					NA	NA					"HPA023265: AB_1845590, HPA023820: AB_1845591"	"unprognostic (7.58e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.38e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.97e-2)"	11.1	8.2	6.4	9.3	13.1	12.9	13.0	9.8	12.2	10.3	8.1	10.1	16.1	6.6	11.3	9.1	7.8	9.0	7.9	6.4	9.6	6.1	7.8	15.2	6.9	23.2	8.1	5.6	14.2	12.4	4.2	11.9	4.9	9.3	16.7	7.5	8.3	8.8	13.4	14.8	9.2	9.9	6.5	7.3	10.5	12.2	9.5	8.2	18.8	14.6	10.4	11.1	8.8	9.0	10.5	4.2	6.1	3.5	4.0	18.7	5.9	4.1	2.2	4.5	5.3	10.5	13.6	2.3	7.9	8.8	5.8	8.7	1.4	2.0	8.1	4.3	8.3	3.0	3.4	1.9	5.7	6.9	5.1	5.3	5.9	3.7	4.5	18.8	3.0	5.5	15.6	10.4	6.1	9.0	10.7	10.1	8.3	4.0	1.5	8.3	1.1	3.9	5.4	3.7	3.0	2.1	3.4	5.3	2.4	10.1	3.1	1.0	6.4	4.2	1.6	9.8	4.9	3.8	6.0	10.3	4.0	2.4	4.5	5.2	2.0	1.4	2.4	7.9	4.5	6.7	3.4	3.5	6.1	3.2	3.0	5.4	8.2	8.8	5.8	4.2	10.5	18.7	12.0	2.5	4.0	3.1	2.4	7.7	5.9	6.4	13.1	9.8	12.2	9.6	6.1	8.1	5.6	9.3	8.2	3.0	1.3	31.2	12.3	4.6	10.4	2.2	2.5	2.7	5.7	1.8	17.7	6.0	3.3	7.7	6.0	6.0	5.1	0.0	7.3	5.7	5.4	10.1	13.9	7.8	5.8	3.2	4.6	4.3	5.1	4.1	14.7	7.9	10.1	10.8	7.4	13.2	7.7	3.5	7.8	6.1	33.4	6.5	10.3	9.2	9.2	4.1	6.9	10.0	4.7	8.9
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602166-8612871	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;lymphoid tissue: 22.3"	"Cell type enhanced"	"Detected in single"	10	"Alveolar cells type 2: 1.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.6"	"Group enriched"	"Detected in many"	6	"B-cells: 6.6;granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"Daudi: 49.6;U-698: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	1.3	0.1	0.1	22.3	0.1	0.4	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.9	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.2	0.1	0.5	15.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.8	0.1	1.1	0.5	3.9	0.1	0.1	1.7	0.2	0.2	0.1	0.6	0.3	0.1	12.2	0.1	0.7	6.6	0.7	1.6	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	41.4	0.0	0.1	0.0	1.0	0.7	0.4	0.4	0.3	0.2	4.3	0.4	0.2	0.4	6.6	0.4	0.4	1.6	0.5	0.4	0.7	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709559-4742043	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 86.8;HEL: 55.6"	"Low region specificity"	"Detected in all"							HPA063324	Enhanced		Supported	Mitochondria		NA	NA		68000	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	24.6	25.1	20.9	9.8	22.4	6.8	24.0	14.6	17.5	17.7	23.7	15.3	16.0	24.4	18.9	17.5	28.3	14.0	16.1	90.0	22.4	16.4	37.7	75.1	16.4	13.1	25.2	15.2	22.4	15.7	16.9	14.1	13.0	22.9	19.0	23.0	17.4	14.5	19.1	72.0	18.1	22.0	21.2	24.1	12.1	22.5	9.3	24.9	15.2	20.8	32.8	14.9	20.1	17.1	7.0	14.4	17.0	5.6	14.7	17.1	10.2	8.8	7.5	12.8	5.2	17.9	13.2	0.9	11.3	26.5	7.1	10.6	1.3	9.9	8.3	3.8	14.3	3.9	5.8	9.3	10.8	12.0	86.8	7.0	55.6	13.3	22.5	14.1	5.8	2.9	20.8	9.7	6.0	8.4	16.5	20.8	8.5	4.2	11.3	21.1	5.3	5.6	16.9	11.4	17.4	2.8	7.6	4.6	4.1	20.6	12.5	21.1	13.3	13.2	4.3	7.5	13.0	6.0	11.7	12.8	5.9	6.0	15.5	8.8	2.9	1.8	10.2	10.9	4.4	4.2	6.8	5.6	17.0	16.2	4.4	14.7	7.0	12.5	14.8	10.5	6.9	16.6	17.1	1.9	14.7	3.4	14.4	16.7	10.2	20.9	22.4	14.6	17.5	22.4	16.4	25.2	15.2	22.9	24.9	53.6	88.6	32.0	59.7	65.9	11.9	155.8	66.2	45.5	68.2	62.8	21.6	83.2	218.8	74.1	2.6	56.6	104.3	0.0	61.0	10.9	79.1	116.1	44.0	282.7	40.3	14.3	105.2	74.3	36.8	1.9	100.7	36.7	70.9	53.3	103.3	22.3	61.2	57.5	140.7	148.4	8.8	103.5	59.8	6.6	15.3	91.2	179.0	38.5	135.0	92.5
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 137.0;Extravillous trophoblasts: 30.0;Spermatogonia: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.3;BJ: 20.7;fHDF/TERT166: 23.6;LHCN-M2: 59.3;U-2 OS: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.9	0.0	11.2	30.3	0.4	20.7	4.4	3.4	1.4	0.1	0.5	0.1	0.1	23.6	1.3	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.7	0.1	0.6	1.3	12.0	9.7	0.1	0.2	0.2	59.3	0.2	0.0	0.1	1.2	5.5	7.5	0.5	2.2	0.3	9.2	0.3	4.6	1.1	0.0	0.0	1.3	0.1	0.1	0.1	2.4	8.2	18.6	0.4	0.6	4.8	4.3	0.0	1.6	1.0	3.0	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9	0.0	0.0	0.0	0.5	0.2	0.5	1.2	0.0	0.0	0.0	1.8	0.0	0.9	6.6	0.2	137.0	1.1	0.0	0.0	0.6	30.0	1.2	2.2	0.0	0.0	2.2	12.7	11.5	0.6	0.0	16.1	1.1	0.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	4.5	0.2	0.0	3.1	6.5	72.5	0.3	2.4	1.5	0.0	0.1
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 165.9;Spermatocytes: 116.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.5	1.8	7.6	13.5	7.1	4.5	5.7	4.0	5.0	4.2	5.7	2.9	5.3	5.5	2.1	3.7	9.2	4.5	2.2	4.3	8.9	11.7	4.7	4.2	4.4	2.9	5.8	5.3	2.6	3.6	8.4	7.7	10.1	10.3	5.5	8.4	3.9	4.6	3.1	5.2	4.6	3.5	1.7	5.8	2.9	6.1	4.2	5.1	6.1	5.0	9.2	7.9	4.8	4.6	6.6	4.5	6.0	6.4	5.8	4.0	2.7	5.8	2.6	2.4	2.1	3.2	8.1	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7	26.8	18.8	6.6	7.7	2.4	14.6	16.1	2.5	165.9	18.2	8.7	13.7	3.3	0.0	7.0	55.8	11.3	10.5	0.0	3.9	1.2	3.5	4.8	20.9	1.8	3.0	19.1	19.0	5.5	4.6	32.1	6.9	5.3	5.0	1.8	14.3	15.2	6.1	7.8	6.0	5.6	48.9	25.8	5.2	116.9	28.5	2.3	4.7	12.8	9.9	7.5
ATRIP	"FLJ12343, MGC20625, MGC21482, MGC26740"	ENSG00000164053	"ATR interacting protein"	Q8WXE1	3	48446710-48467645	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.3"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 5.3;Exocrine glandular cells: 3.3;Pancreatic endocrine cells: 3.5;Suprabasal keratinocytes: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033109, HPA047590"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB033109: AB_634993, HPA047590: AB_2680094"	"unprognostic (5.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"unprognostic (4.72e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.52e-2)"	6.1	5.3	4.9	6.2	5.5	7.1	6.5	9.4	6.4	7.0	5.2	7.2	5.1	3.8	8.2	5.1	7.0	5.7	5.0	5.4	3.5	2.8	5.4	5.4	6.0	5.5	4.8	3.6	6.8	5.3	5.3	5.5	9.2	3.8	6.2	6.0	6.5	5.1	7.2	7.3	8.0	4.6	5.4	3.4	6.3	5.2	38.3	4.6	13.4	9.3	6.6	9.0	5.5	6.2	0.9	2.9	1.0	1.4	1.4	3.4	1.5	7.0	2.9	8.2	6.2	5.0	8.5	8.7	10.7	5.0	13.3	11.1	4.3	5.0	15.7	5.1	4.5	6.2	7.3	9.2	8.4	13.0	9.3	4.7	12.2	13.1	2.9	2.7	11.8	7.8	3.6	2.7	7.1	3.4	2.9	5.8	5.9	9.7	8.1	12.4	3.9	9.9	4.2	6.4	3.6	8.8	6.7	7.5	11.5	4.5	3.5	4.0	5.8	8.6	8.7	3.4	7.7	7.4	4.5	6.5	8.9	5.8	10.7	12.4	9.6	15.3	10.8	4.7	8.9	4.9	0.7	1.4	0.0	3.3	0.8	0.5	0.9	3.0	1.7	0.9	0.5	2.1	3.3	1.0	1.4	1.0	2.9	3.4	1.5	4.9	5.5	9.4	6.4	3.5	2.8	4.8	3.6	3.8	4.6	0.0	1.0	0.0	0.0	2.6	0.8	1.3	0.0	5.3	2.3	0.0	2.0	0.1	0.0	3.0	0.0	0.7	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.8	0.0	0.6	3.5	0.0	0.0	1.5	2.0	0.0	0.9	0.0	0.0	3.3	0.1	0.0	0.0	0.0
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991717-79009867	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Mucus-secreting cells: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 92.2;T-47d: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	NA		2300000	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	13.8	15.3	9.6	13.1	10.2	8.1	13.0	12.2	10.8	17.7	43.8	12.3	25.4	25.5	12.0	14.3	27.5	10.0	19.5	10.8	9.0	6.9	10.3	17.7	11.1	11.5	12.5	7.7	10.4	14.7	13.1	11.8	33.0	12.0	36.7	41.5	7.9	30.3	41.4	9.0	8.9	27.2	8.0	12.4	18.1	25.8	19.0	10.3	14.1	12.4	8.9	14.4	10.3	13.7	4.1	3.8	17.5	4.4	3.1	6.2	4.4	22.2	24.4	6.8	9.9	6.5	7.8	8.8	13.8	12.1	14.8	12.6	11.6	21.1	5.4	8.1	9.6	18.1	11.3	5.8	10.8	14.9	9.0	10.6	7.0	7.4	9.6	5.6	6.7	11.1	8.0	7.0	13.7	7.5	8.8	25.6	9.1	8.8	9.2	9.8	12.1	10.1	4.0	4.7	92.2	26.0	5.7	11.2	6.1	6.5	11.2	9.9	9.9	7.3	48.8	10.4	11.4	60.2	8.0	12.7	22.2	20.1	9.9	17.2	10.9	9.0	5.3	14.2	5.2	13.9	6.1	3.8	8.1	6.2	4.4	6.1	4.1	4.6	5.2	3.8	2.9	4.5	4.4	17.5	3.1	2.9	2.7	3.8	4.4	9.6	10.2	12.2	10.8	9.0	6.9	12.5	7.7	12.0	10.3	26.8	19.4	13.7	13.8	14.7	5.9	11.6	15.3	6.7	10.3	12.2	13.7	30.3	3.3	30.3	11.4	14.3	61.6	23.3	25.4	31.5	12.3	34.8	5.7	12.1	21.5	4.8	49.0	54.6	9.2	10.4	10.9	11.3	13.5	11.8	134.8	6.7	27.4	49.1	7.1	6.1	8.5	6.5	7.2	23.2	5.5	11.4	84.9	10.2	83.2	16.5
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		2100000	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	35.0	17.0	28.5	30.4	24.4	14.8	72.2	18.0	35.8	26.8	44.8	17.8	20.9	53.7	16.5	19.3	42.2	13.5	39.2	28.6	28.0	31.4	26.2	88.2	36.8	46.2	35.1	16.8	16.2	42.3	19.3	16.6	16.0	25.4	32.8	48.1	16.2	50.8	18.3	30.4	22.2	64.9	46.9	33.1	21.6	35.9	8.6	18.2	25.6	31.7	26.7	28.0	34.0	39.0	11.2	10.6	23.1	12.4	15.0	17.5	12.1	30.8	17.3	22.4	20.0	40.9	47.9	31.7	54.9	33.1	33.4	34.0	15.4	21.4	45.7	28.3	37.2	31.4	21.0	16.5	28.4	45.8	69.1	13.5	35.5	23.9	26.5	26.7	50.6	26.0	26.8	34.4	27.8	31.3	31.6	34.5	17.1	33.5	36.9	43.5	11.3	41.0	23.9	14.2	40.6	24.0	25.6	38.8	34.3	32.5	34.0	20.3	10.7	39.3	45.7	31.5	30.9	11.3	30.2	32.3	41.8	24.2	39.9	45.1	26.9	37.2	31.2	33.0	31.3	28.5	23.1	10.2	18.2	13.6	10.7	17.5	11.2	15.5	16.7	10.6	10.2	14.7	14.0	4.2	15.0	12.4	8.9	16.0	12.1	28.5	24.4	18.0	35.8	28.0	31.4	35.1	16.8	25.4	18.2	65.5	42.5	120.7	103.0	155.9	32.3	44.9	101.9	57.6	33.0	71.5	15.7	70.1	147.6	156.9	1.2	74.2	219.2	46.7	158.3	115.0	53.6	209.9	94.4	215.9	69.9	41.3	112.9	68.2	97.0	4.1	55.0	98.6	241.3	77.5	273.0	40.6	127.4	150.8	65.7	149.9	26.0	84.1	148.0	8.2	27.2	170.5	99.0	139.5	184.6	187.9
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	8.8	3.8	3.0	6.8	8.1	14.5	4.2	0.9	5.0	2.7	4.2	4.0	1.3	5.0	2.5	6.4	1.8	2.3	3.4	3.7	3.3	3.9	4.0	3.1	17.9	13.4	3.2	5.7	1.3	3.7	2.9	3.0	4.7	3.6	2.1	2.2	4.7	20.8	4.3	3.0	1.2	6.1	3.1	3.8	7.9	7.4	9.2	0.4	8.8	3.1	1.6	2.6	2.7	1.6	1.4	1.9	7.8	6.4	0.9	0.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.2	14.2	12.9	0.0	1.4	3.1	0.8	0.0	3.7	0.2	0.0	0.0	0.0	0.3	0.2	20.1	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.0	4.9	0.1	0.0	0.1	11.0	3.7	0.3	0.0	1.1	3.5	0.0	0.0	0.0	0.4	0.3	0.5	0.2	0.0	1.7	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.7	0.9	5.5	2.8	7.8	0.7	6.4	0.4	1.4	0.5	0.4	1.9	0.2	0.5	0.5	1.8	0.9	3.2	0.1	0.6	1.2	3.0	8.1	0.9	5.0	3.3	3.9	3.2	5.7	3.6	0.4	3.0	6.9	2.7	0.8	0.3	1.6	1.4	0.0	4.0	0.0	1.8	0.0	2.0	1.7	2.4	2.5	4.7	5.3	70.0	5.8	2.4	1.9	0.7	2.3	1.3	15.9	0.0	6.9	7.4	6.7	1.1	1.4	5.1	0.0	5.4	1.7	4.6	4.1	1.9	5.3	0.6	0.2	0.0	2.0	0.1	4.1	0.4	0.7	4.3	0.9	1.6
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.9;U-698: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	8.0	8.3	11.9	30.9	16.8	17.2	6.9	11.4	14.8	5.6	8.6	10.4	2.6	7.6	7.5	4.4	8.8	5.5	6.1	5.5	12.3	13.1	5.8	4.8	9.7	42.8	11.7	10.3	6.0	5.0	3.6	4.2	7.9	11.1	5.9	10.4	6.4	6.3	4.0	6.8	7.9	12.4	7.5	17.6	17.5	8.2	5.6	8.6	80.9	8.3	3.8	39.9	9.5	6.5	27.9	34.2	17.5	12.7	18.5	24.9	25.1	6.7	4.5	9.9	5.9	3.1	5.5	5.7	17.5	6.5	13.9	11.6	2.9	14.8	60.9	7.6	7.2	8.1	3.9	8.8	5.5	18.8	12.9	5.4	12.6	5.2	4.6	3.2	25.1	16.3	2.7	6.7	8.4	5.1	6.8	7.9	17.3	5.0	23.2	15.8	3.9	31.0	9.9	4.7	11.5	5.5	26.4	20.1	4.8	6.9	4.7	8.8	9.4	6.6	12.9	7.7	4.7	5.8	13.2	6.3	15.7	11.8	13.1	9.4	8.8	5.8	49.4	10.9	15.7	11.6	13.1	10.7	17.5	16.2	12.7	20.3	27.9	21.8	20.0	14.3	26.4	23.4	23.5	5.4	18.5	12.1	34.2	24.9	25.1	11.9	16.8	11.4	14.8	12.3	13.1	11.7	10.3	11.1	8.6	0.0	11.3	75.5	8.0	38.1	13.6	4.6	7.6	1.4	3.4	12.2	5.9	9.8	24.9	17.7	0.4	14.3	9.0	186.9	5.6	16.0	12.9	9.5	23.0	5.3	33.7	17.5	20.2	21.5	48.3	1.1	7.8	41.6	43.9	68.5	17.2	14.3	8.9	7.0	9.6	6.1	8.2	6.5	20.6	34.4	28.8	37.9	3.8	61.7	14.3	6.2
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		13000	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	24.8	46.2	24.7	19.9	23.8	12.9	27.3	11.6	28.3	27.1	20.4	17.3	22.6	16.4	26.0	20.1	30.9	25.9	40.9	25.8	22.5	22.2	25.7	47.6	25.8	29.4	21.1	20.3	35.9	51.7	28.3	25.3	18.9	21.3	23.7	21.5	30.0	26.4	22.8	24.8	19.4	19.1	27.4	25.6	24.9	27.2	11.8	16.7	15.0	52.9	21.3	26.0	24.5	25.1	31.9	24.8	23.7	25.7	30.8	36.8	22.7	22.7	21.0	21.4	19.8	32.4	44.3	28.1	43.9	39.2	31.5	19.5	21.3	44.2	7.9	10.9	42.7	21.5	11.3	15.6	27.4	29.0	38.3	11.8	36.5	12.2	25.3	34.8	35.5	22.9	36.8	29.2	27.6	28.8	31.9	26.9	17.5	36.2	79.2	41.8	16.6	23.0	21.7	17.0	9.2	18.3	25.1	15.3	15.3	25.4	27.3	21.2	13.1	20.7	17.9	20.5	20.8	13.7	18.6	31.3	26.2	20.2	12.6	33.4	30.4	16.4	10.1	28.9	23.3	30.8	23.7	22.0	19.7	29.2	25.7	36.8	31.9	25.6	29.7	24.8	21.7	25.5	26.7	1.6	30.8	24.9	19.1	21.9	22.7	24.7	23.8	11.6	28.3	22.5	22.2	21.1	20.3	21.3	16.7	11.9	15.0	31.7	28.8	22.6	4.3	20.6	38.2	18.7	11.4	31.4	3.9	16.6	31.5	61.9	6.3	32.1	15.5	23.3	47.4	19.9	41.7	29.4	22.0	38.0	48.4	3.2	13.9	25.2	29.6	13.2	40.9	29.6	25.3	38.7	28.6	31.5	60.2	10.5	33.2	34.1	6.3	32.3	28.2	9.3	15.4	20.1	6.1	27.4	29.9	34.5
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423619-30430075	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002832	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes		270000	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	15.3	15.8	14.8	25.0	13.2	12.5	20.7	15.5	19.2	12.1	37.4	10.3	11.3	20.7	14.1	14.4	19.7	18.9	28.1	23.3	12.1	12.6	27.0	25.3	11.2	27.6	13.3	16.6	16.6	25.2	16.4	7.7	16.3	11.4	15.4	40.3	10.6	20.5	21.1	28.3	16.1	22.9	13.9	11.3	22.5	16.4	9.9	7.8	21.3	22.6	26.0	25.0	13.2	13.0	47.3	30.9	19.0	24.5	23.1	26.2	25.3	26.6	32.7	14.9	19.2	4.2	5.7	13.8	12.8	7.7	19.4	19.8	24.6	22.8	36.1	27.0	8.0	12.4	21.0	30.9	25.1	24.3	19.0	48.8	21.0	15.0	32.0	5.5	37.5	32.8	6.6	14.3	21.6	12.5	5.9	19.9	19.4	26.4	12.7	13.7	46.5	44.5	42.1	19.7	27.0	26.4	63.2	16.6	47.0	22.4	17.3	31.8	18.0	8.5	30.5	12.0	10.2	26.3	16.1	10.0	15.0	13.4	19.3	23.0	8.4	25.0	46.0	9.9	31.2	17.5	19.0	12.4	11.7	18.8	22.1	26.2	47.3	24.2	21.3	28.7	40.2	21.8	21.0	1.5	23.1	24.5	30.9	24.1	25.3	14.8	13.2	15.5	19.2	12.1	12.6	13.3	16.6	11.4	7.8	17.9	14.6	32.0	37.1	80.1	23.9	33.1	61.1	20.1	19.4	41.8	7.9	81.7	107.8	107.5	10.2	47.2	79.9	0.0	108.6	68.9	31.5	41.3	31.1	18.1	68.6	14.3	37.0	25.2	16.6	36.0	18.1	35.6	45.5	108.2	103.3	19.7	78.9	105.2	18.7	54.0	16.3	19.4	35.0	2.8	33.6	70.1	23.2	25.9	124.8	43.2
DGUOK	dGK	ENSG00000114956	"Deoxyguanosine kinase"	Q16854	2	73926826-73958961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034766, HPA057246"	Approved					NA	NA					"HPA034766: AB_10669850, HPA057246: AB_2683381"	"unprognostic (3.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (8.69e-7)"	"unprognostic (3.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (7.47e-4)"	23.8	34.8	25.8	26.2	32.3	26.3	33.7	18.4	33.7	26.1	28.0	23.6	24.9	19.4	30.7	40.9	26.6	35.4	28.0	24.5	28.3	26.5	26.7	31.7	24.7	37.2	23.5	22.6	35.5	20.9	11.2	39.9	30.6	27.1	28.6	34.1	25.2	22.5	28.2	14.1	29.2	29.3	25.8	23.5	33.1	23.6	34.3	17.9	41.7	29.0	21.8	44.2	27.2	27.4	43.5	36.4	50.5	31.4	30.0	42.3	31.3	15.8	27.0	28.1	25.0	18.2	20.1	13.8	10.6	21.4	25.6	23.7	34.2	19.2	30.0	10.1	15.6	28.0	12.6	31.9	20.6	30.7	16.4	19.2	23.5	10.2	38.7	26.9	21.6	24.0	18.8	19.5	18.7	22.1	18.6	18.1	33.5	24.0	13.8	29.3	19.4	20.2	38.1	28.5	21.6	19.8	26.1	28.2	20.0	20.3	18.5	32.3	31.6	10.3	10.2	27.2	14.0	12.3	12.3	16.9	16.4	26.4	14.2	19.2	11.3	10.9	30.2	23.7	23.3	34.8	41.3	27.4	50.5	25.3	31.4	29.8	40.6	31.4	27.9	32.4	43.5	42.3	33.1	22.5	30.0	30.8	36.4	29.3	31.3	25.8	32.3	18.4	33.7	28.3	26.5	23.5	22.6	27.1	17.9	29.8	42.6	116.6	116.4	65.9	50.7	16.9	84.1	46.8	45.5	57.6	5.9	137.2	71.3	91.0	9.5	69.4	61.1	23.3	131.5	130.2	91.1	97.5	55.5	62.5	82.3	49.3	108.6	71.8	80.4	10.5	86.6	94.7	104.6	165.1	87.5	62.8	129.3	87.7	81.7	95.0	33.2	90.5	82.4	111.2	113.9	72.8	104.1	113.0	95.7	113.2
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Group enriched"	"Detected in many"	10	"Bipolar cells: 113.1;Cone photoreceptor cells: 84.4;Horizontal cells: 47.7;Rod photoreceptor cells: 70.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 49.8;U-87 MG: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm		NA	NA		440000	Nucleoplasm		"CAB005920: , HPA049910: AB_2680948, HPA061801: AB_2797266"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.3	49.8	4.5	1.1	1.4	15.2	0.2	3.1	7.5	6.3	2.6	0.6	1.0	0.0	4.3	6.5	0.2	6.0	0.7	0.3	3.5	0.0	4.8	3.1	7.1	0.2	1.0	0.4	2.2	4.0	0.1	4.9	0.0	6.1	0.0	2.9	1.1	0.2	0.0	1.4	0.2	1.0	4.8	0.8	9.1	5.9	0.1	1.5	0.9	0.0	6.5	10.9	10.6	0.3	0.4	0.6	0.1	4.3	0.2	0.2	14.4	14.5	6.3	0.4	0.1	0.3	19.0	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8	0.0	0.0	0.0	1.6	7.0	113.1	2.0	7.6	1.4	1.2	0.0	84.4	0.2	1.7	0.7	0.5	1.5	0.6	0.0	0.7	0.2	3.9	0.7	1.1	0.5	8.0	47.7	0.0	0.0	0.8	0.4	2.6	1.9	3.3	1.0	0.1	8.1	1.0	2.9	1.4	3.4	70.6	0.0	4.1	0.3	1.3	6.6	0.7	0.7	0.6	0.5
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	21.3	21.4	22.4	23.0	18.2	18.6	43.4	24.1	18.5	22.8	21.1	29.9	16.4	28.8	16.9	21.7	23.3	19.3	23.6	27.7	27.4	15.2	19.2	32.8	20.6	16.5	15.0	23.2	17.3	16.8	14.1	24.0	24.8	21.9	27.5	15.0	23.6	12.5	26.0	8.3	9.2	19.5	47.3	13.6	10.5	15.7	42.2	19.7	19.2	29.5	19.6	20.1	25.6	17.6	18.7	52.0	20.2	15.9	24.8	19.4	19.6	45.5	22.3	8.8	23.7	30.0	18.9	15.6	14.7	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9	35.7	38.5	29.4	27.6	26.7	71.7	69.9	20.4	26.8	40.9	24.4	123.7	25.6	26.6	27.7	51.2	34.9	15.4	0.0	21.8	50.9	25.9	26.7	49.7	14.8	27.0	119.2	29.3	25.2	33.3	58.7	24.7	32.4	13.5	44.1	18.9	66.0	35.1	14.0	28.7	19.5	150.0	19.4	37.0	66.2	50.8	24.1	30.1	27.7	23.8	31.5
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		500000	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	35.0	29.0	21.3	16.9	22.0	21.5	27.3	23.5	22.3	34.8	29.6	28.9	23.2	25.5	42.3	25.3	16.6	30.8	29.0	25.5	29.2	31.2	23.0	48.9	25.9	32.3	27.1	26.8	46.4	22.1	19.7	26.6	25.1	21.2	33.8	26.3	39.3	43.9	21.4	42.5	37.3	25.6	24.2	41.6	35.2	37.9	23.1	28.7	22.9	52.9	30.7	20.1	26.8	23.0	16.8	24.8	18.4	32.0	30.6	38.3	13.0	53.7	31.0	36.4	37.1	23.5	28.6	41.1	18.9	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4	29.8	21.1	33.5	15.2	20.6	26.5	23.8	15.3	5.3	18.2	48.8	21.6	21.9	43.1	30.7	37.5	27.5	130.4	0.0	27.6	96.1	18.2	17.4	18.5	18.7	42.3	41.3	20.7	20.3	22.9	75.8	15.5	40.5	18.6	50.5	92.3	16.0	35.8	87.7	26.2	31.5	27.7	25.8	19.8	8.0	13.3	27.6	26.5	39.9	56.9	19.7
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 19.5;Cone photoreceptor cells: 27.5;Endothelial cells: 14.6;Rod photoreceptor cells: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 8.5;RPTEC TERT1: 15.7;U-251 MG: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	5.0	19.3	14.1	2.3	28.3	2.6	3.4	41.4	39.7	6.8	2.7	26.8	0.0	1.9	5.9	3.1	3.0	6.0	5.1	3.0	14.3	16.3	5.8	1.4	7.5	2.5	19.6	17.7	4.6	2.6	3.5	10.3	1.6	47.3	3.6	2.7	2.9	3.7	3.6	2.5	4.0	2.4	5.7	16.4	3.6	5.3	5.4	22.1	0.0	3.4	0.0	2.2	4.3	3.6	0.7	0.7	1.1	0.4	1.0	4.0	3.8	0.6	2.0	1.6	0.3	1.2	0.8	0.0	0.4	1.0	0.8	1.0	0.0	3.0	0.0	6.3	0.9	1.0	0.2	1.2	2.3	0.7	0.8	2.4	18.2	3.0	0.0	0.1	0.3	8.5	0.6	0.4	1.0	0.5	0.9	0.4	1.6	0.0	0.3	0.3	0.0	1.1	0.1	4.7	7.5	1.4	1.2	8.2	0.0	15.7	0.1	3.2	0.6	2.2	0.6	0.2	0.6	0.0	0.7	0.2	2.3	3.2	1.9	11.3	3.1	0.5	0.1	2.2	0.9	0.8	0.0	0.4	0.0	0.7	0.0	0.9	0.7	1.0	0.5	0.7	0.0	1.2	1.5	1.1	1.0	0.3	0.0	4.0	3.8	14.1	28.3	41.4	31.6	14.3	16.3	19.6	17.7	47.3	22.1	0.0	5.0	0.0	1.2	2.2	19.5	2.1	0.0	1.4	0.0	0.0	27.5	0.0	3.3	0.3	6.5	14.6	0.0	0.0	0.3	0.1	3.3	0.4	1.1	0.0	0.7	7.9	0.0	4.3	0.0	2.3	1.7	1.3	0.0	0.0	0.4	3.1	1.6	0.0	2.5	0.5	28.5	0.0	1.4	5.0	0.3	1.5	0.2	0.0	0.5	0.9
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675742-241686991	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.4	17.6	11.6	17.3	15.0	29.1	14.4	14.5	12.4	10.0	13.8	16.5	9.3	12.0	12.4	9.7	20.0	9.7	10.2	9.4	9.0	6.5	15.5	19.5	10.5	21.0	14.0	9.5	9.5	13.6	5.0	8.8	10.4	11.8	11.5	11.7	10.8	9.6	10.0	6.7	17.9	13.0	13.0	9.5	18.8	13.5	11.1	15.1	20.7	9.4	16.1	17.9	11.7	11.9	19.8	21.1	12.0	24.7	15.7	21.8	15.7	25.1	27.8	24.2	30.7	8.0	8.7	25.6	20.6	15.5	27.5	32.4	12.7	30.5	12.2	6.4	16.6	32.8	21.2	22.2	25.1	14.8	28.7	26.4	26.1	23.3	24.1	6.6	16.5	21.7	6.1	6.8	26.5	10.8	8.4	26.4	17.7	29.4	10.3	29.1	26.2	30.5	28.7	23.8	28.2	23.4	26.1	35.6	17.0	15.9	14.6	29.2	18.3	13.4	20.6	16.5	7.7	18.7	29.6	17.1	40.1	28.8	25.5	38.0	11.6	12.2	34.2	32.1	26.5	46.6	12.0	14.9	9.5	17.4	24.7	16.8	19.2	16.1	18.2	10.5	19.8	16.0	14.7	2.5	15.7	18.8	21.1	21.8	15.7	11.6	15.0	14.5	12.4	9.0	6.5	14.0	9.5	11.8	15.1	8.9	4.3	11.9	17.5	13.5	18.2	9.2	25.5	8.1	11.4	24.4	2.0	48.5	18.3	37.3	1.8	17.5	9.3	46.7	29.4	118.6	22.0	17.5	15.0	16.6	74.0	4.8	13.8	20.9	13.1	2.0	15.3	23.4	21.9	57.7	19.9	16.3	27.3	14.0	18.0	27.5	14.2	25.8	16.1	27.6	57.7	10.5	23.0	15.8	34.8	12.0
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	26.9	32.9	23.2	51.1	31.8	69.0	31.9	31.7	27.6	26.8	26.3	24.4	27.2	14.5	29.8	31.8	33.7	26.9	28.2	35.5	23.2	26.5	25.4	19.8	25.7	44.7	25.3	23.6	33.4	22.2	23.7	30.7	26.0	22.5	30.3	24.3	28.1	27.5	26.1	25.6	27.3	22.6	25.6	23.9	30.1	25.8	31.9	20.7	120.3	40.5	37.7	43.2	23.5	28.4	34.5	32.3	17.0	24.5	22.2	40.2	24.3	26.1	8.2	20.1	19.0	14.1	15.0	12.0	27.8	17.7	25.7	31.9	9.5	18.1	73.0	15.0	15.2	21.0	36.0	21.1	19.0	25.2	51.4	21.8	59.6	21.7	12.9	7.8	62.4	28.4	9.2	12.9	17.4	9.2	16.7	17.0	43.7	32.2	41.5	18.9	10.6	55.8	73.5	12.7	26.7	15.9	45.5	44.0	76.7	16.9	17.8	29.2	29.7	20.6	16.7	23.8	21.4	23.6	49.8	14.1	26.9	26.0	32.0	36.4	33.5	69.7	71.9	20.3	107.2	29.5	11.3	19.5	17.0	21.7	19.3	28.1	34.5	38.9	34.2	28.2	31.6	40.2	26.5	11.1	22.2	24.5	32.3	34.4	24.3	23.2	31.8	31.7	27.6	23.2	26.5	25.3	23.6	22.5	20.7	50.6	29.3	108.7	177.4	159.5	41.9	99.9	84.1	24.1	61.4	99.5	13.7	138.0	172.5	82.7	26.1	112.3	21.0	140.2	40.7	245.0	140.4	116.4	84.1	71.8	150.1	77.9	92.4	100.1	85.2	25.7	171.2	102.9	146.8	57.7	93.4	81.1	44.6	42.1	166.9	204.1	36.1	155.2	162.6	380.2	218.4	147.3	81.2	113.3	168.7	147.0
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73515750-73523797	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	134.1	124.1	80.2	136.0	75.6	140.9	182.0	103.3	106.2	149.6	133.3	94.9	93.7	81.7	152.0	127.3	136.4	143.1	102.4	88.2	71.5	58.0	130.9	123.1	169.6	135.6	74.3	93.2	240.8	227.6	106.3	111.2	89.1	79.7	115.0	114.7	105.0	133.3	123.6	51.3	139.8	101.6	121.6	108.6	111.3	121.5	129.9	71.6	125.1	132.4	143.1	169.7	151.1	134.8	258.9	209.7	54.6	187.6	184.6	366.8	517.5	112.5	142.8	202.7	276.8	415.8	687.9	161.3	168.6	435.4	216.3	207.7	221.5	155.8	459.7	225.6	285.0	151.5	119.5	247.5	322.3	208.6	80.2	154.9	171.6	116.4	246.7	361.0	318.9	187.4	594.2	548.2	159.2	537.5	445.1	292.9	213.7	317.1	145.4	261.3	150.1	136.5	334.3	216.8	150.1	99.2	272.1	341.5	515.3	277.9	238.6	166.4	184.6	84.5	198.8	333.7	240.5	135.1	515.5	243.4	92.4	131.6	68.4	191.4	163.4	145.2	108.0	95.9	264.6	145.2	54.6	187.6	20.8	198.7	165.4	366.8	258.9	288.8	250.9	209.7	199.5	323.8	277.8	17.0	184.6	169.0	161.7	202.9	517.5	80.2	75.6	103.3	106.2	71.5	58.0	74.3	93.2	79.7	71.6	2945.0	5104.7	7686.4	9440.3	8731.8	946.3	163.3	4537.5	2577.7	4487.2	2501.9	514.4	8108.2	8765.4	4837.4	1096.2	6221.3	1773.7	1425.0	9007.6	10117.9	6235.0	8187.7	3506.7	2998.1	5660.8	467.2	3719.4	4654.6	6431.4	1730.5	8270.0	6531.1	4848.6	19235.8	6485.3	1457.9	7817.3	5029.0	6780.9	10371.8	951.6	3479.5	5699.9	1275.5	709.3	8789.4	9271.7	8651.4	9249.6	10618.3
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 100.4;Cardiomyocytes: 108.0;Horizontal cells: 254.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 56.2;HBF TERT88: 28.3;MCF7: 46.5;SCLC-21H: 29.6;T-47d: 24.1;U-2 OS: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.8	0.2	2.6	0.0	0.1	1.3	2.1	0.3	10.7	3.6	1.4	7.1	0.0	18.9	0.1	2.9	5.1	56.2	0.1	28.3	0.1	2.6	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	46.5	0.1	0.1	1.9	19.3	18.1	1.3	0.0	1.7	0.4	0.5	29.6	18.0	17.1	1.9	0.1	0.5	24.1	0.6	0.0	0.0	32.9	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6	0.0	0.0	0.0	0.5	0.3	100.4	108.0	0.0	0.0	1.2	0.0	11.8	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.2	0.1	0.2	2.9	5.7	0.0	0.0	254.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.8	0.3	0.0	0.0	0.3	33.6	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.9
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985469	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	104.2	84.9	64.0	66.7	57.1	92.7	77.5	55.7	96.2	93.4	91.3	55.8	80.8	95.4	100.1	75.1	115.1	83.4	88.6	104.1	51.6	44.4	65.5	161.0	67.7	108.9	51.4	38.3	167.1	395.7	45.1	72.3	63.7	47.5	105.6	41.3	67.7	191.3	64.4	260.8	87.2	100.9	112.3	46.8	85.4	98.5	70.9	32.4	123.4	127.1	112.5	108.3	111.8	94.7	84.9	60.0	10.0	58.4	48.3	76.3	83.7	95.2	68.4	39.8	105.1	106.7	192.3	57.3	74.9	101.4	71.7	70.6	107.8	44.2	199.0	44.6	69.1	31.9	72.3	62.8	116.0	38.0	49.6	104.2	50.8	65.7	110.7	156.0	109.1	88.4	248.2	122.7	63.1	97.7	104.2	74.2	97.5	99.1	146.7	43.6	138.2	97.9	83.7	105.3	34.4	69.2	109.1	59.2	126.5	59.0	85.2	109.0	101.3	47.1	94.3	135.0	39.5	91.9	132.7	88.9	51.4	53.7	104.4	115.2	157.4	105.6	99.0	76.6	137.2	67.0	10.0	58.4	8.3	38.6	45.8	68.7	84.9	67.7	50.8	60.0	70.7	76.3	59.4	6.1	48.3	43.8	50.5	58.4	83.7	64.0	57.1	55.7	96.2	51.6	44.4	51.4	38.3	47.5	32.4	205.4	339.7	970.0	885.9	1173.5	200.3	547.0	484.1	158.0	288.9	242.5	72.6	782.8	835.6	627.1	628.8	571.1	713.7	186.9	1561.0	1076.2	818.7	720.7	366.9	607.5	546.3	192.3	715.0	498.4	743.9	1007.5	933.7	543.3	612.4	762.0	931.2	218.1	963.4	716.9	782.8	713.6	97.3	575.6	971.3	259.8	261.2	1177.5	1039.5	756.1	908.5	772.4
EFL1	"EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1"	ENSG00000140598	"Elongation factor like GTPase 1"	Q7Z2Z2	15	82130230-82262763	"Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Elongation factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 13.4;Club cells: 7.9;Pancreatic endocrine cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039654, HPA047110, HPA052345"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.92e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (8.58e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.05e-2)"	16.3	14.0	7.0	17.3	9.9	8.9	11.8	10.2	9.4	9.5	17.2	11.0	6.8	13.2	9.2	12.2	14.1	9.1	8.0	10.7	8.8	7.9	11.9	15.4	9.0	10.0	9.5	4.5	9.8	12.5	17.9	15.0	12.8	13.3	12.7	19.6	7.4	12.1	8.5	18.5	14.6	25.7	10.8	10.1	10.1	9.7	13.9	9.9	26.9	9.8	11.3	14.9	10.8	11.7	10.7	6.8	15.8	9.0	5.8	9.0	4.5	4.9	12.3	9.2	7.9	6.2	8.5	5.9	14.4	17.0	10.4	14.0	6.1	8.7	12.1	5.9	10.7	13.1	12.9	24.4	9.5	16.6	10.7	11.9	13.3	11.8	4.6	9.8	8.5	9.5	4.2	14.9	10.5	24.2	12.3	13.7	15.6	9.9	5.5	12.0	6.9	11.1	7.7	8.3	8.8	6.4	11.9	13.7	6.5	7.3	14.9	8.4	9.0	9.0	10.6	11.0	16.7	7.9	7.6	11.5	14.8	10.0	36.9	14.2	7.1	26.3	10.2	13.5	16.0	5.4	15.8	5.6	13.7	9.0	8.1	7.2	8.9	8.4	7.6	6.8	10.7	7.3	6.3	1.0	5.8	9.0	3.3	7.6	4.5	7.0	9.9	10.2	9.4	8.8	7.9	9.5	4.5	13.3	9.9	3.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	7.9	0.0	0.0	6.1	3.3	6.0	0.0	0.0	0.0	0.0	5.3	3.1	0.0	0.0	4.7	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.6	0.0	0.0	7.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95869695	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 59.4"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 57.3;Karpas-707: 47.1"									"CAB002494, HPA014067"	Enhanced		Uncertain	Microtubules		NA	NA			Microtubules		"CAB002494: AB_563557, HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	10.4	7.5	7.4	16.2	8.4	15.6	8.8	7.6	6.9	18.9	12.7	13.1	8.7	5.8	59.4	12.8	13.2	15.6	22.2	6.8	7.4	7.4	6.2	3.9	14.8	14.5	8.5	4.9	10.3	2.8	3.0	4.3	24.0	9.9	14.7	9.1	10.8	6.7	12.7	3.3	5.5	12.2	37.2	17.9	25.3	7.5	5.4	7.2	3.5	13.4	12.5	21.1	25.2	12.4	6.0	11.8	37.4	15.2	0.5	5.1	4.6	0.1	0.3	0.9	0.8	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.5	0.1	1.0	0.6	0.0	1.4	0.3	0.0	0.0	0.0	57.3	0.7	0.6	0.4	0.7	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.3	7.5	0.3	0.6	47.1	0.0	0.6	0.4	1.5	0.6	0.6	0.2	2.4	0.4	0.7	0.5	0.2	0.7	1.1	0.3	1.1	0.8	0.6	0.5	1.6	0.8	0.4	0.2	0.6	0.6	6.7	0.9	0.0	0.6	3.1	0.2	0.1	15.2	37.4	0.1	10.7	0.3	6.0	0.6	0.3	11.8	4.6	0.1	0.1	26.7	0.5	2.4	0.7	5.1	4.6	7.4	8.4	7.6	6.9	7.4	7.4	8.5	4.9	9.9	7.2	0.0	1.4	45.3	0.3	7.9	1.4	8.5	0.0	1.4	1.2	1.8	2.0	0.4	1.7	0.0	5.9	46.6	0.0	0.0	1.8	1.7	8.7	0.4	3.5	0.0	23.2	0.0	0.0	11.6	77.1	6.1	0.6	80.4	15.1	46.9	0.0	0.7	0.2	0.2	2.8	0.3	0.7	6.5	32.0	6.2	4.3	9.8	13.2	14.6	0.4	0.2
ENTPD2	"CD39L1, NTPDase-2"	ENSG00000054179	"Ectonucleoside triphosphate diphosphohydrolase 2"	Q9Y5L3	9	137048098-137054045	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Group enriched"	"Detected in many"	4	"Leydig cells: 178.1;Peritubular cells: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 2.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.9;hTCEpi: 8.8;MCF7: 11.0;OE19: 17.7;SK-BR-3: 14.8;T-47d: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017676	Approved					NA	NA					"HPA017676: AB_1848179"	"unprognostic (1.64e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.71e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (3.51e-6)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.51e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.12e-3)"	1.7	1.6	18.8	1.5	10.1	0.6	7.0	4.0	10.4	9.8	9.1	21.9	1.7	17.6	2.8	4.4	3.3	9.4	10.7	2.7	22.6	9.6	4.5	1.0	1.0	0.5	6.1	12.8	0.8	2.6	1.2	3.1	3.9	11.9	11.2	5.8	2.5	6.2	2.9	3.0	9.3	11.1	1.9	7.5	0.5	9.5	6.8	11.7	0.0	0.7	2.6	1.0	0.9	3.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.9	0.0	0.0	3.4	0.3	2.5	0.0	0.0	0.1	0.0	0.4	15.9	0.0	0.0	0.2	0.0	8.8	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	17.7	2.4	0.0	0.7	1.6	1.9	0.4	2.4	0.0	0.2	14.8	0.0	0.1	16.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.8	10.1	4.0	9.8	22.6	9.6	6.1	12.8	11.9	11.7	0.0	0.0	0.0	1.1	1.4	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.3	0.0	6.1	1.1	0.7	31.6	0.0	3.9	0.9	1.7	5.9	0.0	0.9	0.2	0.0	24.2	0.6	0.0	2.1	178.1	0.0	5.0	1.0	8.1	7.2	4.5	31.7	90.9	8.4	0.0	0.0	0.4	1.2	4.3	1.3	0.8	0.0	12.8	1.0
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387156-40428619	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.2;pancreas: 37.3"	"Group enriched"	"Detected in many"	4	"Exocrine glandular cells: 19.8;Pancreatic endocrine cells: 5.7;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;HBEC3-KT: 12.7;hTCEpi: 8.6;RT4: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.6	2.2	5.7	1.7	25.9	0.5	2.1	5.4	15.8	26.2	3.3	0.6	1.9	1.7	4.0	4.4	7.5	1.3	3.6	1.4	4.9	6.3	3.6	0.5	4.8	0.9	4.0	6.3	2.6	37.3	1.7	4.2	2.9	14.5	5.3	3.6	2.8	21.2	5.1	1.7	3.2	1.6	2.5	1.7	5.1	8.8	1.3	4.8	0.0	7.0	5.6	4.8	13.7	2.9	0.5	7.4	1.4	0.3	0.9	0.8	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.1	3.8	0.0	12.7	0.3	0.7	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	0.3	1.6	18.3	1.9	0.4	0.8	1.4	0.3	0.4	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.1	0.1	1.4	0.2	0.0	0.2	0.3	0.8	0.3	0.2	0.3	0.0	0.5	0.6	0.6	0.0	0.9	0.2	7.4	0.6	0.1	5.7	25.9	5.4	15.8	4.9	6.3	4.0	6.3	14.5	4.8	3.0	3.4	0.0	1.0	2.1	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	19.8	0.0	0.2	2.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	5.7	0.0	0.7	0.0	0.6	19.4	3.1	0.3	0.1	1.9	0.0	0.0	0.0	3.7
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017655	Supported		Approved	Vesicles		NA	NA		28000	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	15.0	21.9	19.8	25.7	15.3	20.3	27.4	15.2	18.5	14.7	15.7	17.0	18.8	17.9	13.3	12.7	14.4	21.0	14.5	12.8	13.0	14.4	19.9	26.0	16.2	12.2	14.7	26.5	30.4	25.2	19.3	20.6	17.6	20.2	18.0	19.5	13.7	14.9	12.2	26.1	16.1	14.5	26.9	19.1	18.7	15.8	17.0	15.8	9.3	30.7	16.7	16.7	9.7	8.0	15.9	9.5	4.4	10.7	6.8	9.3	12.9	16.3	11.2	14.2	18.1	16.6	15.0	14.3	10.2	16.0	18.5	12.5	15.9	10.9	15.1	15.7	11.4	7.3	13.6	19.6	3.8	5.1	8.4	8.0	6.4	11.6	4.4	16.7	11.1	16.6	13.5	14.5	24.9	14.6	12.4	5.8	14.6	17.2	4.2	6.4	5.4	9.5	12.0	4.7	6.4	16.3	4.8	13.0	11.1	13.0	12.4	5.6	8.2	11.0	33.9	6.0	6.3	18.0	18.6	18.4	20.8	11.0	11.7	4.9	20.7	24.9	5.3	18.6	14.9	6.0	13.7	8.5	9.5	10.0	9.7	8.3	9.1	8.0	6.7	10.7	8.3	15.9	4.4	6.9	7.3	6.5	6.8	15.0	19.8	20.3	27.4	14.5	12.8	16.2	12.2	20.6	15.8	17.9	34.6	17.1	9.5	5.8	30.2	20.4	7.6	14.7	28.4	14.0	13.7	12.6	0.0	13.8	6.9	13.7	17.8	23.3	14.7	13.0	12.7	14.2	16.3	10.5	10.5	44.5	16.6	11.1	11.0	15.7	6.6	15.2	11.8	12.6	15.2	18.9	18.1	11.9	8.1	3.7	34.2	12.9	12.3	20.7	21.1	4.8	16.9	15.0	10.5	13.9
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in all"		"RT4: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5000000			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.4	4.4	5.0	9.3	10.0	9.5	5.8	5.7	4.7	3.8	4.4	3.3	6.6	6.2	2.9	7.8	3.7	6.5	5.0	8.3	4.3	5.2	2.4	4.6	3.2	18.1	9.7	2.7	5.4	7.7	8.4	5.4	11.2	5.4	7.6	10.2	5.1	9.4	5.6	7.7	3.1	3.3	1.5	4.9	9.6	3.5	4.8	3.0	6.7	34.5	3.6	3.7	9.7	7.7	5.5	4.0	11.1	2.5	6.4	7.7	8.0	4.6	4.2	6.1	9.5	5.0	4.9	5.1	6.9	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5	14.9	7.9	6.7	4.8	3.3	6.1	4.8	12.7	5.3	10.3	7.0	3.9	6.4	21.6	5.1	13.9	5.4	99.9	0.0	11.3	5.7	4.9	39.5	1.1	120.9	5.5	9.5	15.5	11.6	7.0	8.7	2.6	5.1	5.0	6.4	67.4	4.8	7.4	54.7	5.3	50.1	12.0	12.9	4.1	20.1	18.3	3.0	2.7	4.9	41.0	12.3
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6 (putative)"	O75354	20	25195693-25226729	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		18000	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	12.7	19.7	21.8	11.3	46.5	6.7	12.8	33.1	49.1	9.8	31.3	12.1	12.8	31.6	9.4	10.1	9.0	12.5	18.3	27.5	24.9	25.0	13.4	12.9	11.0	7.4	15.1	29.2	16.1	25.6	11.7	20.5	13.2	15.4	25.5	24.5	9.0	36.8	9.7	15.1	6.8	32.2	9.9	8.2	8.3	24.7	16.1	10.5	9.4	10.4	6.1	8.3	10.2	7.1	7.2	17.1	3.0	16.0	8.8	17.9	12.9	20.7	32.9	9.0	17.3	11.4	14.3	19.4	17.1	12.4	14.8	13.7	17.6	16.1	12.6	25.8	16.4	29.0	27.2	11.0	26.0	9.9	7.7	9.8	10.2	5.0	39.7	17.1	13.6	15.8	13.4	14.5	18.7	14.2	10.9	11.9	12.3	13.3	22.0	11.0	19.9	12.7	8.4	5.7	17.3	25.8	7.2	28.2	28.8	18.6	13.0	14.4	7.5	4.7	28.9	76.8	8.7	21.1	11.5	12.8	17.3	18.0	14.2	20.1	13.8	11.1	5.5	12.4	9.0	32.5	0.0	16.0	3.0	12.7	10.7	17.9	6.1	11.4	10.4	17.1	7.2	12.2	10.6	0.7	8.8	4.8	12.0	10.6	12.9	21.8	46.5	33.1	49.1	24.9	25.0	15.1	29.2	15.4	10.5	17.9	31.6	13.4	14.5	8.8	16.7	4.3	28.1	8.1	7.9	17.4	9.8	53.2	8.3	33.5	18.1	5.8	66.6	0.0	35.1	18.5	10.3	22.0	3.5	13.0	22.9	23.8	32.6	17.2	15.4	46.1	19.0	16.9	10.1	17.2	55.2	3.9	28.8	57.5	39.6	11.0	7.9	6.5	5.9	3.2	9.1	5.3	50.0	8.4	60.2	10.1
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Group enriched"	"Detected in some"	6	"Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	1.6	0.0	0.2	0.1	3.0	0.4	0.0	0.0	8.8	1.4	0.0	0.3	0.9	0.2	0.0	0.1	0.7	4.8	0.2	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.7	0.0	0.0	19.2	0.0	0.0	0.0	0.8	0.0	0.0	107.0	0.0	6.8	0.1	0.0	1.0	0.0	8.2	0.1	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	160.6	0.0	0.5	49.1	0.0	4.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	12.7	0.6
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		1300000	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.2	14.4	21.3	23.6	15.7	16.2	24.0	19.6	16.7	23.0	24.4	27.3	25.7	40.3	11.7	13.1	30.1	16.0	44.7	30.8	33.6	21.1	26.6	60.8	17.2	17.8	21.5	33.7	16.0	14.3	21.6	27.1	39.9	11.7	21.7	32.6	70.6	25.9	20.7	14.5	35.6	22.6	46.6	44.2	17.0	29.7	39.8	57.0	18.4	16.2	22.7	20.5	27.2	21.4	25.4	20.6	27.2	21.7	15.9	15.6	18.7	13.5	21.0	25.8	35.6	44.0	16.4	39.7	23.1	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7	17.9	17.5	28.9	32.0	40.9	17.7	16.9	2.5	14.7	26.1	14.0	33.4	35.3	19.9	22.6	9.1	20.1	11.8	0.0	20.8	29.3	16.6	18.9	7.0	17.1	21.0	4.8	12.6	16.5	18.7	2.2	16.1	16.9	11.8	17.2	15.1	12.9	24.5	10.5	17.0	11.3	25.4	12.9	25.0	50.8	27.2	40.1	21.4	17.5	20.8	38.9
GFM1	"EFGM, EGF1, GFM"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644278-158692575	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	20.1	23.3	17.6	14.1	18.6	14.7	19.8	32.8	23.4	11.4	20.7	17.8	19.1	18.8	15.4	17.9	16.2	14.3	12.6	27.9	18.0	17.9	34.1	42.2	13.5	13.2	18.9	19.5	13.2	17.0	30.9	16.4	17.4	22.6	15.3	23.3	13.8	16.3	15.4	46.5	15.4	16.0	16.0	18.5	14.2	17.1	19.8	17.8	14.5	21.4	17.6	13.6	15.0	13.2	13.2	16.5	10.8	19.8	16.0	21.1	11.5	30.1	17.3	8.4	10.2	13.5	8.8	11.3	15.6	13.6	21.8	17.1	23.1	18.6	25.9	19.8	11.6	10.4	18.4	18.8	14.5	24.4	14.3	12.7	21.5	11.9	12.8	15.4	27.6	11.7	12.2	17.2	14.1	13.1	6.2	14.6	14.4	22.3	15.9	19.8	16.7	16.2	11.0	19.1	32.4	11.7	15.7	10.1	41.7	17.4	12.7	15.3	14.8	24.6	33.4	26.5	7.0	41.1	22.5	10.7	14.6	7.2	22.8	24.6	30.6	19.3	47.1	13.8	23.2	16.3	10.8	13.2	9.1	16.1	19.8	21.1	13.2	15.0	16.9	16.5	11.9	17.6	18.5	1.9	16.0	14.0	8.6	11.9	11.5	17.6	18.6	32.8	23.4	18.0	17.9	18.9	19.5	22.6	17.8	17.9	14.7	27.9	22.5	19.2	53.1	51.8	17.8	28.1	12.5	12.2	29.5	26.9	10.0	16.6	12.5	28.9	18.2	23.3	21.6	15.7	18.2	17.8	18.5	53.5	25.1	14.3	18.6	25.8	22.5	5.7	21.0	23.4	16.9	31.5	21.4	25.3	16.3	5.8	15.9	31.0	49.5	12.9	21.9	25.1	32.1	18.3	25.7	20.0	24.7	18.2
GFM2	"EFG2, FLJ21661"	ENSG00000164347	"G elongation factor mitochondrial 2"	Q969S9	5	74721204-74767371	"Predicted intracellular proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.7	23.8	14.7	8.7	22.4	12.1	13.1	14.2	24.8	10.7	12.8	12.7	17.8	8.3	12.3	16.8	13.0	21.6	8.7	29.5	18.5	15.6	21.9	30.8	9.1	10.3	13.8	18.1	11.6	12.9	19.8	24.9	12.9	20.4	12.5	15.3	11.6	15.7	11.2	26.4	10.5	10.3	10.4	11.7	10.3	16.3	13.7	10.4	18.0	12.3	12.8	14.2	12.3	12.6	8.3	6.1	17.1	9.8	15.6	7.4	4.6	19.4	16.6	14.0	26.6	10.7	14.5	14.3	21.4	13.0	21.9	23.4	18.2	12.7	20.1	22.9	11.3	34.4	16.3	28.2	29.9	28.5	17.7	16.6	11.9	16.8	12.4	13.6	11.6	13.1	16.3	13.4	17.3	20.8	15.6	14.8	19.9	19.9	16.8	24.8	10.9	16.0	7.1	5.8	7.2	15.1	20.1	22.9	22.9	16.0	12.4	23.7	12.8	24.7	19.0	21.1	15.9	16.5	20.2	11.8	8.4	14.4	10.6	13.5	9.8	18.7	20.4	12.8	16.6	12.8	17.1	6.3	8.0	6.6	6.5	6.4	8.3	5.4	7.2	6.1	7.0	7.4	7.2	3.3	15.6	9.8	4.0	6.2	4.6	14.7	22.4	14.2	24.8	18.5	15.6	13.8	18.1	20.4	10.4	11.9	11.7	3.9	6.5	5.4	9.7	10.0	5.1	69.6	6.8	7.0	5.9	15.7	18.3	8.3	5.7	5.8	7.8	23.3	4.6	13.5	5.0	5.3	2.3	19.6	8.4	15.9	5.2	6.7	9.8	1.4	6.6	5.5	8.5	25.2	8.9	12.0	7.6	8.6	7.1	8.4	8.0	0.0	5.2	15.4	9.5	6.0	13.4	4.6	9.0	6.5
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.7	6.2	3.6	1.3	1.9	7.0	3.4	2.0	3.3	4.5	13.2	2.6	1.2	2.7	1.7	3.8	5.1	3.7	2.8	2.6	3.0	4.4	5.2	7.0	3.7	1.4	3.0	12.6	2.9	3.2	3.0	1.6	4.5	6.4	8.1	8.9	2.3	1.8	3.4	3.8	6.5	4.5	2.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.8	4.3	5.0	6.6	4.3	2.8	13.8	5.4	4.2	6.2	2.1	3.7	2.2	2.5	2.3	11.0	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3	6.0	3.5	5.7	0.4	1.8	3.1	0.8	0.0	2.7	1.2	0.0	9.8	0.7	0.0	1.9	0.0	7.9	0.7	0.0	11.8	0.9	2.3	0.9	7.0	0.5	10.7	3.2	0.0	8.0	7.2	0.0	0.9	11.1	0.0	0.0	0.7	1.6	7.3	0.0	0.7	0.7	3.0	0.0	1.2	0.5	0.4	1.8	0.7	3.2	0.6	0.1
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		69000	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	32.7	25.9	12.8	13.3	8.5	12.6	8.5	14.9	20.7	19.6	17.2	20.7	30.5	14.1	13.6	13.6	19.2	28.5	17.6	22.3	13.7	9.2	26.3	35.3	10.7	31.4	16.1	15.1	12.0	12.0	17.1	18.4	11.5	8.1	14.9	11.4	24.2	9.7	17.5	15.0	17.8	43.9	21.4	37.0	26.2	17.1	17.8	37.0	26.8	10.4	19.4	22.9	11.7	41.1	27.3	5.9	17.1	25.2	10.4	22.0	12.3	14.4	31.4	14.5	18.2	26.7	10.2	28.0	23.9	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5	20.8	43.1	32.8	43.8	35.6	18.3	8.0	40.8	26.8	37.5	41.8	13.7	62.7	49.7	88.7	2.3	18.6	41.6	0.0	90.9	108.9	44.0	43.6	41.5	32.1	103.0	4.8	26.4	29.4	43.0	2.3	28.7	50.7	38.8	123.6	48.5	17.1	82.5	52.6	20.8	63.4	20.3	19.4	36.4	14.6	19.4	43.0	47.0	46.3	66.6	52.1
MTPAP	"FLJ10486, mtPAP, PAPD1, SPAX4"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Early spermatids: 194.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	10.9	12.7	9.9	10.2	12.4	32.8	11.1	12.4	16.1	9.6	9.9	7.3	6.5	11.0	10.4	7.0	12.6	9.5	7.6	11.5	7.8	7.2	10.6	11.1	9.4	10.5	11.9	13.0	11.4	18.9	9.5	7.2	10.0	11.4	8.0	12.0	8.2	10.7	10.2	22.3	13.1	10.0	14.3	9.0	9.3	9.7	10.6	8.3	6.7	11.0	12.4	10.5	11.7	9.1	15.6	22.9	18.4	24.4	16.9	17.1	8.3	14.2	14.3	9.1	13.1	9.0	8.5	11.8	10.0	3.5	10.2	10.7	15.1	20.1	20.4	7.1	6.5	9.4	16.9	17.5	11.6	12.5	10.3	13.7	20.7	13.5	15.2	9.4	13.5	16.3	8.3	10.8	11.4	6.8	5.7	11.0	19.2	22.3	16.1	7.6	11.9	16.2	12.0	6.1	10.8	7.7	16.4	16.1	19.0	9.4	9.5	15.0	12.1	9.0	9.4	13.9	8.9	9.1	8.7	10.6	10.8	13.9	15.0	11.0	3.6	8.7	27.9	9.2	24.8	3.8	16.4	18.5	18.4	16.2	24.4	17.1	15.6	15.4	15.6	22.9	13.1	16.7	16.8	3.0	16.9	18.1	12.0	15.5	8.3	9.9	12.4	12.4	16.1	7.8	7.2	11.9	13.0	11.4	8.3	8.9	6.1	9.7	10.8	22.3	0.0	15.3	5.1	10.7	11.4	3.5	0.0	12.2	16.6	7.7	194.2	12.0	7.8	0.0	7.9	9.8	11.5	8.6	4.7	12.1	12.7	0.0	4.1	10.4	12.3	17.1	11.2	11.5	8.5	10.8	13.7	0.0	8.4	0.0	15.6	11.0	0.0	12.9	11.4	21.9	17.2	21.8	9.6	9.6	16.6	14.0
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.5	31.3	4.1	18.8	5.3	6.2	14.0	13.6	6.0	13.7	10.6	23.0	8.0	26.7	15.8	8.0	6.8	24.7	17.0	20.4	6.4	13.3	45.9	12.8	19.3	20.4	8.6	15.0	11.7	9.0	11.7	20.1	10.0	3.7	9.1	15.4	20.9	12.3	5.8	16.9	17.5	5.9	18.8	6.1	16.4	22.7	6.9	17.7	3.2	15.7	8.7	16.7	13.9	9.7	9.2	2.7	9.3	6.1	11.7	11.9	10.7	11.1	38.8	11.1	7.5	10.9	11.3	17.6	15.3	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6	8.9	16.4	12.7	5.2	11.4	7.6	3.6	15.3	10.7	19.4	3.5	11.8	2.6	0.0	8.1	0.4	10.8	5.9	0.0	10.7	4.1	5.9	5.4	4.7	6.6	5.7	9.5	10.9	8.6	3.4	0.4	5.2	5.0	3.3	3.6	8.1	3.5	7.2	3.5	11.3	2.2	5.7	6.5	10.3	2.6	12.0	10.5	0.9	6.9	10.3	5.1
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	46.6	93.2	32.2	44.9	13.5	21.6	54.1	36.4	25.3	75.5	57.3	73.3	28.3	82.1	38.0	33.6	30.0	25.1	61.5	61.9	64.6	39.8	82.8	53.8	72.4	101.8	27.4	59.0	24.7	20.5	39.0	56.8	53.2	13.3	45.5	26.4	79.4	27.3	44.7	79.0	70.1	67.8	38.6	103.3	85.0	43.0	63.6	75.6	57.9	32.6	44.7	51.5	19.1	52.3	33.9	28.8	54.4	39.9	28.6	48.7	44.2	30.3	74.7	35.2	81.2	96.7	29.5	50.1	37.0	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3	29.8	22.5	33.5	67.6	117.7	287.4	27.7	63.7	36.1	59.1	68.0	269.0	166.3	127.6	180.3	23.8	58.6	14.6	46.7	172.7	210.0	82.7	60.4	46.0	102.6	183.6	38.1	86.1	27.0	26.9	65.0	56.7	62.9	123.2	55.9	70.8	61.6	165.1	38.6	55.2	140.8	268.7	12.9	66.0	19.8	83.3	116.3	74.0	40.6	110.8	81.0
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 41.6;Basal keratinocytes: 34.1;Ciliated cells: 25.4;Club cells: 45.5;granulocytes: 20.9;Melanocytes: 21.9;Suprabasal keratinocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.8	29.3	19.7	35.5	16.7	20.6	8.5	13.9	31.2	5.4	7.2	6.7	4.9	14.7	10.6	6.2	10.6	7.4	6.8	8.0	23.0	17.0	10.4	31.3	7.8	18.3	16.9	18.7	8.1	24.1	6.5	11.4	13.6	21.5	6.7	5.7	7.7	23.5	4.7	10.1	8.2	10.7	11.7	11.0	11.9	14.8	5.8	5.6	10.0	8.6	17.9	12.7	9.5	7.6	19.6	37.6	1.0	21.1	14.6	21.9	16.2	29.0	2.0	9.4	34.6	8.8	4.5	7.4	23.0	7.5	6.1	3.8	3.8	19.6	17.0	24.1	11.8	15.3	18.1	9.2	14.8	4.0	25.6	13.8	14.1	3.5	7.3	10.7	23.8	23.5	8.1	11.1	7.7	11.0	14.3	9.7	17.0	11.1	22.0	3.8	4.8	58.2	16.4	28.2	34.6	2.9	34.5	23.1	50.3	7.1	3.8	30.4	17.8	12.1	52.6	26.4	14.4	53.8	40.4	19.4	38.8	28.3	37.6	47.0	37.7	40.7	33.1	22.3	17.2	33.3	0.2	15.1	0.3	15.0	21.1	21.9	19.6	14.7	16.1	37.6	18.4	13.7	16.8	1.0	14.6	11.6	25.7	13.7	16.2	19.7	16.7	13.9	26.4	23.0	17.0	16.9	18.7	21.5	5.6	14.9	41.6	0.0	0.0	34.1	0.0	1.7	0.0	25.4	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	20.9	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.3	8.1	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	45.4	0.0	0.0	0.0	0.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 115.1;Club cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	89.1	131.0	31.4	54.7	70.2	102.4	86.6	61.8	64.3	94.6	72.1	105.7	47.5	75.0	100.2	63.3	48.6	57.1	65.8	84.3	78.0	90.4	194.5	63.0	91.4	153.0	76.6	99.5	44.2	92.6	98.5	61.0	107.4	67.1	56.3	53.7	86.3	50.6	68.1	158.5	49.8	124.4	46.7	205.0	201.3	47.8	104.0	119.7	102.4	112.7	71.5	44.3	38.0	95.6	92.8	61.7	65.9	76.3	57.1	91.3	66.0	64.8	98.2	88.4	114.8	85.9	49.3	50.7	45.7	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4	26.8	56.3	13.7	6.1	12.9	0.9	0.0	22.9	115.1	150.2	5.2	0.0	10.6	31.5	37.0	0.4	14.4	5.6	23.3	30.1	24.4	10.8	3.7	39.5	37.1	14.9	0.0	14.0	31.9	41.2	1.1	23.9	13.6	10.1	88.4	24.3	0.2	47.4	14.0	12.0	26.2	0.8	6.5	5.7	0.5	5.0	13.0	7.3	18.1	29.3	6.8
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7900000	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.7	0.2	9.6	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	14.0	0.1	19.2	0.9	1.2	10.0	0.6	3.8	0.1	13.7	31.3	0.0	5.5	5.5	5.2	2.3	4.4	6.4	3.5	1.2	0.7	2.3	2.5	0.1	4.7	1.9	1.2	17.0	0.2	4.6	12.5	2.3	9.5	6.5	0.1	18.3	2.0	0.5	13.7	10.6	20.7	15.6	1.7	0.5	14.9	5.6	8.7	2.6	9.7	8.3	4.6	5.0	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6	32.8	63.8	51.1	124.1	64.5	115.4	25.8	76.5	58.9	55.7	120.4	56.9	65.8	51.4	53.1	16.8	69.7	85.0	0.0	33.3	35.7	82.8	109.1	50.7	52.9	65.1	62.0	130.1	72.4	57.8	13.2	138.4	78.5	77.6	175.9	94.2	102.4	38.5	89.7	119.9	123.2	117.3	116.4	86.4	1.4	41.7	57.3	38.6	61.8	96.6	69.8
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	50.4	44.8	61.6	18.0	31.6	10.0	23.7	28.6	35.9	30.9	33.6	29.3	0.5	17.9	37.8	13.0	0.6	24.2	25.5	10.6	20.3	36.2	24.4	6.9	44.9	34.0	17.8	9.0	40.6	13.4	22.0	2.1	25.9	23.0	35.1	25.3	4.3	26.7	41.3	15.5	22.4	45.7	12.3	11.2	78.4	10.0	12.7	24.9	0.2	13.1	71.0	6.0	0.4	22.1	17.2	30.0	41.8	28.7	25.7	37.4	17.1	5.9	0.5	0.3	13.3	11.2	3.2	29.6	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9	0.0	11.5	29.0	48.4	28.6	13.9	34.0	35.7	4.0	4.5	55.8	2.0	59.9	212.2	109.2	3.5	43.9	11.0	186.9	35.0	20.4	74.3	109.3	29.9	119.9	107.7	7.9	43.4	47.9	41.0	14.6	82.6	23.2	59.1	66.7	34.5	18.6	75.4	17.3	89.1	59.0	5.4	51.8	95.1	1.4	43.5	21.5	18.2	14.9	56.3	48.5
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115172-138139443	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.1;testis: 36.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.3	5.2	12.3	0.6	18.4	0.3	3.7	3.5	13.9	7.1	1.2	3.9	4.7	0.5	4.1	18.2	1.0	28.1	6.8	2.9	12.0	10.7	15.4	0.6	3.6	0.6	9.4	9.9	4.5	3.5	12.1	8.9	0.4	13.1	4.2	1.1	4.8	3.1	3.9	0.4	0.4	0.5	2.6	4.2	0.4	2.2	36.2	4.8	0.0	9.6	0.3	0.4	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	0.0	0.0	0.0	0.6	0.4	0.6	0.2	0.1	1.5	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	1.9	0.0	0.8	0.0	3.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	25.6	0.0	5.9	2.2	0.0	0.7	3.8	1.5	0.5	1.3	0.0	0.6	0.0	0.0	0.8	0.4	0.6	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	18.4	3.5	13.9	12.0	10.7	9.4	9.9	13.1	4.8	6.0	6.9	0.0	9.1	0.6	11.4	2.8	2.5	327.9	26.1	31.4	13.7	0.4	72.9	18.8	516.0	3.4	0.0	0.0	3.6	0.0	3.2	7.9	0.0	0.5	0.1	6.4	5.2	1.3	0.0	184.0	8.3	0.7	10.1	1.0	2.5	15.8	5.2	0.0	13.1	66.5	21.6	0.0	1.0	142.0	20.4	0.3	0.0	0.0	1.1	5.6
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017909	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	11.7	12.2	7.0	14.4	11.0	7.7	13.5	9.2	10.9	12.2	12.0	11.9	14.6	13.5	16.1	13.2	16.1	16.3	8.8	13.7	9.9	6.8	18.0	17.5	11.1	12.9	9.2	10.3	14.5	20.6	12.1	13.3	22.1	8.8	13.2	12.7	13.5	20.8	17.6	20.1	10.3	13.4	13.3	7.1	14.2	13.4	9.0	8.2	12.6	17.5	14.3	15.1	13.9	15.7	26.4	23.5	43.3	22.7	23.0	25.8	14.3	17.9	11.2	15.3	11.1	12.5	16.8	13.7	17.6	13.6	25.9	19.7	18.7	15.8	18.1	9.2	13.7	24.3	6.3	13.7	19.4	15.4	21.6	13.3	11.8	15.0	15.2	16.7	14.9	12.7	13.7	21.3	23.0	27.4	12.4	13.9	13.7	19.7	14.0	9.7	8.5	12.5	6.4	12.9	12.7	14.7	7.4	13.4	15.2	13.0	15.5	4.7	8.1	12.0	13.2	15.7	12.4	14.8	13.9	12.4	5.1	20.4	12.7	25.0	16.6	22.4	16.3	9.7	19.8	11.3	22.0	20.1	43.3	25.8	20.7	23.6	26.4	24.2	21.9	23.5	24.4	18.7	17.7	22.5	23.0	22.7	21.1	19.4	14.3	7.0	11.0	9.2	10.9	9.9	6.8	9.2	10.3	8.8	8.2	26.8	20.2	17.6	7.9	4.4	12.2	9.2	20.4	44.2	21.6	8.7	13.7	42.3	33.2	22.4	1.9	8.3	11.2	0.0	26.1	34.3	7.8	7.3	9.3	8.3	29.6	9.5	4.1	6.7	6.7	1.5	10.9	12.4	15.1	29.7	8.8	14.6	25.4	7.0	6.7	12.8	12.2	12.9	7.4	9.1	13.2	3.6	16.5	13.8	12.8	5.9
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131795	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021581, HPA023632"	Approved		Supported	Cytosol		NA	NA		600000	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (7.66e-4)"	14.5	16.7	10.7	32.5	10.5	14.4	15.2	16.0	13.8	16.3	27.3	18.5	16.2	25.1	18.0	18.7	21.6	15.9	21.0	16.7	9.6	11.0	21.0	13.5	19.9	30.1	12.3	11.0	19.7	28.0	10.4	9.7	11.6	10.9	17.5	14.2	18.0	17.9	17.7	27.1	16.0	30.1	16.7	13.7	20.5	24.5	11.4	12.0	17.2	22.0	30.4	24.5	20.5	17.1	30.7	16.8	46.7	15.8	22.7	14.3	9.7	21.0	33.1	10.9	11.4	3.3	6.9	15.0	12.6	11.0	12.7	8.1	12.3	24.9	14.7	9.2	8.8	2.3	14.8	7.6	15.7	7.3	6.9	23.9	16.1	25.7	20.6	16.5	15.6	7.4	10.0	7.5	9.1	25.5	5.2	14.1	11.7	15.7	7.2	13.0	21.2	11.4	15.9	11.2	18.3	22.0	10.4	14.3	20.4	16.5	11.4	12.9	26.5	12.1	15.0	17.4	6.5	21.0	11.5	8.1	11.1	27.5	4.2	16.6	14.3	2.1	16.3	10.3	9.6	17.2	46.7	10.2	15.2	13.8	15.8	9.7	30.7	9.0	11.6	12.7	29.1	7.9	11.9	4.6	22.7	15.5	16.8	14.3	9.7	10.7	10.5	16.0	13.8	9.6	11.0	12.3	11.0	10.9	12.0	29.8	21.6	121.5	83.2	42.1	67.1	15.5	94.3	9.4	11.4	55.8	19.6	58.2	66.3	80.9	1.6	21.2	215.1	0.0	106.1	86.7	57.7	61.8	46.1	34.2	66.0	39.7	61.5	16.5	50.0	3.3	55.0	59.6	55.6	144.3	82.5	46.3	97.1	133.3	44.6	119.5	63.7	32.3	67.0	20.7	54.1	38.8	26.1	67.1	96.4	63.4
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA050283, HPA054158"	Supported					NA	NA					"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 52.6"	"Group enriched"	"Detected in some"	90	"Early spermatids: 137.7;Late spermatids: 218.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	52.6	0.1	0.1	0.5	0.1	0.1	0.5	0.1	1.2	3.7	0.0	0.1	0.7	2.6	0.4	3.2	0.7	0.3	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	3.5	1.6	0.5	0.0	2.2	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.6	0.1	0.0	0.0	0.2	0.0	3.3	0.0	0.5	1.1	0.2	0.0	2.9	0.1	0.2	0.6	0.6	1.6	0.3	0.7	0.8	0.1	2.9	2.4	1.2	2.6	0.4	1.5	0.4	0.7	0.7	1.6	1.5	1.0	2.9	0.5	1.0	0.7	2.0	2.5	0.0	1.2	0.0	0.1	0.0	1.3	0.0	2.3	0.1	1.3	1.3	0.3	1.2	2.6	2.2	0.0	0.7	0.1	3.7	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0
NT5C1B-RDH14		ENSG00000250741	"NT5C1B-RDH14 readthrough"		2	18555545-18589564	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	74	"testis: 49.4"	"Group enriched"	"Detected in some"	76	"Early spermatids: 43.1;Late spermatids: 43.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"TIME: 1.1"									HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103088017-103193306	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA					"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	15.0	17.0	17.6	18.2	21.2	31.6	19.7	22.5	19.6	17.5	20.7	25.4	24.5	10.9	24.6	19.6	38.6	14.8	17.0	16.5	16.7	20.7	19.6	15.5	18.8	16.8	21.8	17.3	24.8	19.4	18.7	29.5	16.9	29.1	22.9	17.0	26.2	67.2	21.6	41.6	11.7	13.9	20.4	19.1	20.5	15.9	21.7	14.5	29.7	39.2	16.3	31.5	21.1	31.1	6.7	9.7	23.8	14.5	10.5	8.7	7.1	50.7	20.7	14.4	32.3	12.7	14.1	8.3	25.5	24.8	12.4	12.9	15.0	40.7	24.3	19.8	17.6	10.8	26.0	9.5	13.1	14.6	14.6	8.9	17.5	8.8	14.5	22.7	25.3	8.7	21.7	14.6	10.8	17.5	30.2	11.4	11.8	11.3	17.0	21.5	30.0	22.6	32.8	13.6	15.5	25.6	36.9	12.4	7.0	17.8	29.0	4.3	10.8	13.4	10.6	20.0	20.4	16.1	19.7	11.6	9.9	10.0	14.1	18.6	14.9	24.7	32.6	10.0	29.3	2.8	19.8	11.7	23.8	8.1	11.9	8.7	6.7	7.0	6.5	9.7	4.2	6.0	6.2	21.4	10.5	14.5	7.3	6.5	7.1	17.6	21.2	22.5	18.0	16.7	20.7	21.8	17.3	29.1	14.5	77.4	27.5	10.4	26.3	6.5	19.9	2.4	20.4	32.1	67.1	26.2	43.2	16.3	10.0	27.7	82.0	15.7	21.6	0.0	22.4	10.0	11.0	32.1	8.1	14.9	17.8	44.5	11.1	12.3	30.0	49.8	23.0	20.7	25.3	13.6	16.7	78.8	41.7	14.2	12.7	13.9	53.0	32.3	12.6	23.0	21.5	6.6	29.3	16.6	13.3	73.2
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.3	10.5	9.8	8.7	7.4	6.5	7.9	15.7	10.3	10.7	14.6	6.5	40.6	36.1	9.1	9.2	18.7	21.9	10.5	10.4	15.9	5.6	13.5	16.4	12.4	9.4	7.9	19.5	13.6	7.2	9.3	11.7	23.5	6.5	7.0	12.4	14.1	9.6	13.2	9.8	7.2	30.6	10.0	17.3	9.2	9.6	8.9	21.3	34.1	15.1	10.5	13.1	10.3	19.4	24.6	8.6	12.9	10.9	6.1	9.1	8.2	15.5	20.5	19.3	22.0	17.7	7.5	12.1	14.2	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9	20.8	10.7	82.5	30.5	41.6	22.0	14.0	30.6	37.5	27.3	15.7	39.3	30.8	24.9	25.8	3.2	34.9	102.1	46.7	70.0	25.2	31.9	27.6	17.3	16.3	22.9	1.6	114.8	20.3	26.5	3.6	31.4	25.2	25.3	17.2	74.0	23.6	44.1	98.2	20.8	48.5	23.5	12.9	27.8	30.9	17.2	34.0	23.7	34.5	50.5	60.6
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825181-41836263	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA					"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	10.0	12.4	15.9	8.3	26.2	3.2	18.3	22.8	31.2	11.6	15.6	8.4	10.1	4.4	14.1	21.3	13.9	12.6	11.5	11.4	15.0	14.9	19.2	19.4	11.0	7.9	12.9	16.4	15.5	19.6	21.1	13.7	11.5	13.2	12.6	13.8	12.6	15.9	20.1	7.8	8.6	8.1	22.1	6.7	7.7	12.0	24.8	9.8	1.4	37.8	5.6	10.7	13.3	9.7	5.3	5.2	2.5	5.6	1.0	5.9	4.1	8.6	13.0	22.2	29.2	20.4	17.3	3.1	8.7	25.4	27.8	27.8	10.6	5.1	13.0	4.5	17.8	17.4	8.4	22.0	12.3	45.2	6.4	8.7	7.9	13.5	11.2	13.6	0.1	3.3	12.2	11.8	23.5	19.2	20.9	16.1	10.4	7.3	8.1	19.6	5.1	12.6	3.0	5.9	17.2	1.9	10.8	29.6	12.0	12.1	9.4	13.6	7.0	13.1	47.0	4.6	28.9	12.7	4.7	11.0	8.6	6.7	14.3	17.9	1.6	6.6	6.3	11.2	0.2	10.5	1.5	5.6	0.5	3.8	1.0	5.8	4.7	5.9	5.1	5.2	5.3	5.4	4.5	2.5	1.0	0.7	2.7	0.8	4.1	15.9	26.2	22.8	31.2	15.0	14.9	12.9	16.4	13.2	9.8	8.9	15.0	15.7	49.4	16.1	30.4	11.2	7.6	14.7	7.9	27.9	17.7	35.2	86.2	47.9	69.9	21.5	2.5	0.0	36.0	48.9	37.1	35.6	11.5	19.7	11.9	109.7	37.8	19.0	7.9	92.8	30.0	17.0	33.7	5.4	12.5	29.9	37.1	12.9	28.7	45.0	27.3	38.8	52.0	135.0	29.1	15.1	26.1	13.8	14.0	38.3
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 14.9;Erythroid cells: 23.3;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 10.1;U-266/70: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain					NA	NA					"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	2.6	1.8	7.2	2.0	7.4	9.4	2.1	8.8	11.8	3.3	2.8	3.7	3.1	2.1	2.8	1.9	2.7	3.0	1.9	6.6	5.8	5.3	3.3	5.5	1.7	1.7	5.5	3.9	3.8	1.9	2.9	5.0	1.5	5.7	3.3	1.4	3.5	2.7	2.7	27.1	2.1	2.2	2.0	4.1	1.7	1.3	7.0	2.0	4.2	1.7	2.4	1.6	2.6	1.7	0.2	0.6	3.6	0.0	0.0	1.5	3.1	0.4	0.9	0.4	3.5	2.2	2.4	1.6	0.7	0.2	0.3	0.5	0.0	0.2	4.0	2.1	0.0	0.7	0.0	0.2	0.1	0.0	3.4	2.2	2.6	0.0	0.3	2.1	0.7	5.2	1.7	1.8	0.3	1.4	0.7	0.1	10.1	2.2	0.0	0.0	1.0	3.3	2.9	2.2	1.1	3.1	2.5	0.3	7.1	1.2	0.0	4.4	6.8	1.2	0.2	3.1	2.7	1.2	1.0	0.0	1.1	1.3	0.3	0.9	11.1	1.4	0.6	0.6	0.5	2.8	0.0	0.0	3.6	0.1	0.0	1.4	0.0	0.1	1.5	0.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	7.2	7.4	8.8	11.8	5.8	5.3	5.5	3.9	5.7	2.0	0.0	0.3	0.0	1.7	1.4	5.8	7.2	0.0	0.0	1.2	8.7	2.0	0.5	14.9	0.2	0.8	0.8	0.0	23.3	0.5	0.9	1.0	1.2	0.0	1.0	1.2	15.9	1.2	0.6	0.3	3.6	0.6	0.5	0.0	0.0	0.6	3.5	0.0	0.0	1.1	1.7	1.5	0.0	0.9	0.9	4.1	0.4	0.5	0.9	0.2	0.4
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165325-12196144	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		660000	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	19.6	22.0	17.4	18.6	21.2	13.5	20.2	15.4	21.4	16.7	20.4	16.1	15.2	17.3	10.0	16.5	25.8	16.3	12.1	10.0	16.2	14.3	26.0	57.1	16.8	22.7	21.7	12.8	12.5	16.9	19.1	35.7	19.9	18.5	13.4	24.2	13.2	16.7	19.7	5.1	20.6	15.9	11.6	17.9	22.4	14.1	8.0	21.5	28.2	19.1	16.5	29.5	16.2	18.6	22.4	45.9	50.1	19.5	16.2	37.0	20.4	35.6	26.3	31.5	29.3	30.5	30.2	27.9	26.4	16.9	31.1	33.4	37.7	34.1	35.7	23.0	21.4	19.5	35.9	43.9	40.9	28.7	29.2	42.9	29.7	32.3	55.4	31.8	19.7	20.9	31.7	24.5	33.9	17.3	24.1	39.7	57.2	39.7	24.4	28.3	32.7	36.8	23.1	27.4	57.3	16.4	33.7	11.4	41.4	29.1	12.3	15.2	22.8	32.0	24.7	36.7	38.5	42.3	20.3	24.8	13.3	25.5	37.0	32.3	20.6	36.2	48.0	27.9	25.7	9.8	8.1	19.1	33.5	22.8	19.5	26.2	22.4	24.6	26.8	27.0	18.3	17.0	23.0	50.1	16.2	14.8	45.9	37.0	20.4	17.4	21.2	15.4	21.4	16.2	14.3	21.7	12.8	18.5	21.5	23.8	37.8	33.5	51.1	38.1	19.2	2.8	25.5	60.2	39.8	22.7	15.7	73.5	63.0	74.1	27.1	31.4	34.2	23.3	72.2	127.8	35.8	30.5	31.1	116.5	105.0	20.6	36.8	40.5	41.3	6.6	36.5	39.3	28.7	110.0	34.5	32.9	64.5	28.1	27.3	95.7	22.5	32.3	25.6	20.2	27.5	52.9	48.6	51.7	51.0	40.6
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422582-87459454	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9000	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	14.2	25.6	19.5	10.0	22.7	4.0	31.1	22.5	22.3	17.9	19.6	11.8	18.0	27.0	17.3	24.5	12.8	16.2	11.4	18.0	21.8	19.4	28.1	30.9	15.8	12.2	22.9	16.5	18.4	64.1	35.4	33.1	17.5	20.0	22.5	18.3	11.3	20.2	18.7	23.8	10.2	30.0	16.0	17.0	9.9	14.1	14.1	22.6	7.6	22.7	16.0	9.7	13.6	35.9	13.9	13.8	3.7	13.9	9.3	18.3	10.6	10.6	11.6	12.9	6.5	25.6	16.2	10.4	20.7	13.5	8.0	8.0	8.1	18.5	15.7	21.2	16.7	14.6	7.4	11.9	14.5	12.8	11.7	9.1	5.1	13.5	14.3	16.1	9.4	8.5	15.5	19.3	9.5	9.0	16.5	15.9	5.1	14.4	10.6	15.0	14.1	13.1	10.2	10.4	25.1	4.7	15.4	11.5	9.2	60.2	9.9	15.7	10.7	13.3	23.6	10.5	17.5	13.5	13.6	16.3	12.9	12.5	9.4	10.1	8.1	6.3	12.8	18.5	8.9	16.3	0.9	11.7	3.7	13.4	13.8	12.4	13.9	13.4	13.2	13.8	12.0	15.9	18.3	1.3	9.3	13.9	13.0	12.3	10.6	19.5	22.7	22.5	22.3	21.8	19.4	22.9	16.5	20.0	22.6	62.5	31.4	15.2	36.7	8.9	13.8	35.3	43.3	45.5	60.3	22.7	25.5	27.4	34.9	42.5	19.0	27.0	24.4	0.0	31.7	28.2	26.6	34.7	19.7	42.0	28.9	6.4	16.1	17.8	11.6	7.6	23.6	17.1	10.1	22.6	15.4	21.8	28.5	25.8	25.1	47.3	15.3	25.8	26.7	29.8	21.7	8.3	31.5	7.2	22.2	26.3
PAPD4	"FLJ38499, GLD2, TUT2"	ENSG00000164329	"Poly(A) RNA polymerase D4, non-canonical"	Q6PIY7	5	79612120-79686648	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054468			Approved	Cytosol		No	No			Cytosol		"HPA054468: AB_2682497"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.37e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.67e-3)"	25.4	21.1	15.8	34.4	22.1	42.1	27.9	20.9	30.3	23.8	22.6	24.7	22.7	19.2	34.4	28.1	22.0	20.7	23.3	16.5	16.5	14.6	20.0	25.3	25.6	34.7	19.4	20.2	29.6	21.4	18.0	23.1	25.7	17.2	20.6	23.3	23.8	21.4	28.3	21.0	25.5	25.4	23.1	22.2	37.4	21.0	26.0	21.2	33.8	24.9	21.3	29.3	22.6	21.9	20.2	19.5	22.3	22.1	19.3	29.9	15.7	11.6	8.1	9.1	14.3	15.9	18.5	14.6	14.1	21.7	16.6	26.5	7.2	13.9	21.8	7.4	15.6	19.6	11.2	11.6	15.7	19.0	16.2	10.6	12.4	10.1	11.2	20.7	18.3	17.2	16.3	17.1	11.7	22.0	16.2	14.0	16.0	14.1	16.1	18.2	6.3	20.8	23.6	8.4	8.9	5.8	18.7	9.1	24.3	16.0	16.7	6.0	10.9	11.2	12.3	22.1	15.0	10.5	29.0	12.8	9.0	6.1	8.7	15.6	17.0	14.1	21.6	15.8	19.3	12.5	22.3	19.1	18.6	18.2	22.1	29.9	20.2	19.9	19.9	19.5	16.2	19.3	19.8	17.3	19.3	21.7	10.7	20.2	15.7	15.8	22.1	20.9	30.3	16.5	14.6	19.4	20.2	17.2	21.2	17.9	15.6	14.7	16.3	26.1	21.3	0.0	12.7	24.1	14.8	0.0	21.6	23.1	0.0	0.0	7.5	20.4	16.9	23.3	0.0	18.7	18.8	16.8	20.9	23.2	29.3	31.8	13.8	33.2	52.9	6.6	17.8	36.5	15.1	0.0	17.6	17.1	0.0	20.9	25.1	0.0	33.2	12.9	12.5	24.2	15.0	27.5	28.1	35.0	18.4	20.3
PAPD7	"LAK-1, POLK, POLS, TRF4, TRF4-1"	ENSG00000112941	"Poly(A) RNA polymerase D7, non-canonical"	Q5XG87	5	6713007-6757048	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045487, HPA046742"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA045487: AB_2679346, HPA046742: AB_2679781"	"unprognostic (1.45e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.62e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (8.55e-4)"	13.5	7.9	9.6	13.9	11.1	25.8	16.3	22.7	12.3	15.1	16.6	10.6	14.8	9.5	13.2	8.0	12.2	11.3	11.4	8.6	10.7	7.3	9.7	19.9	13.2	14.1	14.8	5.8	18.5	13.3	13.2	12.2	10.0	9.0	11.6	8.3	10.2	17.0	10.6	10.4	16.7	13.1	13.9	7.9	14.8	10.1	11.1	11.7	25.4	11.3	11.3	11.6	12.5	34.9	1.9	3.8	0.7	0.7	0.5	2.3	0.8	16.5	11.2	13.8	17.0	10.0	9.0	19.9	11.3	14.1	14.1	16.0	11.6	9.3	12.1	8.7	13.8	15.8	12.3	11.3	8.7	13.0	13.6	7.2	6.2	35.5	6.3	6.2	9.3	9.4	6.1	7.6	15.7	10.1	10.4	8.2	9.1	8.3	16.1	11.4	9.1	12.6	12.2	7.5	5.1	8.8	11.5	11.8	3.1	5.6	9.5	13.8	10.5	26.9	13.1	7.7	7.8	7.9	5.1	7.2	16.9	17.8	14.7	15.7	15.4	6.3	10.7	11.0	8.7	10.4	0.0	0.7	0.7	2.1	0.4	2.3	1.9	1.7	1.6	1.2	1.5	1.9	1.7	0.4	0.5	0.6	3.8	1.8	0.8	9.6	11.1	22.7	12.3	10.7	7.3	14.8	5.8	9.0	11.7	6.0	20.8	6.7	8.4	29.1	16.5	0.0	7.6	4.0	9.1	0.0	35.3	4.5	0.0	0.0	9.6	8.2	7.3	0.0	0.0	3.5	14.1	9.6	4.7	13.2	5.8	14.3	4.7	16.0	5.7	2.8	6.1	7.6	3.3	0.0	8.1	7.8	0.0	6.2	8.5	0.0	24.9	0.0	14.7	6.3	4.9	22.6	4.7	6.9	7.6	8.7
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001788	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	35.8	43.4	49.1	45.7	51.6	54.5	39.7	61.2	60.5	41.0	45.1	25.2	45.6	34.9	43.8	48.3	42.0	38.7	35.6	71.8	46.3	39.6	40.0	50.2	37.1	44.7	48.1	39.7	58.2	52.9	50.2	68.7	54.5	45.6	45.1	45.8	24.0	39.2	45.5	46.4	35.5	45.5	38.9	41.9	50.9	40.4	53.0	55.7	53.0	54.8	34.8	49.6	44.9	119.5	26.4	23.0	39.0	23.5	25.2	23.4	19.8	32.2	31.1	40.0	40.1	29.0	32.8	91.1	29.5	31.9	35.1	33.8	35.9	33.3	43.6	34.0	34.5	31.2	27.9	13.0	40.6	63.0	36.0	21.2	35.2	23.6	35.2	30.0	46.0	35.7	29.9	35.6	39.2	35.1	34.3	39.2	22.1	33.0	40.0	33.8	46.9	36.1	23.3	27.3	52.6	35.4	38.5	48.8	25.3	35.0	51.4	41.2	27.3	39.4	30.9	28.7	47.0	43.8	40.6	31.2	24.8	19.8	27.9	35.9	31.6	47.2	38.5	40.1	35.3	41.5	39.0	19.7	32.7	15.5	23.5	20.4	23.8	19.6	22.6	23.0	26.4	23.4	21.8	27.4	25.2	22.6	15.2	18.7	19.8	49.1	51.6	61.2	60.5	46.3	39.6	48.1	39.7	45.6	55.7	74.5	97.8	147.6	322.5	204.0	74.0	149.1	91.7	188.7	112.6	80.3	90.3	292.7	155.9	102.9	458.6	132.1	96.5	93.5	118.9	339.8	138.5	332.8	134.9	110.0	138.1	60.4	112.4	76.1	123.0	196.9	89.2	135.9	160.3	140.7	124.7	87.2	118.9	101.7	75.7	103.9	102.5	103.5	150.3	203.7	195.7	216.4	866.4	116.1	134.7	394.8
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857733-4861994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 67.3;Late spermatids: 69.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"							HPA047285			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047285: "					"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.7	0.0	0.5	16.1	2.3	0.6	0.2	0.0	0.0	0.3
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756230-60802085	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	12.3	9.5	11.6	11.6	11.9	5.8	9.9	19.4	15.3	10.2	8.2	9.8	7.8	6.8	12.1	6.2	10.1	9.0	10.2	8.5	15.1	10.1	8.6	6.9	9.4	14.8	10.9	11.3	17.1	9.9	13.3	18.9	11.8	12.5	9.6	9.2	7.7	11.1	8.7	13.1	11.7	9.7	9.9	21.0	15.0	9.1	14.2	11.0	23.1	27.5	6.6	14.3	10.9	11.1	6.1	3.7	13.2	6.9	9.4	9.7	4.1	5.2	4.9	9.2	7.4	11.8	8.9	8.8	5.8	5.7	5.0	5.3	8.3	4.5	7.5	6.1	4.4	6.6	8.9	13.0	5.5	9.4	13.0	6.9	9.6	4.7	5.8	7.1	10.0	6.6	6.7	6.5	6.0	12.7	7.6	8.0	7.8	9.4	7.2	5.6	4.2	11.5	6.9	14.5	7.7	4.5	9.4	16.3	6.8	5.4	5.0	5.4	7.5	9.3	5.8	5.2	10.7	3.8	6.1	7.5	6.4	7.7	4.8	5.4	7.1	4.2	18.3	5.2	11.4	4.6	13.2	4.1	8.7	6.7	4.3	8.3	5.9	7.2	6.0	3.7	6.1	7.9	7.3	10.6	9.4	6.9	3.3	9.7	4.1	11.6	11.9	19.4	15.3	15.1	10.1	10.9	11.3	12.5	11.0	11.9	9.8	4.5	13.0	11.1	5.7	6.3	5.1	8.1	10.3	8.7	23.6	5.3	3.3	3.9	4.3	9.2	4.3	0.0	3.7	3.5	8.2	12.6	12.7	4.0	6.5	4.8	2.4	10.4	11.6	3.3	6.9	12.4	11.8	7.2	5.1	5.1	3.6	5.8	8.1	2.4	10.1	25.8	8.2	23.3	14.7	13.9	7.3	15.8	3.2	12.0
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720452	"Enzymes, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.3;eosinophil: 62.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 62.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	13.5	7.4	24.3	14.4	28.5	11.1	25.2	16.4	32.2	26.6	10.0	45.0	9.4	7.9	25.1	22.8	18.3	24.9	13.3	7.7	31.3	23.9	16.7	5.1	22.0	14.7	29.7	21.9	15.6	24.6	15.6	15.5	8.5	38.2	21.7	12.7	9.5	32.2	14.0	3.3	24.5	8.5	17.0	59.9	9.6	30.4	8.1	25.5	14.7	10.3	11.0	24.6	16.5	13.7	8.5	9.2	62.2	10.2	4.6	6.8	5.8	10.5	9.7	16.4	20.4	20.2	25.5	13.1	13.5	25.4	13.2	17.8	14.8	15.3	16.5	8.6	24.7	10.2	13.3	15.5	26.7	17.1	38.8	11.7	19.3	21.0	33.0	11.1	29.2	33.4	21.1	13.8	15.2	12.5	32.2	29.3	21.1	4.2	32.2	37.0	16.2	23.5	9.0	17.5	11.4	10.8	19.8	25.9	4.7	19.9	14.7	18.6	26.9	14.0	21.1	16.5	21.8	12.5	4.5	17.3	16.6	17.1	11.1	11.3	25.9	17.2	15.4	20.1	22.4	26.0	50.3	8.9	62.2	3.0	9.6	3.5	8.5	4.0	3.4	9.2	4.1	2.5	2.9	9.4	4.6	10.2	1.8	6.8	5.8	24.3	28.5	16.4	32.2	31.3	23.9	29.7	21.9	38.2	25.5	89.3	19.8	21.5	31.5	28.4	13.4	6.5	30.6	113.8	69.4	54.1	9.8	17.1	14.9	29.3	5.2	17.4	7.0	0.0	40.0	37.0	49.8	27.9	41.5	8.1	53.6	28.6	22.5	20.3	50.0	3.7	16.7	46.3	57.3	35.1	18.0	37.3	29.6	7.0	24.1	21.2	13.7	25.8	22.7	16.5	14.3	35.8	7.4	11.8	15.1	20.1
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.7	1.2	0.0	25.7	32.8	0.0	35.4	30.3	21.6	15.6	0.1	0.7	0.0	1.8	89.6	0.6	1.5	2.6	2.5	24.7	0.0	1.9	1.6	2.6	0.0	38.9	0.0	0.7	11.6	0.0	12.4	1.0	26.0	17.9	0.2	0.0	16.7	15.1	13.5	0.0	0.1	1.4	0.8	4.6	0.0	0.0	0.0	22.5	1.6	0.1	0.3	17.2	0.6	0.2	2.5	2.5	0.9	22.4	7.3	4.3	24.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3	223.4	31.0	5.2	0.8	2.1	0.0	3.5	5.1	2.7	14.8	8.7	0.0	0.4	11.6	4.4	0.9	11.3	147.6	0.0	25.2	0.6	18.5	2.7	0.0	93.7	11.5	0.0	12.1	28.8	29.3	0.2	16.1	25.7	1.7	1.8	25.6	1.0	24.6	48.9	4.9	8.4	0.0	12.9	11.3	0.4	0.6	1.1	1.1	1.3	42.4	0.9
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165986603	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 15.9;Muller glia cells: 21.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.7;LHCN-M2: 14.0;RH-30: 8.2;RT4: 8.5;SH-SY5Y: 8.6;TIME: 14.5;U-2 OS: 7.9"	"Region enriched"	"Detected in many"	11	"basal ganglia: 307.0"	"Group enriched"	"Detected in all"	4	"basal ganglia: 155.2;cerebellum: 80.7"	"CAB045998, HPA047200"	Supported					NA	NA					"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	3.1	1.9	1.7	1.0	36.8	0.0	3.4	4.5	6.9	2.2	1.0	1.1	4.3	0.8	2.9	7.5	0.7	3.1	3.2	3.6	2.6	2.1	8.8	0.9	4.3	1.4	2.7	1.1	3.4	0.8	1.2	2.5	5.3	1.7	2.6	0.5	0.6	0.7	4.9	0.9	0.6	0.8	4.3	1.1	2.5	1.2	8.7	16.0	0.0	12.2	1.0	0.8	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	5.0	0.0	2.8	0.0	0.0	0.0	3.4	0.0	7.7	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	7.5	0.0	0.0	0.0	14.0	0.1	1.1	0.0	1.5	0.0	5.6	1.7	8.2	0.0	7.4	8.5	2.2	8.6	0.0	0.0	0.4	0.6	0.0	0.0	14.5	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	36.8	4.5	6.9	2.6	2.1	2.7	1.1	1.7	16.0	0.0	0.0	0.0	2.8	0.3	8.8	6.9	0.0	1.4	1.2	5.2	2.0	6.0	3.3	1.7	8.9	10.3	0.0	0.0	0.0	5.2	2.0	11.7	1.1	0.0	0.7	15.9	0.0	9.8	0.0	11.8	0.0	0.0	1.7	0.0	0.0	21.0	0.2	0.0	0.4	6.5	0.6	0.0	2.1	6.6	0.5	0.3	2.4	0.0	0.0	2.2
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623252-178072755	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Cushing syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 20.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;fHDF/TERT166: 5.6;HAP1: 3.2;Hep G2: 6.4"									HPA034560	Approved				"Intracellular and membrane"	NA	NA					"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.9	0.5	1.3	0.7	1.0	0.2	2.5	0.2	0.8	4.2	3.1	0.1	0.0	1.2	1.9	1.5	0.3	0.4	5.4	2.6	1.6	2.0	4.0	11.8	0.5	0.0	3.3	0.0	0.5	7.8	9.8	13.6	0.0	1.2	20.8	0.5	5.6	8.5	1.2	7.5	0.3	7.6	1.7	5.6	0.1	0.4	3.8	0.0	0.1	13.2	0.7	0.1	0.6	0.3	1.0	0.8	2.2	0.9	0.9	0.7	0.2	0.1	1.0	0.5	0.2	0.2	0.0	0.2	2.5	0.4	0.1	0.9	0.5	3.8	0.1	1.6	5.6	0.6	0.2	3.2	0.1	0.1	0.0	2.0	2.4	0.2	6.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.1	0.4	0.6	0.9	0.3	1.3	0.1	0.7	0.5	0.1	0.5	0.0	1.1	0.1	0.7	1.7	0.0	0.2	0.4	0.5	0.3	0.0	0.0	0.3	0.6	0.2	0.3	0.5	0.0	0.0	1.0	0.1	0.2	1.6	0.7	1.1	0.7	0.6	0.5	0.7	0.6	0.7	0.4	1.0	0.6	0.7	2.2	0.9	0.9	0.8	0.7	0.2	1.3	1.0	0.2	0.7	1.6	2.0	3.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.0;kidney: 37.1"	"Group enriched"	"Detected in many"	6	"Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9"	"Group enriched"	"Detected in many"	6	"amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8"	"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	7.6	3.9	13.8	3.6	11.5	0.5	4.1	66.0	25.3	11.5	8.8	6.2	1.7	2.6	7.3	6.7	4.7	7.4	18.2	11.8	12.6	4.1	37.1	3.2	3.1	1.8	7.1	15.7	9.2	2.0	1.3	2.3	1.3	6.9	3.8	5.6	3.0	1.8	4.8	2.4	2.1	4.6	11.8	10.1	2.6	4.6	24.6	9.0	0.0	35.1	2.6	1.1	8.3	9.0	0.0	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.1	2.3	0.0	22.8	1.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.2	0.0	13.5	0.0	0.0	28.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.8	11.5	66.0	25.3	12.6	4.1	7.1	15.7	6.9	9.0	0.0	1.6	0.0	2.2	1.1	12.6	3.6	0.0	0.0	2.3	26.2	0.0	0.1	157.5	0.3	314.8	5.8	0.0	0.0	0.3	0.0	1.9	2.0	0.0	0.0	0.1	0.0	0.0	8.0	0.0	455.7	13.8	0.2	0.0	0.0	0.6	0.2	0.2	0.0	7.8	1.4	1.1	51.8	47.4	4.4	3.9	1.1	0.0	0.0	0.0	0.7
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Kupffer cells: 11.5;Sertoli cells: 12.9;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;HL-60: 6.4;HMC-1: 12.3;NB-4: 8.1;THP-1: 7.8;U-937: 6.5"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced					NA	NA					"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.5	0.3	4.7	0.0	0.0	0.0	6.4	12.3	0.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.9	0.0	0.0	0.7	8.1	3.4	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.5	1.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7	0.0	0.6	0.0	0.2	0.9	0.1	3.1	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	4.8	0.3	0.0	23.3	0.0	0.0	0.4	0.3	0.0	0.0	7.3	4.8	1.7	0.0	11.5	3.4	2.0	5.2	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.1	12.9	9.5	0.9	0.5	0.4	0.2	1.5	0.0	0.1
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32299329	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.6;heart muscle: 56.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.9	2.7	10.6	3.2	27.7	0.9	5.1	2.4	17.1	1.2	2.7	30.1	0.0	2.3	3.1	6.8	7.4	8.4	2.4	56.2	14.8	7.5	4.0	1.0	5.0	1.4	31.1	12.0	4.9	2.7	1.3	1.3	4.0	16.3	2.9	2.7	7.9	2.6	4.2	1.4	0.9	2.8	10.4	17.1	1.4	3.8	4.2	33.6	0.0	3.9	0.2	1.0	7.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.2	0.1	0.0	15.2	6.2	7.2	5.9	0.0	0.0	0.0	0.0	49.0	0.0	0.4	0.0	0.0	9.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	10.9	0.6	0.0	1.5	0.1	15.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.1	3.0	0.1	26.5	0.0	0.0	0.0	0.7	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	27.7	2.4	17.1	14.8	7.5	31.1	12.0	16.3	33.6	0.0	0.0	0.0	0.8	0.0	55.0	112.6	0.0	4.0	1.2	1.8	49.1	0.0	0.0	5.6	40.4	2.9	0.0	0.0	0.4	0.0	0.0	0.2	8.1	0.0	0.1	3.2	0.0	0.0	0.0	38.3	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	4.4	0.0	2.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0;lymphoid tissue: 65.4"	"Group enriched"	"Detected in some"	6	"Endothelial cells: 33.1;Intestinal endocrine cells: 33.1;Ito cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.7;T-cells: 9.6"	"Cell line enriched"	"Detected in some"	8	"HeLa: 107.5"					"Group enriched"	"Detected in all"	5	"amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	27.8	18.4	30.4	3.0	34.2	2.5	25.4	1.0	48.0	8.9	7.7	3.8	1.9	3.5	9.4	4.9	10.2	11.6	12.0	11.3	18.0	6.1	7.0	10.4	5.1	3.8	3.8	27.0	3.4	2.4	4.4	3.4	6.6	6.7	4.8	5.2	3.0	2.3	6.3	6.6	4.8	4.2	10.3	2.1	65.4	4.2	2.9	7.4	0.1	7.0	3.9	2.2	8.3	11.2	3.7	1.2	0.2	1.0	0.1	9.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	107.5	0.1	0.2	0.0	1.6	0.0	0.2	0.5	4.4	0.2	2.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	2.9	0.0	0.0	0.2	0.0	0.0	9.6	0.5	0.0	0.0	0.4	0.1	0.0	0.0	13.7	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	9.6	1.0	5.6	3.7	5.7	5.6	1.2	2.5	3.7	3.0	0.2	0.1	0.5	0.0	2.3	1.9	30.4	34.2	1.0	48.0	18.0	6.1	3.8	27.0	6.7	7.4	0.0	0.3	0.0	0.0	2.3	2.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	33.1	0.0	0.0	0.0	0.2	0.9	0.1	1.1	0.9	0.5	1.6	33.1	118.4	10.0	1.5	0.3	1.0	1.7	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.4	0.0	4.3	1.4	0.8	2.5	0.0	0.0	0.0	0.3
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20369245-20684381	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		23000	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	7.1	1.0	1.7	4.7	2.0	0.0	3.8	3.5	1.4	7.8	15.9	1.0	2.0	2.1	7.8	3.5	9.1	4.9	5.5	62.2	1.6	1.4	3.7	1.8	3.9	3.3	1.9	1.1	7.1	6.5	1.0	2.8	13.8	2.7	6.3	9.0	12.0	7.8	4.2	2.0	1.4	21.4	6.0	1.8	2.1	5.5	2.3	0.7	0.0	2.8	1.9	0.9	4.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.9	0.0	1.8	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	39.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	0.0	0.0	2.2	0.0	0.1	14.8	0.0	0.0	0.0	3.5	0.0	0.0	0.2	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	3.5	1.4	1.6	1.4	1.9	1.1	2.7	0.7	0.0	0.0	0.0	0.1	0.2	41.0	107.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.2	2.2	24.6	0.0	0.4	0.0	3.5	0.5	16.2	0.0	0.5	49.3	4.1	0.6	0.0	0.0	1.4	0.0	1.7	0.0	7.4	2.5	0.5	24.6	0.7	2.6	2.2	6.5	51.8	0.2	0.4	0.3	0.0	0.0	13.9	0.2
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469631	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 31.8"	"Cell type enhanced"	"Detected in many"	13	"Late spermatids: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 22.0;NB-4: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	6.4	2.5	9.0	4.2	13.9	3.4	6.3	15.0	38.5	8.4	4.3	3.2	0.4	2.0	4.4	1.1	3.1	4.8	5.0	4.1	12.4	6.9	2.8	1.9	7.7	2.0	5.3	19.4	1.7	9.8	17.3	2.3	4.9	34.7	3.7	3.0	3.1	7.1	4.0	26.1	2.2	2.7	4.7	3.6	4.1	6.1	31.8	4.5	0.0	5.4	1.0	1.9	4.6	3.5	0.2	3.3	5.9	4.4	5.3	2.0	1.3	0.0	1.4	0.3	3.9	11.6	6.9	2.2	3.3	6.6	0.4	1.1	3.5	3.2	1.5	9.7	8.5	0.2	0.3	2.3	0.4	0.2	3.8	3.3	13.6	4.7	3.8	7.5	2.2	22.0	5.1	0.4	3.7	0.0	0.4	3.1	1.2	10.7	3.3	2.3	1.0	1.3	25.3	1.8	3.9	2.8	8.9	2.2	11.7	0.6	0.8	2.5	0.9	0.2	0.1	3.6	0.6	0.5	4.5	6.6	5.0	6.5	3.4	2.1	6.5	0.5	7.2	2.1	0.1	4.0	5.9	2.6	5.1	1.5	4.4	0.8	0.2	0.5	2.0	3.3	0.1	0.1	0.7	0.2	5.3	4.4	0.2	1.2	1.3	9.0	13.9	15.0	38.5	12.4	6.9	5.3	19.4	34.7	4.5	3.0	15.2	8.0	2.7	9.0	23.9	5.8	12.7	10.7	7.9	8.7	0.0	0.3	0.0	2.8	44.2	10.9	1.3	0.0	11.1	4.3	13.4	3.1	32.2	0.8	9.8	52.4	0.0	11.6	18.3	164.4	16.1	37.2	13.5	14.4	6.2	1.3	10.6	0.0	17.0	0.0	2.6	6.5	8.1	7.7	7.8	7.0	0.3	16.0	6.8	1.4
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 81.5;Horizontal cells: 108.1;monocytes: 104.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HUVEC TERT2: 36.6;NTERA-2: 22.2;SK-MEL-30: 22.0;TIME: 20.4;U-266/84: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.1	7.0	13.8	24.4	0.7	0.7	0.0	4.5	5.3	4.2	5.6	0.0	0.0	2.0	0.1	8.4	0.1	0.0	0.1	0.0	4.2	5.9	0.0	0.1	2.0	0.0	0.5	4.9	0.0	1.4	0.2	2.1	0.1	0.6	36.6	0.0	0.0	1.3	1.8	0.1	0.0	2.8	22.2	0.0	0.3	1.0	2.4	1.3	3.4	0.0	0.1	10.6	0.0	1.2	22.0	1.2	0.1	1.7	20.4	3.3	0.8	1.8	0.7	0.6	19.1	7.5	3.4	5.1	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9	8.9	16.4	50.2	24.5	18.0	35.4	29.1	0.0	2.7	12.5	5.2	0.0	5.2	0.0	0.5	7.9	23.2	0.0	0.0	0.8	1.6	9.3	81.5	14.0	1.6	12.6	108.1	4.1	12.3	25.8	5.6	0.3	42.5	49.0	104.6	1.2	12.2	0.1	0.0	2.5	1.6	3.3	0.0	10.3	0.1	0.7	7.0	4.7	36.2	1.1	5.7
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 28.6"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 141.8;Paneth cells: 179.9;Undifferentiated cells: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;Hep G2: 4.0;U-87 MG: 9.0"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		NA	NA			"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	2.0	1.3	1.8	1.5	2.8	1.0	2.0	0.8	6.1	4.1	4.4	1.5	3.1	1.5	6.4	6.8	1.3	4.2	5.6	4.2	1.6	1.9	4.1	2.0	4.1	0.5	1.7	5.1	2.0	0.8	0.3	3.5	7.0	2.8	5.8	1.3	2.5	1.3	5.4	13.4	0.6	4.1	3.4	0.7	2.3	5.2	2.6	1.1	0.4	1.2	28.6	0.7	1.8	3.3	1.3	0.6	3.5	0.7	1.0	0.7	0.2	0.1	0.3	0.2	0.3	0.1	0.3	6.0	0.1	0.0	0.2	0.3	1.2	0.2	0.2	0.6	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.4	4.0	0.2	0.2	0.6	0.7	0.1	2.6	0.0	0.5	0.0	0.3	0.9	2.1	0.1	0.4	0.2	0.3	0.2	0.4	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.8	0.3	0.5	0.0	1.6	0.5	0.3	0.0	0.4	0.2	0.7	0.1	1.3	0.6	0.2	9.0	0.2	0.3	3.4	0.7	1.0	0.6	0.4	0.5	0.5	0.5	0.4	0.2	1.3	0.5	0.7	3.5	1.0	0.4	0.6	0.3	0.2	1.8	2.8	0.8	6.1	1.6	1.9	1.7	5.1	2.8	1.1	3.0	8.8	0.0	2.2	4.8	3.0	28.1	5.1	0.0	1.2	0.0	5.9	1.9	0.0	0.0	29.1	3.6	141.8	0.0	0.0	3.5	4.2	1.8	4.6	0.0	0.4	0.0	6.9	1.3	2.2	26.0	0.6	1.1	1.7	0.0	34.4	2.7	0.0	179.9	3.9	0.0	3.3	45.3	13.4	1.9	1.9	3.3	0.9	0.0	66.4	18.4
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"A549: 25.3;AN3-CA: 29.1;HeLa: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	25.3	5.3	29.1	1.0	1.9	4.2	0.6	0.7	1.4	2.1	9.9	0.8	1.9	0.1	0.2	4.3	4.3	0.0	1.1	2.5	1.1	2.9	3.7	41.9	2.1	3.9	1.7	0.2	3.9	0.9	4.0	0.7	0.4	3.0	0.1	0.0	0.6	2.4	1.8	1.4	4.1	1.0	0.7	1.3	0.4	6.7	4.2	6.6	9.5	0.9	3.3	6.7	11.3	5.7	5.0	0.8	3.7	3.4	0.3	0.1	5.0	1.3	1.4	0.0	0.2	4.3	7.0	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8	29.8	76.9	9.1	30.5	9.4	13.6	32.7	10.2	22.7	48.9	40.1	68.7	9.2	10.0	0.5	16.6	12.4	16.7	0.0	1.6	14.8	13.1	46.1	21.9	0.8	4.3	1.6	32.0	14.1	6.0	29.3	1.4	9.4	10.1	4.6	18.4	16.1	5.4	10.5	4.6	17.7	52.1	0.0	5.3	0.5	7.1	7.8	2.6	37.3	10.1	21.1
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494395-119628991	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 98.6;Smooth muscle cells: 79.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		3100000	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	12.3	4.9	2.0	28.2	2.3	0.4	8.1	3.0	2.3	21.3	28.0	1.7	20.1	6.5	17.3	21.4	30.7	10.7	13.3	5.3	2.0	2.8	3.8	1.2	11.4	4.1	2.4	3.4	10.0	7.8	5.1	3.4	8.9	4.4	31.8	11.7	20.2	8.5	23.7	6.8	4.2	15.6	45.6	2.0	2.1	9.1	7.6	1.2	0.9	9.1	8.1	2.2	25.9	15.9	1.5	0.5	1.4	0.4	0.6	2.1	4.2	8.1	0.4	5.7	0.6	2.0	3.0	1.0	5.5	24.6	0.2	0.5	0.5	0.7	0.8	0.2	6.8	1.5	3.0	1.8	0.8	0.7	0.2	3.7	9.1	1.4	0.4	35.4	1.9	0.9	3.3	1.7	0.6	0.0	12.9	0.7	1.9	1.0	1.5	0.8	0.4	2.4	0.3	1.2	0.9	1.4	0.3	2.9	2.1	2.1	2.5	2.2	4.6	6.3	8.0	0.6	4.4	1.4	1.0	1.2	3.2	2.8	1.7	0.7	2.1	1.0	0.7	3.1	0.5	0.4	0.0	0.3	0.0	0.6	0.1	2.1	1.5	1.3	0.4	0.2	1.0	0.6	0.9	1.4	0.6	0.4	0.5	0.4	4.2	2.0	2.3	3.0	2.3	2.0	2.8	2.4	3.4	4.4	1.2	6.0	4.6	0.0	2.3	3.1	8.1	3.5	12.7	1.4	5.7	1.8	13.7	0.2	0.0	12.0	25.6	3.3	6.3	0.0	2.5	0.2	3.8	2.4	1.1	1.0	0.2	4.8	2.4	1.3	0.0	9.4	19.2	0.7	5.0	0.0	10.1	28.4	4.2	9.1	98.6	0.5	5.9	19.4	79.9	2.9	5.5	2.0	0.2	0.0	8.6	1.6
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857955-149944793	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 153.4"	"Cell type enriched"	"Detected in many"	12	"Rod photoreceptor cells: 2864.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"CACO-2: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA					"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.2	2.3	0.2	0.2	0.2	0.9	0.2	0.3	0.2	0.2	1.8	0.2	0.3	0.2	0.2	20.1	2.4	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.6	0.2	0.2	0.2	1.0	153.4	1.4	0.2	0.2	1.6	0.2	0.2	0.2	0.2	0.1	3.1	0.2	0.2	0.4	0.3	0.5	0.2	0.2	1.5	0.8	3.3	0.8	1.2	0.8	0.1	0.4	0.8	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.4	0.1	7.6	0.8	0.9	1.4	0.2	1.4	0.7	0.2	0.4	0.5	0.6	0.3	1.0	1.1	0.6	0.2	0.8	0.6	0.3	1.1	0.9	0.6	0.6	0.2	0.4	0.3	1.4	1.5	0.4	0.5	0.9	0.5	0.2	0.5	0.3	0.8	0.7	0.5	1.0	0.8	1.1	0.0	0.7	0.2	0.6	1.0	0.5	1.4	0.8	1.7	0.8	0.5	0.6	0.4	0.5	0.8	0.8	0.6	3.3	0.8	0.5	0.6	0.4	0.5	0.7	0.6	0.5	0.2	1.5	0.7	0.8	2.8	1.2	0.5	0.8	0.4	0.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	7.2	0.0	0.5	1.0	117.9	3.6	0.0	5.3	4.5	0.0	229.7	0.9	0.0	0.0	7.0	0.6	3.9	0.0	0.2	1.9	0.6	0.3	3.5	0.8	0.3	71.5	0.0	2.5	0.3	4.0	1.1	0.5	0.0	1.0	0.2	162.2	0.1	2.9	0.4	0.0	2864.0	0.0	1.0	1.1	0.9	0.5	2.4	0.5	0.9	0.1
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625584-670782	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 64.2"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 453.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12.0	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1.0	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0.0	0.2	0.8	0.4	0.2	0.3	0.2	0.0	0.0	0.5	1.4	0.0	0.1	0.2	8.0	0.2	0.7	0.1	1.7	0.4	0.0	0.1	0.0	0.6	0.2	0.0	4.1	0.1	0.3	0.5	0.1	2.4	0.0	0.5	0.7	11.8	0.1	0.6	0.0	0.2	20.5	0.2	6.5	0.4	0.2	11.1	0.2	0.4	1.4	0.9	14.0	8.2	0.0	0.3	0.1	3.3	0.4	0.0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10.0	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10.0	18.1	10.2	29.6	9.8	14.5	22.4	3.0	5.3	4.5	1.2	0.3	18.2	3.7	0.0	16.0	5.7	0.0	78.5	0.1	1.7	5.1	0.4	1.8	0.0	0.0	0.6	0.2	0.8	0.9	3.5	0.0	9.2	11.1	1.7	2.5	3.9	0.0	1.4	3.4	3.3	7.2	0.2	20.9	0.7	0.0	1.4	6.7	453.5	0.0	0.2	3.9	2.7	0.3	0.2	7.0	0.1	0.6
PDE6C	"ACHM5, COD4, PDEA2"	ENSG00000095464	"Phosphodiesterase 6C"	P51160	10	93612588-93666010	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 12.8"	"Cell type enriched"	"Detected in some"	18	"Cone photoreceptor cells: 53.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.23e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.81e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.19e-7)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.80e-3)"	0.4	0.6	0.3	0.4	0.4	1.3	0.4	3.0	0.7	0.8	0.3	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.3	0.5	0.5	1.0	0.3	0.3	1.0	0.3	0.0	0.8	0.3	0.3	0.7	0.0	12.8	0.8	0.3	3.1	3.1	0.7	0.3	0.3	0.9	0.6	0.7	0.3	0.3	0.6	0.3	0.3	0.4	0.7	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.2	0.7	0.4	1.4	0.0	0.1	1.0	0.8	0.0	0.0	0.0	0.8	1.0	0.6	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.6	0.5	1.4	2.4	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.3	0.8	0.0	0.2	1.0	1.6	0.8	0.1	0.4	0.6	0.0	0.1	0.0	0.2	1.2	0.1	0.2	0.0	0.1	0.5	0.5	0.3	0.2	0.0	0.4	0.0	0.2	0.7	0.6	0.6	0.6	0.4	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.6	0.5	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.4	3.0	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE6D	JBTS22	ENSG00000156973	"Phosphodiesterase 6D"	O43924	2	231732425-231786272	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 141.7;Late spermatids: 104.4;Spermatocytes: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037433, HPA037434"	Uncertain					NA	NA					"HPA037433: AB_2675475, HPA037434: AB_10672490"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (7.07e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (4.97e-4)"	9.5	16.4	24.4	11.2	23.8	9.2	11.8	20.6	22.3	11.0	11.4	21.6	8.4	9.7	11.4	11.5	9.6	10.4	10.5	12.0	22.9	21.1	13.0	11.0	10.7	15.5	23.6	16.9	9.1	11.4	14.5	16.5	17.0	20.7	9.9	13.4	18.9	10.0	14.0	6.9	9.5	9.7	16.4	25.8	12.9	10.1	27.3	18.2	20.8	10.5	2.9	17.1	11.4	8.9	24.8	27.7	34.8	29.8	15.5	39.4	19.6	10.6	8.3	15.6	11.8	18.8	15.6	6.6	11.0	18.6	17.2	24.2	3.3	10.2	8.6	9.6	9.5	31.8	8.5	9.2	12.4	22.4	25.4	11.0	12.6	5.4	5.2	8.7	8.2	7.3	10.9	11.1	16.7	12.9	11.7	18.3	28.2	3.5	9.9	11.4	20.7	26.9	25.9	12.0	16.1	11.4	18.5	7.1	13.1	17.7	7.9	15.4	13.9	9.5	8.1	18.6	16.0	7.3	17.5	8.0	11.3	3.1	24.4	8.7	24.3	10.3	21.1	11.7	15.6	17.7	34.8	24.8	32.3	24.3	23.5	19.2	24.8	24.5	24.6	24.8	24.2	17.2	24.0	21.4	15.5	29.8	27.7	39.4	19.6	24.4	23.8	20.6	19.7	22.9	21.1	23.6	16.9	20.7	18.2	0.0	8.3	13.7	11.1	12.2	13.8	10.6	12.7	10.7	12.5	12.2	15.7	14.2	21.6	19.9	141.7	21.4	8.0	0.0	21.2	17.8	14.5	9.6	13.9	4.0	16.6	11.1	16.7	16.0	10.7	104.4	12.0	14.3	21.9	30.7	8.1	16.2	20.4	14.4	11.7	13.4	24.1	19.4	19.8	160.9	31.3	12.4	11.3	17.3	10.4	9.3
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 260.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 2889.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 29.7;NK-cell: 57.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 29.7;NK-cells: 57.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	0.9	1.3	0.4	2.9	0.5	4.7	0.7	0.5	0.6	0.4	0.8	0.5	0.4	0.0	0.4	0.5	0.6	0.3	1.6	0.5	0.5	0.7	3.8	2.6	2.0	13.8	0.6	0.5	0.5	0.4	0.0	0.5	8.6	0.5	0.5	0.5	260.3	0.5	0.4	0.6	0.8	2.8	0.4	0.8	17.9	0.7	2.2	0.5	2.5	0.6	0.4	4.6	2.1	0.4	1.3	8.6	29.7	7.7	57.8	2.4	3.7	0.2	0.3	0.5	0.0	0.3	0.0	0.0	0.3	1.1	1.2	1.3	0.1	0.8	0.6	0.2	0.7	0.6	0.1	0.2	0.2	2.8	0.2	0.0	0.9	0.1	6.3	0.9	0.1	0.2	0.0	0.2	1.2	0.0	2.4	3.3	0.4	0.1	0.3	1.3	0.8	0.1	6.7	11.6	0.0	0.4	13.5	0.1	2.0	0.0	0.0	0.1	0.3	0.0	0.3	0.5	8.6	0.1	0.8	1.3	0.4	0.1	0.2	0.3	0.1	0.6	1.0	1.6	2.7	0.2	29.7	5.1	8.6	1.2	7.7	0.4	0.8	0.3	0.6	8.6	1.3	0.7	2.4	0.7	57.8	4.2	0.8	0.0	3.7	0.4	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.5	0.5	0.0	1.1	1.4	0.0	0.8	338.0	0.0	0.0	0.0	0.0	5.2	486.9	0.2	1.7	0.4	0.6	0.0	0.0	0.0	0.2	0.3	0.2	0.1	24.1	0.0	18.8	247.9	0.0	3.1	3.8	1.6	0.0	3.2	3.3	19.8	0.0	402.2	0.3	0.0	0.0	0.3	2889.5	0.0	0.0	0.7	0.2	1.3	0.2	2.1	0.0	0.0
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973022-14981865	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"retina: 67.4"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 783.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.1	1.3	1.2	0.2	1.5	9.4	0.1	0.1	4.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	1.0	2.1	0.1	0.1	0.2	0.2	2.2	0.1	0.1	0.1	0.0	0.1	2.5	0.7	0.1	0.1	67.4	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.8	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.6	0.7	0.0	0.0	1.4	0.2	0.0	0.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	1.2	1.5	0.1	4.2	1.0	2.1	2.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	47.5	0.0	0.0	0.0	0.0	0.0	783.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	1.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	141.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PDE7A	HCP1	ENSG00000205268	"Phosphodiesterase 7A"	Q13946	8	65717510-65842322	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.5;skeletal muscle: 48.3"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 80.1;Rod photoreceptor cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.0;MOLT-4: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018770, HPA027340"	Approved					NA	NA					"CAB018770: AB_677329, HPA027340: AB_1855127"	"unprognostic (2.76e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (1.44e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.03e-2)"	6.9	1.4	4.4	22.7	4.6	12.3	10.0	7.3	4.3	7.1	4.1	5.8	5.9	5.6	3.6	8.2	3.6	3.8	6.1	21.0	4.3	3.6	13.4	2.7	10.1	27.7	4.3	2.7	3.4	9.2	1.4	7.5	4.0	4.6	7.3	5.0	3.3	11.7	12.6	48.3	4.3	13.6	4.0	3.4	16.3	6.2	4.8	5.5	87.5	13.0	25.4	22.4	5.4	4.7	7.7	2.2	5.3	0.7	2.1	12.6	1.8	4.0	3.6	15.8	7.4	2.3	2.0	6.7	3.0	2.6	3.8	3.7	4.4	2.7	11.4	0.7	1.9	3.4	4.5	5.8	6.4	4.1	13.3	3.0	8.2	5.7	3.1	1.1	6.5	3.3	2.9	10.8	2.5	7.6	3.3	3.8	27.9	6.1	32.0	2.6	2.3	53.3	8.2	16.8	3.2	1.6	19.9	2.4	2.9	2.6	8.1	7.9	9.0	3.2	1.6	1.6	11.4	8.7	17.1	2.4	5.4	6.7	3.8	2.4	15.6	6.7	19.8	5.5	13.9	2.9	0.2	0.7	5.3	3.7	0.6	6.0	6.7	5.7	3.7	1.5	7.7	12.6	9.6	2.6	2.1	0.1	2.2	4.5	1.8	4.4	4.6	7.3	4.3	4.3	3.6	4.3	2.7	4.6	5.5	17.9	17.7	80.1	11.5	16.1	26.4	35.0	17.8	26.8	25.0	3.5	53.0	11.4	0.0	6.7	20.3	9.0	4.2	0.0	4.6	7.2	18.3	16.5	9.2	3.9	9.2	17.5	9.2	8.0	14.5	10.3	6.9	15.6	15.1	10.0	6.4	11.4	5.1	5.8	7.1	15.4	69.6	0.0	10.3	10.0	11.5	16.4	7.2	50.7	6.0	8.1
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851696-136195574	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 112.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.8	4.3	7.3	4.0	21.9	0.8	3.6	1.6	12.8	6.2	4.0	2.3	25.2	3.6	14.2	4.9	2.8	4.2	6.1	7.9	5.1	7.4	9.6	6.4	3.3	2.8	6.4	4.2	22.7	1.6	3.7	8.7	2.2	5.9	6.8	5.0	5.4	5.0	28.5	7.2	1.5	3.7	13.5	5.3	2.3	5.2	2.9	7.1	7.7	8.3	6.1	1.9	10.6	5.1	4.3	2.6	0.6	0.9	0.7	1.8	0.3	0.0	4.5	0.1	0.0	7.3	8.6	0.0	0.4	2.3	1.7	0.9	0.0	0.0	0.0	13.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.8	0.0	3.1	0.1	0.0	18.7	0.0	3.4	0.0	0.7	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	0.5	3.2	3.0	0.1	0.1	0.0	0.0	1.5	0.0	1.9	0.0	9.3	0.0	0.1	0.0	0.0	0.5	0.0	0.7	0.2	0.9	0.6	0.2	0.2	0.1	1.5	0.4	0.2	2.6	4.3	1.8	1.0	0.3	0.7	0.1	0.2	0.2	0.3	7.3	21.9	1.6	12.8	5.1	7.4	6.4	4.2	5.9	7.1	0.0	0.3	3.0	0.2	0.3	2.3	8.5	2.5	0.0	0.0	21.0	0.0	0.1	0.0	0.1	0.4	18.2	0.0	0.0	1.5	0.0	3.3	0.3	10.3	4.7	0.3	6.4	7.0	35.0	1.5	0.0	11.2	0.5	0.0	0.0	0.0	13.8	0.1	0.0	7.4	1.2	0.7	12.9	3.1	0.1	0.2	1.3	0.0	0.0	0.0	0.1
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 40.2"	"Low region specificity"	"Detected in all"							HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	14.3	16.6	14.0	8.5	18.7	2.6	9.8	2.6	14.8	11.4	21.0	35.5	9.1	13.2	9.0	8.2	5.9	8.8	14.3	7.8	17.2	9.8	21.7	26.2	10.5	5.4	23.3	12.1	12.0	12.7	17.6	7.1	10.1	20.1	6.9	19.8	12.6	8.2	9.2	5.6	6.2	11.7	10.7	17.6	6.7	10.8	10.6	25.5	2.2	11.2	4.8	5.0	11.9	10.6	1.3	1.7	1.7	4.5	0.6	3.2	0.6	12.8	21.5	3.7	2.5	15.5	8.2	4.4	8.6	9.6	7.7	8.9	4.8	7.7	2.5	6.8	11.6	9.2	9.1	15.6	6.8	10.4	4.7	9.3	3.4	13.9	6.9	11.2	2.0	5.2	8.2	4.2	9.0	8.7	6.7	9.9	2.9	6.8	8.4	7.0	10.8	1.1	1.9	1.7	4.2	4.0	1.5	3.0	3.6	6.1	40.2	8.5	6.5	8.5	9.4	25.0	4.2	3.0	3.9	7.7	18.1	6.3	6.4	14.1	4.1	7.2	2.8	12.3	8.1	5.1	0.0	2.4	1.7	1.1	2.2	2.1	0.8	1.8	1.9	1.7	1.3	2.2	0.9	0.2	0.6	4.5	0.0	3.2	0.6	14.0	18.7	2.6	14.8	17.2	9.8	23.3	12.1	20.1	25.5	6.0	31.1	9.3	10.7	10.1	13.4	5.2	30.6	10.7	15.9	7.0	11.8	6.3	6.6	8.7	5.6	17.9	20.8	0.0	8.2	5.8	13.3	17.2	20.9	20.8	9.7	9.5	13.9	16.5	12.5	4.1	10.0	16.1	10.1	6.4	17.5	2.5	11.6	31.7	10.6	15.7	32.2	38.8	14.1	22.4	14.5	9.2	3.8	4.8	22.9	22.5
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77429807	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 67.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	6.8	2.5	9.9	0.7	14.2	0.4	3.8	1.1	16.3	6.3	1.2	2.3	0.3	1.2	11.3	3.2	1.1	10.1	2.1	7.9	8.2	9.2	3.1	1.2	2.2	0.7	5.4	8.3	1.9	4.2	0.3	3.8	13.1	8.6	10.5	0.8	2.0	5.3	7.1	0.4	0.7	1.3	10.3	2.3	0.4	1.5	1.5	5.7	0.3	67.7	0.3	0.7	0.8	1.4	0.2	0.8	1.4	2.3	0.4	0.4	0.1	0.3	3.4	1.4	0.4	1.2	0.0	0.5	1.1	12.4	0.2	0.1	1.4	0.2	0.5	0.2	0.1	0.3	0.9	0.1	0.0	0.2	0.2	1.1	0.7	28.4	0.3	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.6	0.0	0.6	0.2	0.3	0.0	0.2	0.6	0.7	0.8	0.3	0.1	0.8	1.4	0.7	0.0	0.3	3.8	1.1	1.7	7.6	0.8	1.1	1.6	1.1	0.6	0.4	0.2	0.2	0.6	0.9	0.5	0.6	1.6	0.7	0.4	0.0	0.3	1.4	0.3	2.2	0.1	0.2	0.2	0.3	0.8	0.2	0.4	0.0	0.3	0.4	2.3	0.5	0.1	0.1	9.9	14.2	1.1	16.3	8.2	9.2	5.4	8.3	8.6	5.7	3.0	3.2	0.0	1.6	0.3	11.8	26.4	0.0	0.0	2.3	1.8	51.1	0.0	0.0	1.8	3.6	0.7	0.0	0.0	0.0	0.0	2.3	41.8	1.1	0.0	0.3	65.2	4.7	4.3	0.6	3.0	5.5	0.0	1.7	0.0	0.6	77.6	0.2	0.0	0.0	0.8	4.6	6.5	8.2	0.6	2.1	1.0	0.0	0.0	0.5	2.4
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653636-42775509	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 168.7;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.7;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	6.1	6.6	9.9	6.8	15.2	0.8	9.4	13.7	9.0	3.7	37.1	11.9	14.0	3.0	5.7	18.8	6.1	10.3	7.7	3.5	6.2	7.7	13.2	2.5	4.7	4.6	10.0	4.9	4.1	4.0	4.7	6.0	9.6	6.9	33.2	15.8	9.7	8.8	15.9	2.3	3.8	26.1	22.3	8.0	15.9	8.4	1.5	8.9	4.9	5.2	2.1	4.1	12.6	4.0	0.5	0.9	1.0	0.1	1.7	6.8	0.5	0.0	1.5	16.3	2.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.8	9.8	0.0	16.5	0.0	1.1	0.0	1.4	5.3	0.0	0.0	5.6	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	12.2	0.8	18.2	22.5	8.0	0.0	0.0	0.0	0.6	11.2	4.5	12.5	7.4	2.8	0.0	0.2	4.0	0.1	10.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.1	0.6	0.2	0.5	6.8	1.7	1.0	1.7	0.1	0.9	2.2	0.5	9.9	15.2	13.7	6.7	6.2	7.7	10.0	4.9	6.9	8.9	3.0	5.3	0.0	8.5	0.9	21.0	1.4	5.1	1.4	0.0	17.4	0.0	0.0	24.9	6.2	0.3	6.7	168.7	0.0	2.1	0.1	3.1	27.6	1.1	0.8	5.6	33.4	12.6	3.7	0.6	1.7	10.9	1.0	27.0	1.8	19.3	9.4	5.1	77.2	5.6	7.6	2.7	12.9	5.9	0.4	0.7	0.5	0.3	2.1	22.2	13.1
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 82.7;U-937: 94.3"					"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.4	18.2	3.8	8.7	4.4	3.5	11.9	13.8	6.5	11.3	11.1	10.5	12.3	36.0	16.0	7.3	13.3	14.6	20.4	26.0	15.0	11.6	17.9	30.1	15.5	17.3	4.1	82.7	15.7	2.4	9.4	34.0	15.1	6.2	48.1	22.3	14.8	22.5	14.1	12.5	24.3	48.8	11.0	34.4	30.4	20.6	5.8	14.0	40.1	12.8	16.9	3.7	26.5	33.7	2.1	5.6	12.4	14.7	38.5	7.7	10.3	17.3	23.4	10.3	17.2	40.7	6.6	94.3	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5	0.0	26.3	18.6	51.4	75.2	4.8	3.1	28.1	8.1	17.0	78.5	13.7	276.6	33.2	38.4	1.0	60.2	56.3	93.5	44.5	26.6	19.4	21.8	56.6	23.1	63.4	15.9	44.5	19.6	22.4	0.0	0.3	46.2	28.7	1.0	31.7	70.2	85.7	56.1	0.7	91.5	17.0	0.0	33.8	0.2	0.6	55.8	540.4	19.3	34.8	70.5
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693919-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	10.5	5.5	8.0	15.0	10.2	14.3	10.9	12.0	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11.0	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9.0	7.9	5.7	10.0	30.1	7.0	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.3	10.7	14.1	11.4	2.6	3.2	3.1	10.7	5.8	11.5	13.2	8.8	7.5	18.3	3.6	4.5	10.3	11.8	26.8	8.6	15.6	9.5	11.4	13.6	20.9	6.6	1.1	17.8	7.3	2.0	1.8	14.3	4.1	2.9	5.9	9.5	12.5	9.3	8.0	9.9	19.3	5.9	13.7	9.6	9.0	17.3	37.0	13.8	4.2	9.4	12.8	7.9	12.6	6.0	5.7	16.3	11.8	5.9	4.6	10.2	7.0	19.4	10.2	5.6	8.1	14.7	5.9	8.5	11.3	0.0	2.0	1.2	3.0	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8.0	10.2	12.0	9.6	7.8	6.6	10.3	4.5	8.7	10.0	8.9	6.2	2.2	3.8	2.5	2.9	9.3	0.0	9.4	11.4	1.8	2.0	4.3	3.3	2.8	0.3	3.6	1.5	46.7	2.6	4.3	2.4	2.0	9.2	2.8	3.9	1.6	4.1	3.7	4.3	0.4	5.8	2.4	0.0	1.8	3.7	4.5	1.3	0.0	3.2	1.2	7.2	6.5	3.8	3.4	4.2	1.9	1.9	2.9	4.3	2.2
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261762-65305589	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	7.5	6.6	4.9	11.9	8.8	9.8	7.5	14.1	8.8	12.0	9.6	9.8	6.4	6.7	10.1	5.5	10.4	9.3	5.9	6.1	5.2	4.5	7.9	7.0	7.5	14.7	10.3	5.5	10.3	7.9	8.0	4.8	9.3	6.5	7.1	9.6	6.7	8.9	7.5	6.5	8.0	9.2	10.7	10.2	13.6	8.8	15.0	8.4	35.7	7.9	10.3	19.7	8.6	7.3	6.0	13.3	8.0	10.1	4.9	7.3	7.7	14.4	13.3	22.0	10.2	3.3	3.9	7.5	9.9	15.8	32.0	23.7	5.3	12.7	17.4	11.4	8.6	15.5	9.1	17.9	14.8	27.4	9.4	6.7	13.1	20.2	6.0	1.9	12.1	10.8	2.7	2.1	27.7	5.8	5.8	11.9	8.9	12.6	11.8	21.6	20.0	26.0	5.4	16.4	10.7	8.5	14.1	12.8	16.8	9.6	10.0	14.4	8.6	9.5	10.4	3.3	14.4	13.0	6.2	4.3	11.8	9.5	15.6	7.2	5.5	6.6	17.9	8.5	7.7	15.8	8.0	10.1	3.9	6.5	9.5	7.3	6.0	6.9	7.1	13.3	5.6	5.6	5.1	5.0	4.9	7.6	10.4	7.1	7.7	4.9	8.8	14.1	8.8	5.2	4.5	10.3	5.5	6.5	8.4	0.0	4.3	0.8	3.8	1.4	2.5	2.7	5.1	2.7	3.4	5.2	2.0	8.3	3.3	5.7	2.1	3.5	1.0	0.0	3.0	14.9	4.4	2.2	0.0	1.6	8.4	3.2	2.9	3.7	2.1	2.9	6.9	4.3	0.0	10.8	2.2	2.3	3.6	2.6	7.1	1.4	4.9	6.5	3.6	12.0	14.5	1.3	6.1	5.1	5.3	3.2
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 173.0;Late spermatids: 102.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.2"	"Low region specificity"	"Detected in all"							"CAB011616, HPA049104"	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	5.5	8.6	10.1	9.5	10.7	21.9	13.5	73.6	16.6	7.0	5.5	5.8	6.0	4.9	6.2	11.2	12.4	6.3	11.3	16.3	9.8	9.6	7.2	15.8	9.1	11.8	8.4	10.3	10.3	7.7	10.3	11.6	5.0	10.9	11.4	6.3	6.8	22.1	6.9	36.6	10.8	4.9	6.6	10.0	8.1	6.4	29.5	5.4	9.7	7.7	17.2	10.1	11.5	9.2	4.9	33.8	25.1	9.4	7.9	7.2	4.2	11.0	6.6	11.5	23.0	6.4	6.1	9.7	7.1	8.2	11.7	10.8	9.3	13.0	10.0	9.0	4.5	12.4	5.7	9.6	8.2	14.5	6.5	10.4	7.3	5.5	12.5	9.9	5.1	81.2	5.4	9.8	8.6	10.2	14.9	8.9	21.6	15.8	6.4	11.3	6.6	21.2	14.5	15.5	13.2	7.6	12.1	11.6	8.6	22.0	8.9	6.6	11.9	8.4	5.6	21.3	12.4	14.9	8.8	4.9	5.6	7.8	14.0	6.8	9.3	15.6	14.1	5.6	10.9	14.6	12.5	5.9	17.3	4.9	7.2	5.5	4.9	5.2	5.3	6.1	4.5	5.8	5.4	25.1	7.9	9.4	33.8	7.2	4.2	10.1	10.7	73.6	16.6	9.8	9.6	8.4	10.3	10.9	5.4	3.0	12.8	13.8	19.3	14.9	3.3	19.1	7.6	22.7	28.4	7.0	7.9	6.3	5.0	11.3	173.0	10.3	3.6	0.0	8.4	5.6	5.6	27.3	22.0	11.9	6.5	6.4	5.8	6.2	5.6	102.4	6.6	8.9	6.8	4.6	4.7	6.0	22.7	5.9	3.5	5.6	4.3	0.0	5.8	19.1	12.9	17.6	9.3	10.5	6.1	25.5
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418016	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Paneth cells: 38.7;Spermatogonia: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	7.9	5.7	5.4	18.3	9.9	31.6	6.6	9.4	5.4	8.2	10.0	6.1	5.9	6.8	9.5	7.2	11.3	6.9	5.2	5.5	4.4	3.2	7.6	9.3	10.9	15.7	7.0	3.6	8.2	8.4	5.2	5.1	10.9	6.7	6.3	5.2	4.9	8.1	5.4	7.2	13.1	9.9	6.2	7.7	14.1	6.5	13.2	6.5	27.4	12.1	8.1	14.2	5.9	7.8	9.3	10.5	2.1	8.5	5.4	7.3	5.6	18.2	25.2	13.8	7.9	1.8	1.5	14.2	11.4	5.0	14.1	17.9	13.7	14.5	26.2	6.4	3.4	6.3	15.0	16.3	12.4	4.8	22.1	43.8	22.8	24.4	18.0	1.6	21.7	20.1	2.9	3.8	12.7	3.8	3.0	7.2	22.0	24.5	20.4	5.8	12.3	33.5	33.9	16.3	11.8	18.3	33.3	23.2	23.0	4.5	17.5	14.4	13.0	11.3	13.9	2.6	5.2	7.6	20.6	5.6	7.1	23.2	7.7	20.0	19.2	31.6	28.0	7.8	24.5	7.0	1.6	6.2	2.1	7.3	7.8	6.2	7.8	6.5	5.9	5.7	9.3	6.5	5.9	1.1	5.4	8.5	10.5	4.5	5.6	5.4	9.9	9.4	5.4	4.4	3.2	7.0	3.6	6.7	6.5	3.0	3.8	3.7	1.7	5.7	3.3	2.8	2.5	2.7	3.4	3.5	5.9	12.2	0.0	4.4	1.7	2.6	4.6	0.0	3.4	11.7	4.1	1.3	0.0	2.1	13.6	0.0	6.9	1.8	6.3	1.1	2.8	5.0	5.0	3.6	5.3	1.2	3.9	38.7	4.9	2.2	4.1	0.0	2.1	10.9	26.7	4.5	6.4	4.3	10.0	0.6
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114681-44124358	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 217.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	17.2	19.1	17.5	14.3	16.7	16.3	33.9	14.3	25.9	15.8	15.4	17.1	12.6	13.9	16.1	9.7	27.5	34.5	14.5	35.9	16.3	13.8	15.9	43.6	15.3	16.2	15.2	14.7	24.4	49.0	18.9	17.9	12.9	15.0	15.9	12.9	17.4	19.9	14.3	42.6	19.3	11.5	15.7	13.7	11.9	16.0	14.4	14.8	27.7	20.3	25.1	15.8	13.4	16.7	28.1	37.0	3.2	13.7	13.3	29.3	21.3	26.5	35.1	19.6	41.0	17.4	18.7	19.4	16.4	16.5	22.5	16.9	29.6	25.6	61.5	21.0	23.5	45.1	36.8	32.0	44.7	14.7	17.4	37.6	13.5	37.7	25.0	19.9	41.3	16.6	17.0	27.4	34.8	33.9	23.7	18.8	41.6	49.5	29.6	24.8	43.3	50.3	78.1	30.8	38.3	34.5	33.9	26.3	87.2	19.5	17.2	38.9	30.4	20.4	73.7	14.0	13.2	42.6	53.3	14.7	29.9	37.7	36.6	51.2	46.5	68.7	58.9	26.8	41.9	42.2	0.5	13.7	3.2	17.9	12.4	26.8	28.1	21.6	18.2	23.2	27.3	29.3	21.4	1.1	13.3	11.8	37.0	17.0	21.3	17.5	16.7	14.3	25.9	16.3	13.8	15.2	14.7	15.0	14.8	6.0	35.1	22.3	62.4	43.8	38.9	57.0	38.2	60.2	37.5	27.9	29.5	61.7	87.9	57.0	88.9	29.0	11.8	0.0	52.0	69.9	44.0	51.0	25.5	84.6	40.8	50.9	40.3	20.3	12.3	217.8	38.6	15.8	47.2	10.0	53.1	37.9	39.5	14.0	50.2	78.7	48.2	19.4	68.0	59.4	64.6	52.9	29.6	23.3	71.7	63.1
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	12.6	8.2	11.3	12.8	17.5	8.3	12.7	10.3	16.4	13.8	15.6	12.5	10.3	14.5	18.1	11.7	14.1	15.6	14.1	9.6	10.2	7.8	40.3	10.0	12.7	14.0	12.1	13.1	15.9	17.5	9.3	16.0	12.4	12.3	13.2	17.2	9.9	13.0	11.8	10.4	10.8	17.1	18.2	9.1	13.9	14.5	19.8	13.9	15.2	14.2	8.0	13.5	15.9	13.7	8.1	14.7	16.5	19.0	8.7	11.0	9.6	12.0	11.0	17.0	11.6	5.3	9.1	12.1	16.4	9.2	17.2	14.6	14.4	15.7	17.2	12.2	7.8	10.0	15.8	14.1	10.7	21.7	12.9	9.0	11.0	17.1	4.8	3.8	20.9	10.0	4.0	6.8	20.0	10.8	5.4	6.6	15.3	9.9	13.9	9.8	9.5	23.5	9.4	10.2	36.0	11.3	22.6	42.9	14.3	7.8	11.7	11.4	7.7	19.5	9.8	19.0	10.8	11.5	13.4	6.3	17.0	12.3	19.1	12.9	9.8	20.5	38.6	9.7	13.3	12.8	6.0	19.0	12.5	8.2	15.1	8.1	8.1	10.4	7.2	14.7	6.7	10.4	8.5	16.5	8.7	14.8	4.3	11.0	9.6	11.3	17.5	10.3	16.4	10.2	7.8	12.1	13.1	12.3	13.9	11.9	18.3	8.2	6.3	5.3	11.8	5.6	7.6	53.5	23.9	8.7	7.9	13.0	5.0	14.6	22.4	11.1	10.3	23.3	28.4	23.6	8.2	7.5	18.5	3.4	13.9	22.3	5.2	6.2	8.5	19.4	11.5	15.5	3.3	22.6	9.2	14.6	17.7	8.5	8.1	23.8	17.1	6.5	4.7	34.3	31.1	4.6	10.9	8.2	16.6	10.5
POLD4	"p12, POLDS"	ENSG00000175482	"DNA polymerase delta 4, accessory subunit"	Q9HCU8	11	67350777-67356972	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 380.3;Paneth cells: 312.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 50.0"									HPA078008			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA078008: "	"unprognostic (7.55e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.36e-2)"	19.0	19.7	6.5	47.0	9.3	19.6	15.0	3.3	8.9	14.9	35.1	11.4	13.6	47.2	13.2	15.6	32.4	10.3	26.9	24.0	6.1	6.1	34.3	90.7	21.3	42.9	10.8	5.2	13.0	26.8	2.7	9.8	23.7	9.1	20.2	9.9	10.0	27.2	13.4	25.7	12.7	56.9	16.5	10.5	30.1	36.2	10.9	8.3	20.6	18.5	19.4	48.9	25.4	17.2	69.6	28.3	49.0	65.8	9.8	24.8	24.3	13.5	37.1	1.0	4.0	5.3	14.4	2.2	16.0	7.6	2.9	3.1	6.2	44.1	35.8	50.0	7.1	12.6	17.4	0.2	15.6	0.2	14.6	1.8	9.0	9.1	7.3	15.2	2.9	40.1	13.2	10.4	7.4	8.1	14.6	11.5	7.1	7.8	11.9	5.9	22.4	3.5	7.0	2.7	28.5	23.7	6.5	8.2	9.7	7.3	9.2	0.3	3.9	8.5	6.3	26.9	3.3	17.4	10.6	24.4	9.9	6.4	23.3	5.4	16.0	4.6	18.7	29.1	7.0	10.6	22.3	30.1	49.0	15.4	35.7	14.1	59.2	17.2	15.3	28.3	69.6	19.5	16.8	29.0	9.8	65.8	22.6	24.8	24.3	6.5	9.3	3.3	8.9	6.1	6.1	10.8	5.2	9.1	8.3	17.9	35.1	43.0	2.4	38.5	2.4	1.9	10.2	6.7	13.6	7.0	5.9	6.8	13.3	122.5	6.2	12.7	380.3	0.0	164.2	8.8	20.6	3.8	68.0	34.7	28.8	3.2	79.8	20.9	36.4	12.5	6.4	71.5	57.3	171.3	167.5	4.0	177.4	312.1	3.5	20.7	4.1	6.5	49.5	1.9	1.7	60.2	10.4	40.5	109.7	3.1
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687365	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 34.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.1	3.4	6.7	10.2	4.4	29.3	6.2	34.8	14.4	7.0	6.6	2.0	7.6	7.3	6.1	4.4	7.5	6.2	6.5	4.7	5.6	1.6	3.8	8.6	5.4	8.2	3.3	4.3	8.7	6.8	3.6	3.1	6.5	5.1	6.8	7.7	4.3	8.7	7.4	8.9	17.9	8.5	6.8	3.7	16.7	7.8	25.6	4.4	29.8	5.1	6.0	10.3	6.7	8.7	0.5	1.7	0.8	0.8	4.8	0.7	0.5	11.2	15.0	22.3	10.6	4.7	3.7	19.9	11.5	5.2	13.8	10.1	18.2	6.7	12.9	4.9	6.2	5.3	15.7	15.5	7.8	8.4	6.0	19.6	20.4	19.4	8.9	0.9	15.9	11.7	2.8	3.1	14.4	4.7	3.8	4.8	16.6	22.8	7.3	6.8	18.2	26.1	29.2	17.3	5.3	9.0	21.7	12.6	5.8	4.4	18.4	18.6	10.7	13.4	11.0	2.5	11.2	16.2	9.9	4.4	12.6	12.9	9.5	11.6	9.7	6.5	20.3	6.9	22.0	8.9	0.0	0.3	0.8	0.5	0.1	0.7	0.5	0.3	0.4	0.7	0.3	0.5	0.3	0.1	4.8	0.8	1.7	0.6	0.5	6.7	4.4	34.8	14.4	5.6	1.6	3.3	4.3	5.1	4.4	0.0	7.9	4.5	3.5	5.0	8.1	5.6	0.0	2.7	0.0	1.8	0.0	6.2	0.0	2.1	6.5	3.0	4.7	0.0	2.7	9.0	4.7	3.7	2.3	8.9	10.4	0.0	6.9	12.9	7.9	7.0	6.4	3.2	5.0	1.0	6.7	3.7	2.4	5.8	3.2	0.8	5.0	25.8	3.3	25.4	7.9	6.8	3.3	5.7	9.8	2.5
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 17.6"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 23.3;Spermatogonia: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	3.3	2.2	1.5	11.6	2.8	17.6	3.4	1.7	1.6	4.4	4.2	1.1	1.5	2.6	2.8	3.5	9.0	2.4	2.3	1.6	1.0	1.2	2.5	5.1	2.2	5.3	1.1	0.3	2.7	5.0	1.4	2.5	4.1	1.4	2.1	5.2	2.6	2.6	0.7	1.1	3.7	7.7	2.9	2.7	5.4	3.0	5.3	2.4	17.6	1.6	10.3	8.4	2.1	4.2	1.2	0.9	0.7	0.0	3.2	2.7	0.5	17.3	8.9	16.9	7.8	0.8	5.0	8.6	9.9	5.0	15.8	18.3	8.9	13.6	10.8	5.6	5.5	8.5	10.7	16.9	6.1	18.7	12.6	9.3	16.1	9.8	11.0	0.4	19.2	7.0	1.4	0.4	8.6	1.4	2.0	9.1	14.5	14.1	6.9	15.8	15.2	19.5	12.5	9.9	14.2	20.8	16.6	15.5	9.8	5.7	9.8	12.2	7.0	10.0	5.9	3.1	8.5	11.8	6.8	3.2	2.5	18.8	10.5	7.8	5.1	10.3	25.0	4.8	14.2	10.2	0.0	0.0	0.7	0.9	0.0	0.7	1.2	0.9	1.7	0.6	1.2	0.1	0.8	0.0	3.2	0.0	0.9	2.7	0.5	1.5	2.8	1.7	1.6	1.0	1.2	1.1	0.3	1.4	2.4	3.0	0.3	0.8	1.6	4.2	0.8	0.8	0.0	1.4	1.2	0.0	0.0	5.3	0.0	1.2	0.9	0.8	0.8	23.3	1.3	8.5	2.6	1.2	0.0	3.2	4.7	0.0	1.2	6.7	3.7	0.2	1.4	1.2	1.7	1.0	2.0	2.1	0.6	0.0	2.8	0.8	3.3	0.0	1.9	3.0	22.2	3.1	2.9	0.9	2.9	0.8
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.9	19.9	14.0	21.0	8.0	7.2	12.3	21.3	10.9	24.2	19.1	18.4	14.5	58.1	13.3	12.4	14.7	27.4	27.3	23.4	22.4	11.0	16.5	30.1	20.7	18.8	8.6	62.4	18.2	8.1	16.2	21.0	27.0	8.8	16.7	29.6	41.9	32.5	16.7	40.6	42.8	33.6	18.1	34.3	36.1	43.9	58.5	32.6	10.5	15.3	30.5	17.6	31.0	19.6	16.7	8.9	29.3	28.1	13.7	17.9	24.3	22.7	36.4	17.0	55.5	78.3	16.4	36.9	21.4	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9	35.7	27.5	46.8	23.7	83.3	13.9	39.7	22.9	46.8	44.3	29.6	5.9	49.3	36.5	26.8	4.0	34.3	14.2	0.0	39.2	47.2	34.7	19.7	54.5	37.2	44.5	12.7	23.6	23.4	27.8	11.5	33.1	54.6	38.8	53.3	31.4	30.3	28.9	10.5	40.0	22.0	17.1	12.9	47.2	27.9	98.5	82.9	29.2	63.4	39.3	18.2
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958492-74970128	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.2	14.5	23.6	15.2	17.3	27.1	21.4	4.4	15.5	18.4	13.4	8.6	7.0	9.0	10.4	9.0	10.0	9.7	13.1	18.1	15.9	10.6	11.6	18.8	10.7	17.0	13.9	12.6	12.8	12.5	2.8	3.9	9.6	12.2	12.0	8.8	13.9	16.2	11.2	28.1	8.1	12.4	14.1	11.7	12.2	12.5	11.0	10.0	5.5	13.1	15.1	10.4	13.9	31.9	14.7	14.7	8.0	22.2	4.4	9.9	12.3	11.8	11.3	1.0	1.0	3.9	8.6	0.0	8.0	10.0	12.9	11.0	15.0	5.3	11.6	6.8	9.1	3.2	5.4	5.4	6.7	15.1	5.3	14.5	9.0	6.5	14.8	14.0	12.7	14.2	8.7	13.1	5.4	11.9	4.0	5.6	1.6	11.0	6.8	9.8	11.5	3.7	35.8	7.9	6.9	21.2	4.5	9.7	9.3	10.7	0.3	3.6	5.4	11.0	4.6	6.4	0.6	3.4	4.1	6.2	2.9	3.3	2.0	7.7	2.4	1.6	4.3	10.5	19.1	14.2	2.3	22.2	8.0	6.3	13.2	7.0	14.7	8.9	7.8	12.9	13.7	9.9	6.9	1.6	4.4	12.4	14.7	8.5	12.3	23.6	17.3	4.4	15.5	15.9	10.6	13.9	12.6	12.2	10.0	23.8	36.0	84.1	81.2	75.1	21.9	40.6	58.6	34.8	21.6	69.8	41.2	124.8	126.0	43.1	10.2	56.2	119.0	23.3	70.2	125.8	83.2	82.4	61.1	123.4	106.6	17.5	11.7	68.7	111.2	19.3	62.2	91.0	92.8	30.7	80.6	78.1	62.4	147.3	51.2	125.5	104.8	77.6	87.3	41.3	86.7	85.4	78.6	69.3	78.6	82.9
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	17.8	15.2	19.8	19.0	19.2	16.8	24.6	23.2	20.9	14.1	16.0	14.6	13.6	20.0	17.6	9.0	20.7	14.3	14.0	17.4	16.7	8.8	14.9	19.5	17.8	21.8	17.3	15.3	16.6	17.9	17.7	12.9	16.2	16.0	15.4	13.2	10.5	15.9	12.0	35.9	19.8	18.5	14.1	12.7	22.9	16.2	12.4	17.3	29.0	15.4	12.1	19.2	16.5	18.9	6.0	9.0	9.0	6.5	9.2	10.9	6.7	6.7	12.8	8.8	11.5	14.4	9.2	11.2	13.4	7.2	13.8	10.9	18.6	16.8	10.6	20.7	10.5	16.5	14.6	23.5	11.4	4.7	22.8	20.2	16.0	13.4	6.7	12.2	14.9	26.5	8.3	16.7	9.5	8.2	12.3	16.4	30.2	14.1	11.9	11.1	11.8	16.9	15.2	8.0	13.4	5.7	17.4	10.8	15.0	7.9	16.5	19.6	7.2	19.1	14.0	15.6	10.9	11.6	16.7	12.3	18.7	12.9	27.4	12.8	12.8	7.5	14.7	12.0	17.1	14.9	4.9	6.3	9.0	9.2	6.5	8.0	3.3	7.6	10.9	9.0	6.0	6.6	6.9	2.3	9.2	5.2	6.0	4.3	6.7	19.8	19.2	23.2	20.9	16.7	8.8	17.3	15.3	16.0	17.3	11.9	11.0	15.5	9.7	10.9	6.8	15.7	10.2	1.4	6.8	10.4	2.0	12.0	8.3	9.0	0.9	12.1	12.3	0.0	9.3	13.6	11.4	12.5	8.1	14.0	11.4	3.2	5.2	17.2	19.0	1.1	13.3	12.7	18.6	20.8	23.4	6.0	10.2	17.0	9.9	6.2	6.2	6.5	15.1	7.4	12.9	10.5	18.2	16.6	15.7	12.0
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497036	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017030, HPA023202"	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Nuclear bodies"	Mitochondria	"CAB017030: , HPA023202: AB_1855523"	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavorable (6.59e-4)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	6.7	9.3	5.4	17.5	10.0	8.1	8.2	10.9	8.7	7.7	7.8	7.0	11.1	7.9	10.2	6.8	6.4	7.5	7.9	7.3	5.6	4.4	7.8	7.8	10.4	12.2	10.8	5.2	13.0	9.4	5.0	9.9	6.9	8.7	8.0	5.7	5.8	8.6	11.9	10.7	10.5	8.4	9.3	5.6	11.5	6.9	24.2	7.9	9.8	9.6	5.4	13.3	6.6	11.5	12.2	10.5	6.5	8.2	6.0	12.2	4.4	6.9	8.5	6.1	7.5	5.8	4.7	7.4	4.1	3.9	6.3	5.4	8.8	5.5	12.7	5.0	2.2	6.5	5.7	8.3	3.9	7.9	3.5	9.7	8.6	10.3	8.7	6.5	12.1	9.6	4.7	4.5	5.0	7.5	8.7	4.5	7.7	15.1	4.9	6.1	9.2	12.9	16.1	6.4	7.6	9.5	12.0	20.1	13.4	5.7	2.0	8.6	9.6	3.3	7.4	7.6	9.9	7.3	10.2	5.0	6.8	9.0	5.8	10.7	8.7	5.9	9.6	5.3	11.4	4.7	6.5	5.9	6.5	7.9	3.5	7.5	12.2	8.8	7.6	10.5	12.1	12.2	11.6	1.2	6.0	8.2	4.8	8.4	4.4	5.4	10.0	10.9	8.7	5.6	4.4	10.8	5.2	8.7	7.9	11.9	23.4	11.1	7.7	7.2	4.0	15.7	17.8	5.3	14.8	3.5	0.0	10.9	0.0	4.3	9.2	12.4	11.2	0.0	3.2	12.2	9.9	9.7	12.7	3.8	8.2	6.4	10.5	18.4	7.8	5.0	6.1	6.9	6.8	3.6	13.9	3.0	2.7	16.7	2.8	4.3	8.4	6.5	8.6	52.0	8.2	7.5	3.3	10.2	18.2	4.7
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.5	4.7	6.4	9.3	9.1	15.1	15.2	22.0	6.9	12.9	14.8	5.4	3.6	22.8	5.5	8.9	3.7	5.2	6.4	13.8	16.1	11.5	4.9	6.7	13.3	15.6	6.8	11.4	9.0	10.1	17.0	10.5	5.7	5.2	12.1	7.0	10.5	13.7	16.2	6.8	10.3	3.0	1.9	15.7	3.6	11.3	6.6	5.7	4.9	15.4	7.2	2.5	7.0	5.8	3.5	7.4	8.3	5.1	16.4	11.9	11.6	5.6	11.1	12.9	8.9	41.2	5.7	6.7	12.9	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8	11.9	5.1	4.9	2.6	4.1	6.3	2.4	2.5	5.3	7.9	3.5	9.8	1.7	5.0	2.0	7.6	2.1	2.6	23.3	0.7	2.4	2.6	2.1	0.0	2.1	1.5	0.0	5.2	0.6	1.5	6.0	3.1	1.7	1.7	2.8	2.2	2.3	1.6	2.9	2.8	1.4	8.5	0.0	3.1	17.9	5.9	2.6	1.6	2.9	3.1	2.5
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269404-54321266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 68.1;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: AB_2685325"	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	16.5	11.1	10.2	9.5	14.0	5.2	15.8	9.6	14.7	12.9	9.9	13.4	13.7	6.6	13.2	13.1	6.6	10.3	8.3	9.1	8.7	7.6	12.9	6.4	9.0	7.4	10.9	9.0	16.4	11.8	17.6	21.3	17.4	15.3	12.7	7.7	9.6	11.3	14.7	7.2	8.2	7.6	10.9	12.0	8.2	9.0	30.5	10.9	17.3	27.3	1.5	7.0	12.7	10.5	9.9	10.3	10.9	10.7	7.9	12.7	7.1	7.6	2.8	21.0	12.7	7.1	13.9	6.8	6.3	13.6	7.3	12.2	2.1	7.3	3.6	2.1	9.2	7.4	6.3	4.9	7.3	8.2	8.7	2.4	4.5	3.1	5.3	11.6	7.2	3.8	15.1	11.1	6.3	13.3	16.6	15.4	6.0	3.1	10.3	12.2	6.0	5.1	6.4	7.2	2.0	3.1	3.3	4.3	9.0	8.3	10.2	9.9	10.1	4.5	4.0	6.7	14.2	14.7	3.3	7.4	13.8	3.8	2.0	5.2	8.4	1.9	5.2	9.8	6.5	10.0	5.4	10.7	10.9	8.3	5.7	7.7	8.6	8.8	8.6	10.3	9.9	12.7	7.6	6.7	7.9	5.8	8.1	9.8	7.1	10.2	14.0	9.6	14.7	8.7	7.6	10.9	9.0	15.3	10.9	23.8	16.0	4.5	7.9	2.3	15.1	9.5	2.5	24.1	10.3	5.2	9.8	26.3	8.3	7.9	68.1	6.0	2.0	0.0	5.4	14.9	7.1	3.8	12.7	5.8	7.9	3.2	5.8	10.4	8.4	12.8	18.4	6.1	6.8	6.4	4.7	18.8	5.6	2.9	17.0	12.5	20.8	32.3	8.0	70.7	28.2	2.3	23.3	4.4	3.9	2.4
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	14.7	12.7	10.1	8.6	12.9	6.3	13.4	17.0	13.4	18.1	10.7	8.8	13.6	6.3	21.3	12.1	11.7	10.5	9.5	11.4	14.1	10.5	12.6	12.3	12.2	9.2	14.1	12.9	15.5	11.1	18.5	23.9	15.2	17.2	13.9	8.1	6.5	10.2	10.5	15.2	10.3	9.2	15.4	16.9	13.1	9.0	9.8	12.4	12.1	18.8	9.3	8.9	12.7	10.2	7.0	7.5	6.0	13.3	4.6	4.5	2.5	6.4	6.6	4.1	5.3	5.5	10.9	3.5	12.3	8.8	9.6	10.0	4.2	5.2	6.6	10.2	8.1	6.3	2.5	3.8	4.2	11.6	7.3	4.5	6.0	5.8	2.0	10.4	3.9	5.0	5.1	5.3	7.7	5.3	7.7	8.0	4.4	5.3	3.9	9.1	0.5	7.5	3.1	1.5	0.7	3.9	3.2	10.6	4.6	5.8	2.2	4.2	4.6	9.3	2.5	3.3	2.9	3.6	3.7	10.1	7.1	3.6	3.3	7.0	4.6	4.1	6.0	4.7	6.1	12.1	5.7	7.1	3.4	3.3	7.9	2.9	7.0	3.7	4.0	6.1	5.4	4.5	3.0	6.0	4.6	13.3	7.5	4.1	2.5	10.1	12.9	17.0	13.4	14.1	10.5	14.1	12.9	17.2	12.4	29.8	39.4	38.7	18.4	13.1	33.6	17.1	30.6	18.7	29.6	27.9	19.6	14.0	19.9	16.1	167.0	32.1	9.2	23.3	13.7	11.0	21.7	14.6	49.8	20.9	18.7	62.0	14.3	49.7	37.8	38.8	34.8	32.2	21.9	27.9	12.4	23.5	16.5	11.5	36.0	17.0	40.7	6.5	16.5	43.4	16.6	11.3	5.6	18.5	10.6	10.5
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	11.0	15.1	14.4	16.0	17.1	9.2	13.4	11.2	22.1	13.7	12.6	16.4	15.6	14.3	15.1	22.1	15.4	18.1	17.7	12.3	11.1	10.4	16.4	16.5	11.8	13.0	9.6	13.0	20.9	30.7	21.7	23.7	11.7	12.7	17.2	15.0	19.5	17.8	14.7	26.1	12.8	11.9	12.7	9.4	15.6	16.7	53.2	11.2	4.6	18.3	10.2	14.2	14.8	11.6	8.5	10.7	1.1	8.5	8.4	11.9	7.1	11.7	10.7	8.5	11.8	8.6	16.0	11.9	7.8	13.5	11.9	12.6	7.8	14.2	2.9	12.3	7.0	6.7	14.8	9.3	11.5	9.7	10.3	12.7	9.2	10.1	8.9	15.9	9.5	8.4	14.6	15.7	13.2	27.4	33.6	12.8	5.7	10.2	10.2	7.5	9.3	0.0	10.4	4.5	6.5	6.4	0.0	7.5	4.8	10.0	7.1	5.9	8.7	4.8	8.1	13.3	13.0	24.5	5.6	6.8	4.3	8.7	4.9	8.5	14.7	7.4	4.4	9.3	8.3	3.2	0.5	8.5	1.1	6.7	5.9	10.6	8.5	7.4	6.8	10.7	7.1	11.9	7.9	0.9	8.4	5.7	0.2	8.9	7.1	14.4	17.1	11.2	22.1	11.1	10.4	9.6	13.0	12.7	11.2	6.0	11.7	10.2	7.5	3.3	15.9	6.7	12.7	4.0	5.7	7.0	45.2	14.0	5.0	8.6	16.4	5.6	10.5	0.0	18.3	7.2	6.9	5.2	13.9	8.1	10.0	20.6	12.6	4.9	12.3	39.9	13.0	8.8	10.1	15.4	12.0	9.9	11.4	7.0	10.6	8.4	22.0	12.9	5.7	23.8	9.1	1.8	9.6	9.6	12.8	5.2
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072247-44082540	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	10.7	8.7	7.0	18.0	7.1	7.6	12.2	11.9	8.8	13.8	11.2	11.1	11.7	12.2	10.1	12.0	11.7	11.8	11.8	10.8	6.8	4.4	13.0	12.5	10.1	20.9	9.9	7.0	13.8	12.3	10.0	9.0	8.1	8.2	11.8	7.1	12.4	13.5	14.3	11.2	12.0	12.6	8.9	9.0	18.7	12.0	6.8	8.1	30.1	15.4	8.3	17.6	12.4	10.7	5.9	4.8	31.6	2.1	3.5	4.2	1.3	1.1	1.5	1.5	3.5	2.2	2.6	5.0	3.5	4.0	2.7	1.6	1.9	2.6	11.3	3.6	3.0	3.4	3.4	1.6	38.3	1.6	3.9	3.6	1.3	1.6	0.7	3.1	3.5	5.1	4.0	3.7	2.3	2.8	5.6	4.9	11.3	1.6	5.5	2.3	2.6	7.1	3.1	3.3	3.4	8.2	5.7	0.9	4.4	3.0	1.8	1.6	3.0	1.7	7.3	3.7	2.7	4.6	6.0	3.4	1.9	2.8	1.9	5.1	9.0	4.5	8.8	3.5	3.2	4.6	8.6	1.8	5.1	3.3	2.1	3.3	4.0	2.9	3.0	1.6	5.9	4.2	3.4	31.6	3.5	1.6	4.8	2.7	1.3	7.0	7.1	11.9	8.8	6.8	4.4	9.9	7.0	8.2	8.1	3.0	8.5	24.9	9.9	3.9	18.3	5.5	15.3	4.0	9.1	12.2	27.5	10.7	1.7	6.4	0.4	6.4	12.3	0.0	8.2	8.5	5.0	11.9	24.2	8.9	9.0	17.5	5.2	12.9	10.8	0.4	13.0	9.1	10.1	10.0	7.3	7.2	6.9	15.6	9.6	3.8	38.8	0.0	13.0	10.8	11.5	4.4	8.1	14.4	10.1	10.7
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	13.6	3.9	6.1	2.5	5.7	1.8	5.2	11.1	5.5	2.8	2.9	3.5	2.9	2.7	4.0	5.8	2.6	3.6	3.3	2.8	4.4	2.9	3.6	3.4	3.0	2.7	4.3	4.0	2.8	3.1	2.4	7.6	2.3	3.8	4.6	1.8	1.7	4.7	3.5	2.7	2.7	2.4	3.3	5.6	3.5	2.9	12.3	5.2	8.5	2.4	0.9	2.6	2.5	2.6	0.2	0.1	2.4	0.0	0.0	0.9	0.1	0.3	2.7	0.5	2.0	5.7	2.2	0.0	2.0	1.0	1.1	1.6	0.1	0.2	1.2	0.6	1.7	1.0	0.4	2.2	0.8	1.6	0.3	2.9	0.1	2.0	0.0	0.7	0.2	2.6	3.1	0.8	1.7	1.4	2.6	0.6	0.5	0.2	2.3	3.1	0.3	0.2	0.2	0.2	0.1	0.6	0.0	3.8	0.9	0.8	0.5	2.5	0.0	0.2	0.0	0.2	1.0	0.1	0.7	0.3	0.1	1.9	1.1	0.6	0.6	0.7	0.0	0.6	1.9	1.1	0.0	0.0	2.4	0.2	0.0	0.9	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.1	6.1	5.7	11.1	5.5	4.4	2.9	4.3	4.0	3.8	5.2	0.0	0.0	0.0	1.0	0.8	3.2	1.6	2.5	1.4	2.3	0.0	0.0	0.2	3.3	0.4	6.8	0.8	0.0	0.0	0.9	0.2	1.7	1.1	0.0	0.6	0.5	3.2	4.6	4.9	1.0	9.2	4.0	1.4	0.0	0.0	0.0	2.6	0.4	0.0	3.5	0.5	3.6	0.0	1.3	17.6	10.0	1.4	0.0	0.7	0.2	1.3
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.5	9.2	7.9	5.6	0.7	0.9	7.2	6.4	2.5	7.6	10.2	7.3	5.0	16.1	2.9	3.5	9.2	10.7	9.3	4.1	12.9	4.7	5.1	10.3	5.7	4.5	0.0	11.1	9.5	0.1	0.3	6.9	4.3	1.3	3.7	6.0	6.8	12.3	7.9	5.2	10.0	6.5	7.5	4.1	4.5	8.5	9.5	5.7	2.4	7.8	4.3	3.9	7.4	4.0	2.6	7.2	3.7	11.1	2.9	6.7	8.8	2.6	8.3	6.2	5.0	16.7	3.2	8.3	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6	0.0	0.3	0.0	0.4	0.8	0.3	1.4	0.0	1.4	3.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.2	0.3	1.5	0.0	1.0	0.4	0.5	0.3	0.3	0.0	0.1	0.1	0.0	0.5	7.0	3.3	0.1	0.2	0.9	0.9	0.9
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.4	21.6	9.6	18.5	9.5	7.6	14.0	8.7	5.8	12.6	7.8	27.0	7.5	21.7	9.3	8.9	12.2	11.0	24.7	12.9	11.2	9.0	12.8	18.7	9.2	18.1	6.7	17.7	10.1	5.8	8.1	18.6	14.5	4.8	9.7	10.1	24.7	5.5	8.6	8.4	13.1	7.5	17.5	12.7	14.3	15.8	21.1	10.2	5.6	15.5	15.0	7.8	9.6	12.8	6.9	6.9	7.5	6.2	15.4	15.3	12.1	13.0	17.5	7.8	7.5	19.0	7.9	15.3	13.4	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9	3.0	7.8	6.1	2.9	3.8	11.5	7.8	15.3	6.7	3.4	8.7	15.7	5.7	3.3	5.9	2.4	5.7	4.2	0.0	4.0	4.4	3.8	4.3	5.8	7.2	10.2	11.1	9.2	4.9	2.8	1.5	5.8	3.1	5.0	1.8	6.1	2.9	5.0	0.0	4.9	3.0	10.1	0.0	4.7	4.2	7.5	2.4	3.2	4.4	9.0	3.7
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
POLR1C	"RPA39, RPA40, RPA5, RPAC1"	ENSG00000171453	"RNA polymerase I subunit C"	O15160	6	43509702-43562419	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	16.2	20.8	11.8	15.6	18.6	7.4	22.1	11.8	19.2	19.1	19.1	16.4	14.1	14.0	22.5	18.0	24.0	23.3	14.5	12.7	11.7	13.3	26.9	26.6	12.4	13.5	12.4	10.3	22.9	30.7	14.2	20.5	18.5	13.4	19.3	17.4	19.1	24.1	15.4	17.5	21.9	12.8	16.2	9.9	21.3	16.1	20.9	11.4	17.4	35.2	18.3	27.9	16.3	16.8	23.0	18.6	2.1	13.4	17.5	26.2	14.7	19.8	16.6	7.3	19.7	11.2	12.2	11.5	12.1	9.0	13.7	11.7	21.9	6.7	22.5	13.3	11.8	11.7	12.1	17.5	15.5	16.0	11.9	18.3	15.3	16.7	30.3	14.1	23.4	10.8	10.8	15.0	18.7	23.7	8.1	10.7	9.5	35.3	6.6	11.9	28.0	12.2	17.0	13.4	80.8	14.4	8.4	11.4	15.1	16.4	27.8	13.5	9.0	10.6	9.2	16.0	5.6	10.0	20.7	12.7	9.8	13.2	10.5	19.1	9.6	21.2	37.6	6.6	16.1	10.8	2.1	13.4	1.9	16.0	10.3	21.7	21.6	19.0	15.8	18.6	23.0	26.2	23.5	1.3	17.5	8.3	16.9	13.6	14.7	11.8	18.6	11.8	19.2	11.7	13.3	12.4	10.3	13.4	11.4	11.9	15.3	11.0	39.5	55.0	7.2	4.5	17.8	44.2	26.1	5.2	5.9	25.7	13.3	23.9	7.2	21.5	4.9	0.0	21.0	14.4	16.4	14.9	13.9	11.1	11.7	4.8	12.5	15.4	7.0	5.6	10.6	9.4	20.3	6.4	11.2	8.1	16.9	14.0	11.0	20.8	14.5	6.5	25.3	27.7	39.0	35.8	11.3	14.1	15.2	34.1
POLR1D	"MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 641.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	30.5	43.8	17.0	35.4	22.1	46.5	36.5	41.2	23.7	34.6	40.8	15.9	34.4	30.9	26.0	29.9	58.9	21.4	32.3	28.5	16.7	14.4	27.3	29.9	32.6	36.5	14.8	20.6	43.6	115.9	16.7	24.3	24.7	15.6	37.4	32.7	20.9	46.2	39.5	38.1	44.8	36.4	41.2	17.4	31.9	41.7	23.7	13.0	50.9	32.3	40.7	40.7	56.8	54.0	29.2	42.7	21.4	39.3	27.9	56.6	26.2	20.0	18.9	21.8	22.3	25.1	45.1	29.3	19.9	34.4	26.4	26.2	30.5	40.9	65.1	15.1	22.4	43.8	31.0	40.1	63.6	31.4	20.1	23.8	46.2	20.6	51.1	37.9	42.0	36.4	40.5	67.3	21.4	40.1	29.7	36.4	37.5	25.2	11.6	25.6	20.8	41.2	51.2	52.5	62.8	20.1	28.4	37.5	29.2	41.6	31.2	37.2	29.2	13.3	26.9	71.8	28.7	16.4	39.2	25.2	11.7	18.3	20.0	21.7	19.1	21.5	36.8	10.2	30.4	22.7	21.4	38.4	17.3	24.9	39.3	32.8	28.4	40.2	31.4	42.7	29.2	43.6	34.2	13.7	27.9	34.2	31.2	56.6	26.2	17.0	22.1	41.2	23.7	16.7	14.4	14.8	20.6	15.6	13.0	83.4	87.9	125.7	260.0	299.0	36.8	61.7	99.3	46.8	102.4	27.9	15.7	139.0	63.0	120.2	371.4	103.0	105.8	70.0	267.5	226.2	97.1	149.2	93.5	69.2	148.4	42.9	119.5	90.9	175.3	641.0	107.9	125.4	75.9	153.3	182.4	43.5	227.4	97.9	74.3	100.6	35.5	77.6	116.0	153.7	85.9	277.2	122.0	126.4	173.3	290.2
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485935-37503697	"Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	15.4	12.2	10.5	20.2	11.6	9.3	19.7	10.7	9.0	19.0	13.9	10.0	14.9	7.0	20.5	14.7	15.1	17.3	13.7	14.9	9.1	9.2	7.6	23.9	10.1	15.5	9.0	9.2	36.9	25.9	10.3	9.6	8.7	9.5	17.3	9.3	9.5	19.5	18.4	17.2	13.1	9.0	22.4	10.2	10.8	13.0	11.2	11.5	16.0	15.3	13.3	17.1	21.9	16.8	8.1	3.9	1.4	4.3	9.0	16.9	5.5	19.7	18.6	10.3	16.3	19.3	24.9	6.7	17.6	6.8	18.3	16.2	15.9	6.6	28.8	8.5	20.2	12.4	8.3	25.1	20.9	23.1	27.8	11.8	13.8	23.6	11.3	14.5	26.4	9.8	26.4	7.4	35.7	30.9	11.5	9.2	16.1	36.0	12.7	16.0	9.5	18.2	9.0	18.3	13.6	15.3	16.2	9.5	13.8	9.5	7.4	14.7	12.1	11.7	9.4	15.1	8.9	9.2	17.6	6.3	21.7	33.1	18.5	35.0	7.0	9.8	30.3	7.5	16.8	18.0	0.0	2.5	1.4	10.6	4.3	16.9	7.4	10.2	10.8	3.9	8.1	12.8	11.1	0.8	9.0	3.4	2.7	5.4	5.5	10.5	11.6	10.7	9.0	9.1	9.2	9.0	9.2	9.5	11.5	0.0	6.7	8.5	20.9	25.1	6.4	7.6	15.3	5.3	9.1	0.0	3.9	12.9	6.6	12.3	4.4	7.5	2.7	0.0	18.2	17.4	12.1	6.6	8.1	15.8	6.6	3.2	1.7	3.7	8.6	8.6	13.8	7.3	5.0	8.2	7.3	6.7	14.5	0.0	14.2	4.1	5.7	0.0	17.9	11.5	16.1	15.6	7.0	12.9	12.1	11.6
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"	P24928	17	7484366-7514616	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription"	"DNA-binding, Nucleotidyltransferase, RNA-directed RNA polymerase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HL-60: 2.7;HMC-1: 4.0"									"CAB012226, CAB016388, CAB022311"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, CAB022311: "	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	5.0	5.9	4.5	5.7	7.4	26.4	8.5	5.8	7.8	7.2	4.3	4.8	4.5	4.3	5.5	5.4	7.0	4.6	4.2	4.5	6.0	3.5	4.6	4.4	6.4	11.5	4.7	4.2	5.2	5.8	5.4	4.8	4.2	5.4	4.3	4.9	6.3	5.5	8.1	6.6	6.6	6.0	4.5	6.1	6.2	5.3	13.2	2.9	15.0	5.6	4.1	5.0	5.3	4.6	0.7	0.7	4.9	1.0	0.0	1.2	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.4	3.0	0.7	1.2	0.2	0.0	2.7	4.0	0.4	0.0	0.3	0.0	0.4	0.2	0.7	0.3	0.0	0.5	0.0	0.1	0.8	0.5	0.0	0.9	1.2	0.0	0.0	0.0	1.4	0.3	0.9	1.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.5	0.8	0.4	0.2	0.4	0.0	0.6	0.3	3.0	0.5	0.6	1.2	0.4	0.3	0.3	0.5	0.4	0.1	0.7	0.6	0.5	4.9	0.0	1.0	0.7	0.5	0.0	4.5	7.4	5.8	7.8	6.0	3.5	4.7	4.2	5.4	2.9	20.8	47.7	32.5	35.2	38.0	86.4	20.7	38.2	29.4	23.9	22.7	104.1	31.3	3.3	23.3	19.9	38.6	39.3	0.0	26.5	23.6	28.9	29.0	41.5	22.9	39.8	52.4	73.6	38.6	32.1	7.2	34.2	31.4	35.4	35.1	39.1	29.5	28.0	30.0	39.3	10.6	80.9	6.5	33.7	53.7	121.1	36.0	45.0	39.2	30.5	29.3
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031168	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	24.5	34.3	31.1	34.6	31.0	21.4	24.8	43.8	33.3	25.9	26.0	18.8	24.9	22.5	35.1	21.4	27.4	28.3	21.2	32.9	29.3	21.7	26.2	21.4	21.2	32.4	28.0	30.2	26.4	28.1	40.7	37.3	25.4	28.3	24.8	26.5	18.4	30.5	28.2	61.8	24.4	27.3	27.6	26.4	27.1	28.8	26.6	26.8	33.4	27.0	34.7	35.1	31.5	22.4	19.8	15.2	27.8	13.9	18.0	23.8	12.7	25.3	21.1	38.2	32.3	31.6	28.5	20.5	33.7	34.3	33.8	31.7	26.9	25.5	39.5	32.0	31.2	24.3	18.0	45.9	25.6	48.4	18.7	20.6	29.7	23.6	23.4	36.6	51.0	34.3	30.7	25.8	38.6	23.5	28.1	40.2	31.8	44.0	33.7	38.9	18.5	48.0	19.7	31.4	32.8	24.8	35.1	25.2	21.7	23.1	28.9	31.9	35.7	21.0	39.9	29.0	32.0	21.4	28.4	29.3	24.6	33.1	25.7	44.2	27.2	25.9	57.5	28.1	27.5	30.4	27.8	12.2	16.8	20.7	12.4	22.0	19.8	20.3	21.4	15.2	14.4	19.9	23.8	11.3	18.0	13.9	12.9	20.9	12.7	31.1	31.0	43.8	33.3	29.3	21.7	28.0	30.2	28.3	26.8	26.8	41.7	44.7	39.5	36.7	45.8	30.9	38.2	57.6	45.5	34.9	41.2	41.3	16.6	52.1	4.5	31.4	29.1	0.0	47.4	25.1	30.5	50.4	55.6	27.2	25.9	42.9	28.7	35.6	42.2	5.4	53.2	38.7	42.2	44.1	31.2	30.4	47.4	30.2	35.7	26.9	48.2	71.1	26.2	79.4	64.2	34.9	34.3	61.0	31.7	71.1
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462387-57472010	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	26.2	30.1	24.2	18.4	26.9	23.9	25.8	34.1	37.6	27.2	22.9	28.8	23.1	21.5	26.0	45.0	26.2	30.3	29.9	32.6	24.5	25.9	38.3	44.8	29.9	30.2	25.0	30.1	37.2	39.4	33.7	35.0	29.2	25.5	29.2	26.0	29.6	30.4	31.4	47.5	23.7	27.9	26.1	24.1	22.4	25.2	26.4	21.9	30.5	35.8	27.3	27.1	27.5	22.2	21.8	16.2	41.7	19.8	26.2	28.6	21.9	17.7	29.4	24.6	22.3	22.3	20.1	21.9	23.5	25.6	37.7	24.9	37.6	22.6	20.1	27.6	25.8	22.9	18.7	32.5	24.7	42.0	9.2	24.2	15.4	17.6	42.8	25.3	27.9	29.7	18.0	20.4	28.7	26.6	20.6	22.7	27.5	26.7	11.4	24.6	24.5	30.9	29.6	36.9	21.4	44.8	45.1	29.2	35.6	30.5	17.6	31.3	36.5	38.0	21.3	24.6	24.2	16.2	25.8	17.5	23.8	24.3	18.1	26.7	26.3	22.5	40.9	24.0	24.1	31.4	24.8	17.3	29.0	20.7	16.4	22.6	21.8	23.6	19.1	16.2	20.9	28.6	26.8	41.7	26.2	19.8	13.2	22.5	21.9	24.2	26.9	34.1	37.6	24.5	25.9	25.0	30.1	25.5	21.9	23.8	34.7	45.5	39.7	27.5	84.3	9.7	33.1	28.1	14.8	26.2	53.0	65.7	77.9	47.3	3.0	36.0	36.6	0.0	57.8	72.3	37.6	40.0	61.0	18.5	36.7	49.3	36.7	22.1	18.6	6.6	47.8	21.9	38.8	64.9	27.6	87.9	46.7	36.8	48.8	96.7	87.2	45.3	39.2	40.2	65.5	26.2	77.7	42.4	33.6	35.9
POLR2D	RBP4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843551-127858157	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	8.2	9.4	8.1	8.9	9.1	17.9	7.9	9.3	12.6	6.9	7.7	12.3	6.9	6.3	7.5	6.2	9.8	7.7	7.6	7.3	7.8	6.3	6.3	13.5	7.2	11.8	9.9	7.5	10.3	17.4	7.4	9.4	10.2	8.7	7.2	9.9	7.3	7.6	6.5	21.9	8.9	7.8	9.8	8.8	11.1	7.8	46.4	9.9	16.7	6.3	9.1	16.8	8.0	7.2	16.7	20.6	11.4	22.1	16.7	21.0	14.3	18.4	12.1	22.5	15.7	8.4	9.2	18.1	17.7	8.4	21.4	19.2	27.3	15.3	28.7	15.3	11.9	12.2	9.8	32.3	15.3	33.2	16.8	17.6	28.4	12.1	25.0	9.8	30.4	15.8	6.5	11.5	28.5	16.4	5.9	13.9	21.1	39.5	25.8	12.2	14.7	30.2	13.8	31.5	19.4	14.0	29.1	23.8	25.9	7.1	12.7	14.0	18.7	11.9	14.8	14.9	17.6	16.6	21.1	14.0	18.6	26.2	10.5	20.4	30.5	49.4	51.7	16.2	15.2	18.2	5.7	15.8	11.4	19.4	21.5	18.1	16.7	15.6	16.9	20.6	15.1	21.0	17.8	5.0	16.7	22.1	13.5	13.9	14.3	8.1	9.1	9.3	12.6	7.8	6.3	9.9	7.5	8.7	9.9	3.0	9.4	14.9	17.2	9.6	14.8	9.0	10.2	8.1	12.5	12.2	7.9	26.9	10.0	17.6	54.9	9.5	7.0	23.3	15.2	23.1	10.3	13.9	18.4	14.9	19.4	31.8	8.1	9.2	9.1	142.9	16.4	11.5	8.5	25.2	10.6	11.8	13.4	10.5	17.3	8.7	12.9	12.9	14.1	61.1	55.3	8.8	22.3	13.8	13.4	14.0
POLR2E	"hRPB25, hsRPB5, RPABC1, RPB5, XAP4"	ENSG00000099817	"RNA polymerase II subunit E"	P19388	19	1086579-1095380	"Predicted intracellular proteins, RNA polymerase related proteins"	"Host-virus interaction, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 562.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063030, HPA068992"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063030: AB_2684926, HPA068992: AB_2686065"	"unprognostic (2.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.77e-2)"	41.4	26.2	29.6	22.8	27.9	19.8	27.6	19.0	36.9	20.1	26.5	18.6	18.4	20.1	21.4	22.6	34.1	26.3	25.8	27.6	29.6	26.3	34.0	57.9	25.1	25.1	30.1	22.6	22.0	21.0	39.7	13.0	26.4	33.4	24.3	29.5	20.3	17.9	18.9	33.2	23.7	26.9	25.7	22.1	23.1	21.5	29.3	15.5	31.9	30.6	21.1	36.7	22.1	20.6	12.8	28.2	17.9	30.4	16.7	17.5	20.9	14.3	13.3	18.7	14.9	25.7	16.0	8.7	10.7	14.8	17.6	10.4	15.6	5.3	12.1	4.8	31.5	2.7	11.7	35.0	11.7	33.0	12.5	10.6	15.8	16.5	14.3	10.2	23.1	11.9	11.7	7.7	12.3	23.4	18.4	16.2	6.4	17.7	13.8	19.8	11.9	12.7	7.2	15.0	10.4	10.2	13.6	18.5	11.5	18.1	16.7	9.5	10.8	17.8	12.4	7.4	17.5	13.1	10.8	22.0	8.9	9.9	16.2	12.3	21.3	28.4	21.0	14.7	15.0	10.2	12.1	30.4	17.9	16.4	20.5	17.5	11.7	15.5	17.2	28.2	12.8	12.4	12.7	16.1	16.7	22.2	19.6	14.7	20.9	29.6	27.9	19.0	36.9	29.6	26.3	30.1	22.6	33.4	15.5	29.8	62.4	90.1	75.3	92.6	50.5	67.4	50.9	58.9	45.5	52.4	39.3	221.3	147.6	142.7	13.0	69.6	118.5	23.3	122.2	211.1	104.5	73.3	70.3	80.1	223.7	52.4	67.8	65.7	94.1	29.8	64.2	133.4	94.5	562.7	71.8	57.9	139.5	77.7	58.4	154.9	42.3	25.8	93.9	81.4	85.2	95.9	196.2	79.8	97.1	90.4
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II subunit F"	P61218	22	37952607-38041915	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	31.7	31.4	37.5	23.4	43.8	23.0	28.2	32.6	54.5	25.2	27.8	57.3	20.4	26.3	24.2	18.7	24.6	23.2	20.3	37.8	33.5	31.2	25.1	58.5	17.9	19.8	44.8	44.1	30.2	26.1	43.5	28.8	21.2	38.4	21.4	21.0	21.0	38.0	29.6	67.9	19.0	25.7	20.8	39.6	16.8	26.9	21.9	48.3	13.1	28.5	23.4	18.0	19.0	26.8	36.1	49.5	52.4	36.7	40.1	38.5	29.3	34.3	40.7	28.8	30.7	34.6	20.3	25.7	32.3	18.9	33.1	31.2	47.2	12.2	26.6	23.3	27.9	33.2	24.8	39.6	31.2	16.4	32.5	66.9	24.8	41.9	64.0	30.2	48.3	15.9	26.9	23.7	44.7	17.3	17.2	28.3	29.7	47.3	22.5	24.0	48.9	37.5	58.3	41.4	40.0	31.0	37.4	26.4	31.0	18.2	21.4	43.3	16.2	29.7	21.3	46.5	17.5	14.9	33.5	25.9	29.2	41.5	36.1	36.4	25.3	39.2	55.5	29.7	24.6	32.8	34.5	36.7	52.4	34.3	33.3	32.1	36.1	30.0	33.2	33.4	28.9	27.3	27.2	46.2	40.1	28.1	49.5	38.5	29.3	37.5	43.8	32.6	42.7	33.5	31.2	44.8	44.1	38.4	48.3	35.7	81.8	93.0	98.8	181.6	23.8	0.2	117.2	73.6	56.9	115.1	23.6	207.5	164.2	148.0	67.2	91.8	136.4	46.7	138.2	263.3	141.6	91.0	88.8	237.4	154.9	27.0	112.4	95.2	90.9	30.1	147.9	85.4	214.2	119.0	111.6	70.5	150.4	114.3	142.1	213.7	31.1	155.2	124.9	159.7	214.2	196.1	177.2	87.1	119.2	105.4
POLR2G	"hRPB19, hsRPB7, RPB7"	ENSG00000168002	"RNA polymerase II subunit G"	P62487	11	62761544-62766710	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053000	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053000: AB_2682010"	"unprognostic (7.58e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (6.02e-5)"	"unprognostic (8.50e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.21e-1)"	27.9	34.6	39.4	28.7	37.7	29.4	37.2	18.6	33.5	28.0	25.4	39.9	25.0	17.3	27.0	44.0	27.4	32.3	25.2	25.0	35.0	27.7	30.6	32.1	29.8	47.5	41.4	27.6	28.1	29.0	29.6	20.4	29.0	30.7	28.3	32.9	31.4	22.3	27.2	18.9	27.5	19.5	32.6	45.4	30.7	22.6	18.7	33.6	47.7	28.2	26.3	49.2	25.4	23.2	48.9	61.3	51.5	54.1	46.4	47.4	64.6	25.3	45.3	48.9	30.6	25.6	24.9	12.1	18.0	22.9	43.5	34.6	27.4	29.6	36.9	42.0	27.4	19.2	24.9	22.2	34.0	38.8	70.3	27.9	24.3	36.1	32.1	36.0	32.3	22.3	24.3	34.5	20.2	41.2	23.3	33.9	34.7	30.4	24.4	30.8	79.7	46.8	42.5	30.3	27.3	46.4	38.5	44.8	48.4	32.1	21.7	20.5	34.7	30.8	23.5	45.0	19.4	67.6	27.9	13.4	21.9	23.6	42.5	20.9	19.2	35.5	40.2	22.3	20.7	28.9	46.9	49.0	51.5	45.2	51.7	43.5	48.5	39.0	43.9	57.6	48.9	37.1	45.7	21.6	46.4	54.1	61.3	47.4	64.6	39.4	37.7	18.6	33.5	35.0	27.7	41.4	27.6	30.7	33.6	35.7	53.8	83.6	47.8	40.0	39.2	42.0	71.4	26.8	27.3	73.3	7.9	194.5	119.3	105.3	6.0	64.2	28.4	0.0	97.0	114.7	79.8	30.5	88.8	64.4	164.9	36.5	56.2	66.3	73.0	11.5	65.6	81.3	84.4	189.4	51.6	114.6	76.4	55.7	58.4	119.9	42.6	77.6	50.4	42.6	40.8	52.8	116.3	115.1	66.7	30.2
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II subunit H"	P52434	3	184361718-184368596	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	18.1	32.6	19.6	19.2	17.5	14.8	24.5	24.2	24.6	28.8	29.9	13.8	19.8	32.0	19.9	23.5	26.7	23.1	26.7	16.3	17.8	16.3	34.1	41.0	17.8	21.7	16.4	17.0	21.8	46.4	15.8	20.7	27.2	17.0	19.2	33.6	19.7	26.0	17.0	19.9	20.7	38.8	20.0	13.2	21.5	25.6	20.6	12.5	28.1	29.7	23.1	26.3	18.5	16.2	17.4	18.2	7.7	15.3	14.6	26.6	11.5	49.5	17.4	18.8	27.8	21.0	14.9	23.4	18.7	19.7	25.7	33.1	44.5	23.8	28.1	47.0	14.6	39.1	20.1	33.6	33.6	22.9	27.4	44.4	26.9	20.5	27.8	19.0	28.3	15.7	19.2	19.2	16.7	30.3	23.1	26.5	28.2	20.7	18.6	20.3	58.8	27.9	37.9	20.4	62.1	36.4	16.4	17.3	38.0	30.5	22.5	28.5	20.3	15.8	49.1	27.2	19.0	61.4	22.8	13.8	12.2	19.4	16.3	49.8	37.5	38.8	52.5	19.4	30.3	16.3	3.4	9.6	7.7	15.2	15.3	18.4	17.4	18.0	16.2	18.0	16.4	26.6	19.7	0.7	14.6	9.6	18.2	18.7	11.5	19.6	17.5	24.2	24.6	17.8	16.3	16.4	17.0	17.0	12.5	35.7	40.3	38.7	63.2	100.7	21.3	13.7	53.5	36.1	31.8	41.8	15.7	88.4	119.3	59.7	14.9	50.9	83.1	0.0	78.5	122.8	54.6	65.8	31.1	57.8	53.4	23.8	53.5	32.5	21.4	9.6	42.6	31.5	49.0	30.7	62.9	23.6	80.3	69.9	26.2	102.6	23.4	38.8	60.4	72.4	110.1	64.7	102.3	28.8	72.3	83.9
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113710-36115346	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 926.9;Late spermatids: 1719.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035632: AB_2674711, HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	9.6	10.7	27.4	6.1	26.7	10.7	14.3	17.5	29.3	15.1	12.4	24.5	9.8	12.4	9.2	10.7	11.5	18.2	10.4	21.6	25.8	23.7	10.7	19.8	8.6	10.1	29.0	17.1	14.0	25.9	9.7	14.0	8.3	16.2	10.9	6.6	7.4	18.4	18.5	30.3	14.8	7.1	9.4	37.8	10.3	11.4	26.8	16.6	9.7	11.4	15.9	9.3	8.3	7.9	13.5	22.0	6.9	10.2	9.2	13.7	10.3	7.4	23.6	4.0	4.1	2.9	2.4	8.9	6.7	3.6	9.5	5.4	14.6	5.4	15.9	13.9	2.4	3.5	4.9	6.6	9.7	2.0	14.5	24.7	18.2	6.9	11.1	6.8	15.3	7.8	3.6	5.4	5.4	5.6	2.8	4.2	8.9	11.4	7.1	3.0	21.2	8.0	16.4	9.2	22.7	20.4	14.6	5.9	10.4	7.6	4.5	25.8	14.7	7.8	14.0	4.0	3.0	6.7	5.1	4.1	6.4	11.0	4.2	9.0	6.7	13.0	11.2	8.7	9.9	6.8	6.9	10.2	5.9	9.0	7.2	11.8	13.5	11.2	12.3	13.2	13.3	13.7	12.7	0.6	9.2	8.7	22.0	10.7	10.3	27.4	26.7	17.5	29.1	25.8	23.7	29.0	17.1	16.2	16.6	77.4	63.0	61.4	82.8	70.2	62.0	215.0	145.2	326.6	109.2	155.3	23.6	129.0	298.4	131.5	926.9	106.7	149.5	140.2	208.3	142.1	97.5	103.1	80.8	234.2	108.6	31.8	101.9	92.7	71.3	1719.1	128.9	73.2	160.3	125.4	134.4	86.3	165.9	201.5	144.9	353.5	48.4	109.9	114.1	313.9	161.1	95.2	86.8	65.0	140.6	77.0
POLR2J	"hRPB14, POLR2J1, RPB11, RPB11A, RPB11m"	ENSG00000005075	"RNA polymerase II subunit J"	P52435	7	102473118-102478907	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	19.0	28.1	30.9	16.5	28.9	37.0	52.2	17.9	27.6	20.0	20.6	15.1	22.7	22.2	16.3	27.9	20.0	19.6	27.9	65.7	26.1	25.1	21.0	40.9	21.2	31.9	28.5	17.8	21.7	50.2	16.0	23.4	15.6	22.3	18.4	16.7	19.4	28.2	23.9	75.9	19.1	24.3	28.1	35.9	18.6	20.7	18.1	23.1	20.8	24.9	38.8	18.6	19.9	18.3	42.8	42.3	63.4	40.1	25.5	44.8	38.1	31.5	32.3	22.2	29.2	21.1	16.3	16.3	17.5	18.8	25.8	22.0	29.3	24.7	14.6	33.9	24.4	37.2	17.0	20.5	21.6	15.9	27.2	36.6	14.6	23.2	28.3	25.8	28.2	21.9	21.2	27.1	23.1	13.0	16.9	23.0	31.4	34.1	43.7	21.1	97.3	46.3	50.4	20.5	31.5	41.7	22.1	21.8	43.0	20.6	21.0	18.9	31.5	21.1	40.4	24.9	23.6	18.1	34.6	18.5	29.2	37.2	45.7	34.2	27.0	39.2	37.8	26.0	35.2	33.9	48.3	40.1	63.4	32.1	39.1	30.4	42.8	34.5	35.6	31.3	37.6	29.8	30.0	58.5	25.5	35.5	42.3	44.8	38.1	30.9	28.9	17.9	27.6	26.1	25.1	28.5	17.8	22.3	23.1	32.8	37.7	101.2	100.0	84.3	36.9	165.4	71.4	69.6	36.4	118.7	11.8	175.6	232.1	122.3	40.3	90.9	189.8	140.2	173.5	165.1	101.3	117.4	42.7	165.1	176.1	33.4	98.9	85.3	97.5	33.8	117.6	117.2	135.0	153.3	115.9	97.7	155.7	164.9	104.0	180.9	34.8	51.8	107.2	95.4	243.8	101.5	152.3	76.2	104.4	130.5
POLR2K	RPB10alpha	ENSG00000147669	"RNA polymerase II subunit K"	P53803	8	100150584-100154002	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047477			Supported	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA047477: "	"unprognostic (3.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.75e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (5.73e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.43e-2)"	31.4	43.7	51.1	22.0	38.7	32.9	41.5	34.7	53.0	33.8	28.5	24.7	20.8	21.2	29.3	42.7	33.1	23.8	23.9	35.3	46.2	51.0	47.5	46.6	27.3	29.7	49.0	35.0	26.2	20.2	28.2	36.8	27.1	46.0	37.8	31.8	21.5	32.7	33.3	23.3	21.8	28.4	34.8	40.4	31.9	26.6	22.6	23.7	24.9	36.6	22.3	31.5	39.3	23.1	29.0	30.0	24.2	19.2	25.0	30.9	24.2	38.7	19.6	25.4	17.9	27.3	24.9	17.1	28.7	23.7	29.3	35.7	12.1	26.7	26.0	57.1	22.7	17.2	17.9	27.2	23.7	38.8	41.3	30.1	35.3	24.8	25.5	21.6	22.7	25.7	20.2	31.7	23.3	23.9	19.2	26.6	30.7	27.5	25.5	28.6	24.6	57.5	33.7	26.4	55.8	39.0	22.6	14.7	37.5	36.5	21.9	53.4	35.1	19.5	17.5	41.6	25.8	35.8	34.7	20.1	17.3	24.9	26.7	30.5	26.3	41.5	40.9	32.9	40.1	26.9	24.2	15.2	22.1	23.7	19.2	28.2	29.0	30.9	29.4	19.0	19.7	27.1	29.3	5.8	25.0	18.2	30.0	30.9	24.2	51.1	38.7	34.7	53.0	46.2	51.0	49.0	35.0	46.0	23.7	62.5	52.6	109.1	130.8	144.5	56.3	82.6	79.0	57.6	46.6	139.6	15.7	120.3	373.0	129.1	4.5	101.4	82.6	93.5	113.7	159.7	121.8	169.5	108.3	110.7	133.6	46.1	117.2	79.2	67.1	12.6	108.4	91.7	129.9	180.3	82.5	71.2	120.6	71.9	114.2	283.0	42.3	71.1	124.9	125.4	165.5	148.7	115.1	121.8	77.5	235.5
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II subunit L"	P62875	11	837356-842545	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 87.6;PC-3: 112.2"	"Low region specificity"	"Detected in all"							HPA073614			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073614: "	"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	42.9	27.7	22.4	18.4	18.3	16.9	63.3	10.1	18.8	16.6	28.3	9.9	29.7	18.7	14.1	23.8	37.5	15.0	28.5	86.7	19.2	17.3	32.9	43.3	26.3	21.2	18.8	10.7	16.6	88.3	14.8	21.1	21.0	12.5	19.3	11.5	23.0	41.6	35.4	44.8	17.3	18.9	21.5	13.5	19.2	17.1	18.3	9.3	18.7	37.9	41.8	15.7	17.6	21.0	28.6	52.3	43.0	44.1	41.7	38.6	42.2	16.0	87.6	8.3	10.3	23.9	17.4	7.5	20.7	14.5	20.5	13.7	25.6	15.0	10.1	5.7	25.7	17.4	10.8	12.3	24.8	6.5	9.3	60.4	9.6	26.1	32.3	14.2	9.2	7.8	28.6	11.2	11.6	5.8	12.5	16.2	10.7	10.2	11.2	24.1	40.5	9.3	9.7	13.0	18.7	112.2	9.1	6.7	15.4	24.7	12.4	16.8	5.3	20.6	21.2	15.9	4.7	12.7	5.5	18.0	13.9	11.0	7.6	12.8	6.8	7.8	9.8	21.0	9.1	12.2	26.4	44.1	43.0	36.1	38.4	38.6	28.6	34.4	35.7	41.7	26.0	29.5	35.6	11.5	41.7	25.9	52.3	33.0	42.2	22.4	18.3	10.1	18.8	19.2	17.3	18.8	10.7	12.5	9.3	381.2	358.3	236.7	203.3	543.4	62.5	432.3	639.5	250.3	323.0	499.0	23.6	587.7	1090.9	434.7	67.7	336.6	720.6	350.4	588.2	345.4	532.7	243.7	259.8	1459.1	606.2	47.7	482.2	661.1	436.0	177.8	283.0	301.5	624.2	530.2	452.3	186.9	631.2	462.9	239.7	1293.9	56.1	155.2	446.5	174.7	248.7	608.9	376.0	284.4	422.8	251.0
POLR3A	"hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029545	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	7.1	10.2	10.3	8.3	21.7	5.9	10.6	22.2	29.7	9.2	8.1	12.8	7.4	8.6	9.4	13.3	8.6	8.5	7.4	7.4	9.4	9.6	9.3	9.3	6.8	8.7	8.1	11.0	11.5	10.7	13.8	17.3	10.1	20.4	10.2	10.7	10.4	8.6	8.2	17.6	11.2	7.8	9.7	6.6	8.9	8.2	11.7	9.8	12.6	9.6	4.4	13.4	7.9	8.0	7.5	5.4	8.0	6.4	6.5	8.8	3.6	7.4	8.9	9.5	15.7	6.3	8.0	6.3	8.6	11.2	11.1	11.0	11.7	5.4	9.3	5.3	7.4	6.3	8.8	16.4	9.4	13.6	6.8	12.0	7.5	7.1	14.4	5.9	12.8	6.3	6.8	6.8	19.7	18.3	10.7	9.7	7.6	13.8	5.8	10.7	5.6	9.6	8.1	10.3	6.1	40.8	9.2	6.0	6.0	5.6	4.9	8.7	11.0	8.2	15.4	8.8	8.9	11.4	6.7	10.6	7.2	7.0	7.7	17.0	9.0	9.5	11.3	12.8	13.5	3.5	8.0	5.2	2.9	7.8	6.4	7.6	5.6	6.0	7.2	4.8	7.5	5.7	6.6	3.3	6.5	5.4	5.4	8.8	3.6	10.3	21.7	22.2	29.7	9.4	9.6	8.1	11.0	20.4	9.8	0.0	7.8	6.1	4.6	8.9	27.0	10.4	7.6	14.7	12.5	0.0	60.9	6.7	1.7	5.4	1.2	7.3	6.3	0.0	5.3	5.6	5.7	3.5	5.8	9.2	4.8	14.3	6.9	6.2	5.7	0.0	12.0	4.5	1.7	3.6	9.8	15.5	7.1	7.0	7.8	3.8	32.8	6.5	6.6	10.9	17.0	8.0	3.4	4.9	8.6	3.2
POLR3B	"FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357658-106510198	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	6.4	14.0	7.1	7.9	14.6	6.5	6.9	8.6	13.6	8.6	7.2	8.2	5.7	6.0	10.1	7.2	14.8	7.7	5.8	8.2	8.9	7.1	9.9	17.5	7.1	11.4	6.2	10.4	11.3	11.9	22.5	17.0	22.9	12.3	8.0	8.3	6.2	8.6	9.9	12.1	15.3	5.7	7.8	6.0	6.4	7.5	9.9	4.7	10.3	8.5	10.2	10.0	7.3	10.1	4.3	4.9	9.8	4.1	3.7	6.3	3.1	11.2	5.3	11.9	5.7	10.6	9.7	16.6	15.9	9.5	11.0	8.5	9.8	3.1	14.4	5.7	9.8	4.1	10.5	13.8	13.5	13.7	11.6	9.2	11.5	7.1	8.3	6.8	18.1	12.4	8.6	9.7	11.0	12.8	7.8	8.1	7.0	16.8	4.7	8.4	8.3	13.1	6.0	12.9	8.2	20.1	8.0	7.1	9.4	6.2	15.4	12.9	7.0	9.7	13.0	9.3	8.3	12.2	5.4	7.8	6.1	7.1	9.8	9.1	5.9	15.0	21.4	3.0	11.2	6.5	9.8	3.9	2.6	4.1	4.1	5.5	4.3	4.5	4.3	4.9	2.6	6.3	3.9	2.6	3.7	4.0	1.8	4.7	3.1	7.1	14.6	8.6	13.6	8.9	7.1	6.2	10.4	12.3	4.7	0.0	8.6	0.0	1.6	1.5	5.6	8.7	2.5	9.4	9.1	5.2	5.9	8.2	1.7	4.3	5.3	2.9	2.7	0.0	4.0	7.9	3.1	1.0	4.7	10.2	2.7	3.2	4.1	3.1	1.2	3.1	3.4	1.7	3.3	0.0	5.7	2.5	3.6	0.0	4.6	2.7	6.8	6.5	2.1	6.7	9.8	2.6	6.2	1.7	4.9	0.8
POLR3C	"RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145842505	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 260.3;Late spermatids: 416.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	21.1	11.9	13.5	21.2	13.4	16.9	21.7	28.3	16.4	18.0	14.2	12.2	11.1	9.4	19.2	16.2	15.1	16.9	14.6	12.7	12.1	9.9	15.7	15.3	13.3	25.4	14.7	15.8	21.9	23.1	16.7	10.9	13.9	12.6	15.7	15.9	11.9	16.9	13.0	18.3	20.3	14.9	17.5	11.0	20.5	14.9	29.3	15.0	26.5	15.9	11.4	21.3	17.5	15.8	21.1	23.6	29.5	23.9	20.6	20.7	15.9	16.1	13.4	11.2	9.2	14.7	18.0	11.9	15.3	18.8	21.8	20.9	19.3	8.7	27.9	15.5	20.9	11.9	16.0	18.1	16.3	22.7	11.4	14.2	14.9	15.7	11.5	26.6	30.6	19.3	17.1	12.0	24.4	43.5	12.5	13.5	13.4	18.7	16.5	23.0	22.4	15.8	13.9	16.0	16.9	18.0	14.9	14.0	18.3	14.2	11.6	10.4	15.7	13.7	20.2	20.7	18.5	15.5	28.6	14.1	19.2	15.3	10.4	21.3	25.8	25.0	32.4	7.0	15.9	14.8	29.5	20.9	21.1	15.9	23.9	20.7	20.1	17.6	16.4	22.0	21.1	18.0	16.4	1.7	20.6	17.3	23.6	14.9	15.9	13.5	13.4	28.3	16.4	12.1	9.9	14.7	15.8	12.6	15.0	6.0	9.6	9.0	6.7	4.4	3.1	15.7	5.1	8.1	10.3	3.5	3.9	9.9	10.0	9.4	260.3	6.8	4.7	23.3	18.5	10.2	9.0	4.8	8.1	4.5	12.4	1.6	4.1	7.4	9.7	416.7	9.5	9.1	1.7	11.8	6.5	3.6	14.3	7.0	13.8	10.2	3.7	19.4	11.3	18.9	17.0	3.8	8.0	8.7	7.3	8.1
POLR3D	"BN51T, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245104-22254600	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	14.7	12.9	10.3	14.0	13.6	9.8	18.4	8.8	15.7	13.9	11.9	13.9	8.2	9.3	14.3	9.3	16.5	11.9	13.9	16.6	10.0	8.3	11.7	11.2	12.7	13.4	16.5	13.7	18.1	20.8	10.5	16.3	20.2	13.2	14.5	11.9	9.7	14.5	11.2	34.4	11.9	9.6	17.5	13.5	13.2	12.2	29.4	12.0	8.0	12.6	10.8	13.1	14.7	15.9	9.1	13.6	1.6	5.7	11.2	10.7	5.3	6.7	20.2	11.0	12.4	10.8	15.8	11.9	18.2	11.3	15.6	13.4	14.3	5.7	22.2	15.5	11.5	16.6	11.8	25.2	8.4	12.6	7.3	9.5	19.4	10.2	19.4	17.2	6.0	15.3	13.1	17.1	19.7	23.0	16.8	13.1	16.4	25.6	14.6	12.7	10.1	22.1	12.8	27.8	15.0	11.5	17.4	14.7	17.0	7.4	6.0	12.7	23.4	7.3	8.4	25.3	14.8	6.5	8.5	14.3	15.3	14.3	18.9	17.9	16.8	15.5	13.7	10.2	11.2	20.1	0.1	5.6	1.6	8.5	5.6	10.4	8.3	9.1	10.3	7.4	9.1	10.7	9.4	0.2	11.2	5.7	13.6	5.9	5.3	10.3	13.6	8.8	15.7	10.0	8.3	16.5	13.7	13.2	12.0	8.9	6.2	12.3	29.1	17.3	11.2	10.2	2.5	12.0	11.4	10.4	15.7	13.5	10.0	17.8	33.8	11.9	5.9	0.0	10.2	25.8	15.8	23.9	18.4	4.9	12.5	3.2	20.6	12.9	8.4	31.7	14.7	7.7	8.5	14.4	13.3	4.3	19.8	5.8	12.0	10.6	11.4	19.4	15.5	36.2	50.0	16.8	22.5	12.9	11.2	32.9
POLR3E	"FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335103	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	10.8	15.8	8.9	10.4	11.1	9.8	15.5	11.7	12.9	11.7	10.7	12.0	13.0	9.7	12.4	9.3	13.1	11.1	8.5	13.9	10.9	7.0	9.5	14.0	9.5	12.7	11.1	9.8	11.0	21.2	15.7	15.8	8.9	10.7	12.7	6.6	11.8	15.0	15.2	50.7	12.7	8.9	9.2	10.0	9.5	12.4	9.6	10.7	10.4	12.3	9.1	14.0	11.4	10.4	5.9	5.7	1.9	3.8	5.3	7.2	4.8	6.6	9.3	2.7	6.7	5.3	4.0	9.2	5.4	2.8	3.6	2.5	11.7	4.7	13.8	7.1	3.8	2.5	6.4	13.3	7.5	2.9	9.1	19.0	7.0	10.1	22.3	6.5	10.9	7.8	3.9	8.3	7.7	9.4	1.7	9.1	5.8	19.9	5.6	4.1	10.8	10.9	4.5	13.7	7.4	7.9	14.3	6.0	17.7	3.7	4.0	9.9	7.4	5.1	9.5	5.2	2.3	5.5	6.3	5.7	3.6	4.1	3.1	5.9	7.6	13.5	12.7	4.1	8.4	6.7	0.0	3.3	1.9	6.5	3.8	7.2	5.9	7.2	6.8	5.7	5.1	7.0	5.8	0.3	5.3	3.1	3.3	7.2	4.8	8.9	11.1	11.7	12.9	10.9	7.0	11.1	9.8	10.7	10.7	3.0	14.3	16.6	20.1	28.8	22.8	16.2	7.6	16.0	11.4	17.4	29.5	19.3	5.0	10.9	31.0	13.1	10.9	0.0	11.0	16.4	14.4	22.7	27.6	11.1	11.5	19.1	14.5	5.5	12.3	13.9	11.5	9.4	13.5	7.2	16.4	10.6	13.0	11.5	8.5	9.1	38.3	12.9	16.5	18.4	16.2	34.6	23.7	19.2	15.0	23.8
POLR3F	"RPC39, RPC6"	ENSG00000132664	"RNA polymerase III subunit F"	Q9H1D9	20	18467127-18484643	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049441, HPA050173, HPA072298"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510"	"unprognostic (4.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (8.87e-9)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.98e-3)"	8.6	7.8	8.1	6.0	11.9	4.4	8.0	24.6	15.3	9.9	7.5	8.7	8.5	5.6	11.6	6.5	11.0	9.6	6.7	14.2	8.7	10.1	11.2	7.3	5.9	8.8	7.8	12.9	12.5	7.3	4.5	9.8	8.0	13.9	9.2	6.4	6.7	7.5	7.4	12.0	6.2	5.0	9.0	8.5	6.3	6.7	10.0	7.7	6.3	16.3	7.2	9.1	10.7	6.5	3.1	3.2	1.9	4.5	3.3	6.4	4.1	6.5	6.7	7.0	8.8	5.7	6.9	12.6	9.7	6.8	12.5	9.6	8.4	6.7	5.1	4.1	9.4	8.3	9.0	9.2	8.0	8.2	5.0	7.7	3.7	2.6	3.6	8.1	11.0	6.3	4.4	5.2	18.7	8.6	6.0	5.6	4.5	9.4	4.5	8.6	7.1	9.2	4.7	9.9	6.7	15.3	6.5	15.3	5.6	5.6	2.8	14.6	9.6	7.5	12.6	15.7	4.9	5.8	7.4	5.4	12.9	6.3	9.6	13.6	2.3	15.3	4.0	5.4	5.1	9.3	0.1	2.1	1.9	4.3	4.5	6.4	2.8	3.9	1.2	2.2	3.1	4.1	2.1	0.8	3.3	1.9	3.2	3.4	4.1	8.1	11.9	24.6	15.3	8.7	10.1	7.8	12.9	13.9	7.7	8.9	3.7	5.4	3.0	7.9	17.3	7.3	2.5	12.0	4.5	1.8	9.8	8.6	8.3	7.0	15.9	6.5	2.9	0.0	5.9	10.3	6.7	3.5	5.7	4.5	6.7	11.1	6.4	6.7	7.0	4.1	5.8	6.9	5.0	11.8	3.1	12.5	6.4	0.0	9.6	9.8	17.4	12.9	5.5	17.7	22.0	9.9	6.1	8.5	3.9	2.7
POLR3G	"RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514553	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatogonia: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	2.7	1.6	7.1	3.6	10.2	4.4	3.8	7.2	7.2	3.7	2.6	6.7	1.4	2.8	2.7	8.4	7.3	2.7	2.4	2.7	7.7	7.7	1.7	4.0	2.9	8.1	10.3	6.1	4.1	4.1	11.1	3.9	3.1	20.2	2.9	3.1	2.6	4.2	1.5	4.4	7.4	2.3	4.2	16.0	3.3	2.1	8.0	8.1	1.0	5.9	8.5	3.2	4.4	4.7	3.9	2.1	6.8	2.8	5.4	3.2	0.8	10.7	6.2	7.4	1.9	2.3	4.1	3.4	5.4	1.7	8.6	7.0	3.6	8.0	29.4	1.8	2.2	8.5	4.5	9.2	8.6	30.8	13.5	8.2	10.8	2.9	5.5	3.9	7.5	2.7	2.7	4.0	14.3	10.9	1.7	10.6	11.7	15.3	2.7	3.1	5.2	7.9	4.7	34.9	1.5	27.7	7.0	3.2	16.6	2.5	1.0	9.4	2.5	2.2	4.1	14.9	3.4	2.2	2.1	12.7	4.7	9.0	6.6	20.3	6.8	17.4	21.7	10.4	10.0	37.3	6.8	0.6	0.3	3.2	0.8	1.6	3.9	1.1	2.0	0.9	2.4	2.4	2.6	1.6	5.4	2.8	2.1	0.5	0.8	7.1	10.2	7.2	7.2	7.7	7.7	10.3	6.1	20.2	8.1	6.0	2.1	0.8	1.2	3.2	2.7	3.4	0.0	2.7	0.0	1.8	7.9	0.7	3.3	2.6	3.0	1.4	0.5	0.0	3.9	5.2	1.5	3.0	6.9	2.4	1.5	3.2	6.4	3.7	0.3	1.0	0.3	0.6	1.7	0.0	1.3	0.6	2.9	2.0	1.1	1.3	0.8	0.0	1.4	7.7	27.4	7.4	0.7	0.0	1.6	0.6
POLR3GL	"flj32422, MGC3200"	ENSG00000121851	"RNA polymerase III subunit G like"	Q9BT43	1	145964702-145978848	"Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA027288	Uncertain					NA	NA					"HPA027288: AB_10602119"	"prognostic favorable (2.96e-4)"	"unprognostic (3.58e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (6.52e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	30.4	23.9	20.7	18.9	21.4	16.6	21.2	16.0	17.2	17.8	21.9	18.4	14.8	13.3	18.0	19.8	17.7	15.5	29.4	47.4	18.0	15.5	16.6	36.6	18.0	23.9	20.7	17.1	22.0	11.5	26.0	20.7	13.3	14.5	18.7	17.4	20.8	14.6	17.8	66.3	14.1	18.7	16.8	18.1	25.2	19.3	10.7	20.9	26.6	25.2	22.9	26.8	20.2	23.5	28.5	13.4	61.6	17.3	25.7	41.7	22.7	10.1	4.5	10.6	9.7	26.8	30.3	2.5	10.2	16.1	7.0	10.7	1.4	11.3	21.8	15.4	14.3	5.7	3.1	5.1	10.1	10.8	23.5	5.6	14.4	3.7	7.0	16.5	14.4	20.6	22.8	6.7	11.6	13.5	20.7	18.5	23.3	24.0	19.1	26.9	10.8	11.7	18.2	2.2	15.4	10.1	9.9	13.1	32.8	11.3	2.3	5.8	10.8	14.5	0.9	20.4	9.0	9.1	23.4	19.1	6.6	4.3	12.9	6.8	31.2	9.5	17.0	12.0	17.4	6.0	46.8	13.2	61.6	32.0	17.1	30.5	28.5	32.7	31.4	13.4	26.9	33.5	34.4	10.2	25.7	17.3	10.5	41.7	22.7	20.7	21.4	16.0	17.2	18.0	15.5	20.7	17.1	14.5	20.9	26.8	47.4	43.4	22.8	24.7	30.5	74.2	45.9	26.8	17.0	19.2	7.9	16.8	104.5	27.9	28.6	42.1	22.7	0.0	34.2	22.5	46.4	22.8	82.1	74.4	62.7	54.0	20.3	50.3	61.4	7.8	41.7	50.0	55.6	66.7	33.6	56.7	28.8	31.6	44.2	32.2	16.4	25.8	41.1	9.8	25.4	26.2	7.9	94.9	36.6	15.3
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.3	11.0	10.2	14.9	11.2	10.2	6.8	13.7	12.8	23.4	18.9	22.2	5.4	13.9	10.8	23.0	13.2	7.5	18.6	22.4	14.7	12.7	23.0	8.3	17.5	10.6	11.6	34.4	14.2	12.7	14.6	30.8	8.3	8.9	11.4	13.9	17.4	8.9	13.0	15.5	8.8	9.4	7.2	21.7	14.3	13.5	8.0	14.5	10.9	9.6	9.8	5.9	17.9	18.2	8.7	6.6	7.2	9.8	10.2	14.0	15.2	24.3	18.1	6.8	12.6	21.0	24.4	12.3	13.3	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5	0.0	23.5	18.2	9.8	15.8	16.9	5.1	12.7	9.4	21.6	15.7	15.7	29.8	39.7	26.3	30.8	8.2	2.9	23.3	25.7	23.4	15.5	13.0	11.5	29.7	27.4	20.6	13.7	9.2	6.9	113.5	15.5	10.0	23.6	22.6	4.1	18.5	23.5	7.0	19.1	28.8	20.6	0.0	10.5	44.7	55.2	22.3	15.0	10.2	8.5	11.3
POLR3K	RPC11	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53628	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	7.3	12.4	15.4	16.6	17.6	11.3	8.3	14.3	18.8	8.0	9.1	9.0	11.9	9.8	8.3	9.3	9.8	9.3	7.4	12.0	13.7	15.4	9.1	10.3	7.6	19.6	11.9	15.5	9.1	11.0	12.1	7.5	8.0	9.0	10.0	9.2	5.9	11.1	12.7	21.8	5.7	9.3	8.2	9.8	14.0	9.1	5.7	7.9	13.7	11.5	12.4	18.6	9.9	8.6	39.6	25.3	32.2	18.9	13.5	30.0	18.2	10.8	18.7	11.9	12.3	4.9	3.0	9.5	15.5	4.9	13.8	9.1	24.1	11.7	28.2	11.8	5.4	5.5	10.8	27.7	7.1	9.9	16.9	25.5	20.7	14.0	17.1	3.7	18.6	20.4	3.0	6.3	15.3	7.8	3.2	6.7	12.6	29.5	9.0	8.9	26.9	22.3	12.3	19.5	13.7	17.9	27.1	13.8	29.4	7.8	7.8	17.5	10.3	10.6	19.9	9.1	5.2	11.7	16.8	6.4	8.9	10.9	11.9	18.7	5.8	13.9	55.5	3.8	13.7	13.3	9.0	13.6	32.2	15.8	18.9	16.2	39.6	20.3	18.2	12.4	35.1	18.4	17.2	9.8	13.5	17.3	25.3	30.0	18.2	15.4	17.6	14.3	18.8	13.7	15.4	11.9	15.5	9.0	7.9	3.0	9.9	34.1	17.9	29.7	15.1	25.5	25.5	12.0	7.9	17.4	3.9	34.6	41.4	28.4	0.6	20.3	13.2	0.0	30.5	38.6	19.5	23.0	21.9	26.0	38.9	9.5	17.2	19.0	13.1	0.4	19.5	22.5	21.9	56.9	19.5	12.9	29.0	14.0	15.6	36.1	8.4	12.9	17.5	4.7	15.1	38.6	10.8	27.7	24.8	19.5
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617224-633604	"Enzymes, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 63.9;Spermatogonia: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favorable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	10.2	10.7	10.1	16.3	11.9	6.9	8.1	12.1	20.7	9.5	11.6	12.3	4.4	16.7	9.8	12.2	14.4	8.7	12.7	24.7	11.5	8.9	12.9	21.4	7.3	11.8	9.4	15.1	10.1	15.9	9.5	10.7	6.2	9.7	10.2	8.8	8.5	9.6	11.7	42.2	16.7	12.8	10.8	8.4	12.8	11.2	32.1	6.3	11.6	11.1	8.6	10.4	10.1	7.8	8.2	7.3	3.1	5.5	7.5	9.0	5.3	10.5	19.1	4.4	19.2	9.2	5.2	16.1	4.9	5.9	7.4	6.7	19.2	7.3	10.8	10.1	4.5	3.7	10.9	16.2	9.4	5.5	12.1	38.5	8.4	11.9	24.6	9.6	14.2	16.1	5.0	13.3	7.5	9.1	5.3	10.3	15.2	15.8	10.9	6.7	14.9	18.8	19.5	17.4	13.8	13.4	18.2	6.0	18.5	9.7	9.0	14.0	10.0	4.5	12.2	12.3	4.9	6.9	13.0	6.1	8.0	10.2	12.5	14.5	25.9	21.3	16.5	17.1	11.9	9.7	0.0	3.7	3.1	9.0	5.2	7.1	7.8	6.7	6.6	7.3	8.2	5.7	6.3	0.6	7.5	5.5	7.2	4.1	5.3	10.1	11.9	12.1	20.7	11.5	8.9	9.4	15.1	9.7	6.3	11.9	14.4	8.8	5.0	7.1	17.9	15.6	10.2	4.0	9.1	15.7	17.7	13.3	6.6	5.3	31.3	7.1	22.6	0.0	6.7	7.0	6.0	5.1	12.7	22.5	9.2	11.1	12.5	8.6	7.9	63.9	11.5	9.2	10.1	3.6	12.0	7.8	5.6	11.5	12.4	14.6	15.8	6.5	9.9	30.7	84.7	6.4	6.4	8.7	19.1	5.4
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905264-34918989	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.1	6.5	3.4	3.2	4.9	4.8	4.4	5.2	4.7	5.4	3.2			2.9	4.6	3.8	3.7	3.5	3.3	6.6	3.5	4.4	3.7	3.5	5.6	6.1	2.9		4.0	3.3	3.0	3.4	6.0		5.3	3.1		4.3	3.7	7.4	4.5	3.6	3.3	2.6	3.1	3.7	5.8			5.2		4.7	3.8	4.7	9.4	7.6	7.2	3.1	4.8	9.3	2.6	5.8	6.8	7.3	14.0	5.1	6.0	10.4	9.2	9.0	9.7	8.0	6.4	8.0	15.2	3.3	8.2	11.7	5.4	8.0	5.6	10.9	6.8	6.8	8.1	20.7	4.4	8.8	11.1	7.5	5.3	4.8	10.6	7.1	3.6	4.7	6.6	14.4	9.1	8.2	7.3	11.3	7.9	9.5	3.8	10.3	10.4	15.2	5.3	4.7	6.2	7.5	7.9	19.0	13.0	8.5	5.3	8.0	9.3	4.2	12.7	9.7	6.5	9.6	5.0	9.1	13.4	6.6	16.8	8.8	7.2	3.0	6.8	5.9	3.1	7.7	8.7	6.5	8.0	2.9	9.4	9.3	8.0	2.3	4.8	2.9	7.6	5.3	2.6											20.8	39.2	16.0	18.1	26.0	22.1	20.7	15.3	9.4	13.6	19.2	25.5	69.8	16.6	14.1	15.1	14.1	9.5	23.3	19.5	44.4	23.7	18.0	20.8	12.1	20.7	22.3	12.6	9.2	13.2	11.8	23.3	15.3	16.9	10.0	11.0	18.9	14.2	10.5	20.5	13.2	33.2	12.9	19.1	59.4	59.0	25.0	67.4	26.3	11.2	19.7
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.4	5.2	7.0	10.6	8.4	10.8	6.1	7.7	6.3	6.7	11.8	8.5	5.1	14.2	7.1	4.1	8.2	12.1	6.3	6.1	3.8	3.5	6.9	9.4	9.5	9.0	7.8	2.5	6.8	20.1	3.7	7.2	10.2	5.5	8.6	3.3	4.9	12.8	8.1	7.8	12.8	17.5	5.5	4.1	10.7	11.3	7.2	6.0	18.2	11.7	7.2	16.8	6.2	7.1	6.7	5.1	8.9	3.9	4.7	9.0	3.2	6.7	11.0	5.8	8.3	1.7	0.8	7.8	4.3	2.9	5.0	4.3	13.1	12.9	8.1	8.1	0.9	7.9	11.4	3.4	3.3	0.7	7.7	9.5	10.9	5.9	6.5	2.4	7.1	14.4	2.1	3.3	4.3	1.8	3.1	3.3	15.3	8.8	9.0	1.0	20.9	13.8	13.8	8.8	9.4	8.3	11.5	7.9	9.2	1.3	5.4	6.7	7.2	6.0	16.4	13.6	1.3	11.6	6.8	2.5	7.2	9.4	14.6	5.1	9.6	8.9	7.0	4.8	7.0	5.9	8.0	3.2	8.9	9.0	3.6	6.4	6.7	7.2	7.3	2.1	5.3	4.9	5.7	4.7	4.7	3.9	5.1	3.9	3.2	7.0	8.4	7.7	6.3	3.8	3.5	7.8	2.5	5.5	6.0	20.8	17.9	32.3	16.6	15.1	18.1	0.8	12.7	29.4	23.9	19.2	66.8	21.0	11.6	10.1	18.0	13.7	57.3	0.0	11.5	18.5	14.7	20.0	19.7	5.9	13.4	20.6	13.7	8.6	7.1	9.4	9.8	22.6	18.6	4.6	18.9	14.0	9.0	24.6	11.7	6.9	31.2	12.9	9.7	27.6	15.0	15.2	34.0	41.5	24.0	11.9
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.2;ASC TERT1: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	21.0	7.1	7.8	8.8	7.3	7.3	15.1	26.0	7.6	31.7	11.0	5.8	14.1	5.4	34.5	18.5	7.6	12.2	7.4	7.1	6.5	6.1	6.5	6.4	10.8	6.3	5.4	5.8	11.3	8.1	7.8	15.1	10.2	6.8	11.4	7.4	8.3	6.9	16.3	17.1	8.2	7.0	18.0	6.9	7.1	8.6	10.3	6.7	10.2	9.2	7.2	5.5	18.3	16.2	5.1	2.8	6.0	2.9	1.7	4.6	1.0	4.7	3.0	5.8	8.8	40.2	30.6	6.4	6.7	11.1	3.7	6.1	5.3	2.9	10.4	4.9	9.7	5.8	4.9	8.5	3.7	6.3	6.1	4.7	6.9	7.6	7.1	5.6	7.2	4.2	19.5	3.4	6.8	10.7	6.4	6.8	5.4	8.8	6.6	7.1	4.4	8.5	1.5	2.0	2.4	5.0	5.5	6.4	3.4	2.8	5.9	7.7	6.1	8.4	3.1	7.2	4.7	3.8	7.8	7.8	5.6	5.2	26.0	7.6	7.0	8.1	9.3	5.4	5.6	7.3	1.9	1.7	3.3	3.3	1.3	4.6	2.8	2.5	3.0	1.7	5.1	1.6	2.8	6.0	1.7	2.9	2.8	1.9	1.0	7.8	7.3	26.0	7.2	6.5	6.1	5.4	5.8	6.8	6.7	44.7	73.8	34.3	19.1	27.1	106.3	31.0	12.7	56.2	45.5	19.2	53.0	18.3	3.3	13.5	30.3	42.0	13.4	0.0	9.9	10.9	62.7	15.8	45.1	12.5	10.9	33.4	57.4	19.0	18.3	11.9	46.6	44.7	20.3	15.4	14.8	74.6	10.1	13.5	36.7	9.2	58.5	38.8	60.6	40.2	68.7	23.5	27.6	22.4	17.7	6.7
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	9.4	9.3	9.8	15.1	10.7	30.3	11.7	14.4	12.5	11.4	11.0	10.2	12.6	10.2	12.9	10.8	14.3	12.2	8.4	6.7	15.2	6.5	9.3	13.9	8.4	16.0	7.0	10.1	18.7	12.3	7.3	11.4	9.1	11.0	8.7	14.5	8.5	9.9	12.6	7.3	11.2	11.5	9.0	9.3	11.1	9.8	16.4	9.3	33.4	12.0	11.2	17.0	12.6	10.8	12.9	8.8	14.2	10.4	9.1	14.1	7.9	19.5	21.4	21.0	11.7	5.2	6.1	23.0	14.8	10.1	28.7	21.5	22.0	8.5	23.1	10.5	7.6	17.6	18.8	28.9	14.5	27.1	16.2	24.1	18.1	16.8	14.4	3.1	28.3	13.8	3.2	4.8	21.6	6.9	12.3	11.9	28.5	24.1	8.4	13.4	21.4	35.6	21.4	15.9	11.8	19.7	26.7	25.8	22.0	12.4	17.8	28.2	12.3	25.5	7.1	9.1	12.8	26.3	10.9	5.5	15.4	17.3	21.0	27.8	14.3	18.5	28.3	14.8	20.4	26.1	14.2	6.2	3.9	11.2	10.4	10.0	12.9	13.7	9.8	8.8	11.1	10.7	9.3	6.1	9.1	5.8	7.6	14.1	7.9	9.8	10.7	14.4	12.5	15.2	6.5	7.0	10.1	11.0	9.3	0.0	3.5	0.0	7.8	7.4	3.7	2.6	2.5	17.4	4.5	8.7	2.0	12.7	8.3	7.5	1.3	4.1	2.5	46.7	5.6	22.1	4.3	2.5	5.7	5.8	8.0	1.6	4.1	4.3	2.6	1.7	3.7	4.1	0.0	2.8	5.6	7.8	3.4	3.5	7.8	4.6	6.3	0.0	5.2	12.6	9.3	4.6	7.4	6.9	10.8	1.8
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Cell type enhanced"	"Detected in many"	14	"Extravillous trophoblasts: 178.8;Hofbauer cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes					"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.8	54.7	10.9	13.8	1.0	4.3	7.1	32.7	17.2	48.7	67.6	48.3	27.8	21.4	11.5	19.6	20.3	30.0	9.9	29.2	25.2	7.4	36.5	37.8	19.6	31.6	0.3	16.0	24.4	2.1	1.0	25.4	3.5	3.4	19.8	7.5	23.2	47.5	18.6	49.1	8.0	9.0	5.6	38.5	38.1	21.7	44.2	47.8	12.9	21.4	4.9	14.5	25.1	68.9	9.2	10.0	46.5	21.5	9.1	47.9	47.0	34.1	42.0	20.0	10.4	27.5	23.5	10.8	21.5	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6	0.0	2.4	8.2	6.8	25.2	0.0	0.6	2.5	4.0	7.9	12.2	0.0	46.0	6.6	6.3	2.6	3.2	3.9	46.7	9.8	178.8	7.2	3.3	0.0	8.6	55.5	0.0	5.2	9.8	10.8	4.2	0.6	11.3	3.3	8.2	12.4	0.0	11.2	8.6	0.7	14.7	0.0	0.0	2.2	1.1	18.4	9.8	42.7	7.2	25.1	12.3
TK2	SCA31	ENSG00000166548	"Thymidine kinase 2, mitochondrial"	O00142	16	66508003-66552544	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041162	Uncertain					NA	NA					"HPA041162: AB_10961178"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.18e-6)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.05e-2)"	34.0	25.4	18.5	9.0	18.9	6.2	25.5	13.1	22.4	19.8	10.9	17.2	18.5	9.5	15.2	29.0	11.0	17.4	18.3	15.2	19.2	15.5	20.9	27.8	16.5	11.5	18.2	18.5	23.7	21.6	50.2	18.0	12.9	27.9	14.9	11.5	13.7	18.1	18.8	20.8	10.0	10.5	17.0	28.2	17.4	12.0	29.4	15.5	6.5	23.4	9.0	8.7	15.5	18.6	1.4	12.6	10.3	15.6	4.4	4.3	3.3	4.7	9.3	5.0	5.2	27.7	22.8	0.3	8.1	9.8	6.5	7.6	2.7	10.4	0.1	9.0	25.2	8.2	4.1	2.5	6.7	4.2	3.1	2.3	0.8	5.9	5.2	19.8	1.3	3.5	16.9	6.4	7.5	10.4	26.7	9.7	6.2	2.7	10.9	15.3	1.6	2.5	6.2	2.5	2.1	5.5	2.7	9.0	10.7	20.0	3.9	1.9	3.2	24.4	2.4	10.5	2.6	3.7	6.7	10.2	12.6	6.5	10.1	2.9	12.3	5.2	5.5	15.1	2.4	7.4	4.7	15.6	10.3	4.3	13.3	3.3	0.9	2.9	3.0	12.6	1.4	1.4	2.3	8.2	4.4	9.8	5.2	2.8	3.3	18.5	18.9	13.1	22.4	19.2	15.5	18.2	18.5	27.9	15.5	20.8	9.4	2.2	4.9	5.0	17.1	5.5	22.9	9.4	6.8	21.0	21.6	7.1	8.3	12.3	17.6	10.9	7.9	0.0	19.4	4.5	8.5	4.3	25.3	42.3	19.3	20.6	9.2	29.4	48.2	27.3	21.6	17.8	10.1	6.4	5.1	17.5	22.8	3.5	18.0	31.5	20.3	0.0	4.7	49.3	10.3	3.3	2.4	6.5	6.8	3.3
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 8.0;Cardiomyocytes: 5.0;Melanocytes: 23.6;Smooth muscle cells: 7.6;Suprabasal keratinocytes: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.9"					"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		14.2	14.3	16.7	14.6	10.6	20.7	17.2	13.0	16.9	13.4	11.0	12.8	17.5	10.3	8.1	14.9	16.6	14.5	12.3	9.8	14.4	14.2	11.6	12.7	12.5	26.2	14.6	17.4	7.3	13.0	6.8	31.2	11.6	11.2	15.4	9.3	10.8	32.2	19.3	10.8	22.9	10.9	8.2	12.6	25.5	12.4	4.6	10.1	18.5	7.4	18.3	21.7	13.3	10.6	24.9	35.5	23.3	41.8	8.6	13.1	20.1	8.0	7.4	6.2	4.4	7.7	7.9	0.0	2.6	13.1	22.0	30.9	0.1	9.6	9.5	5.4	11.1	20.8	9.4	0.4	11.8	3.1	8.0	0.7	5.5	26.5	0.4	9.7	5.0	3.9	6.9	1.1	11.1	4.4	4.5	9.3	6.6	0.0	14.6	9.3	0.1	7.0	3.6	0.0	4.7	4.6	5.8	1.6	18.5	5.8	1.6	0.0	3.7	9.6	13.0	6.3	0.4	0.4	8.4	9.8	4.1	3.9	8.7	6.1	11.8	6.8	4.0	9.1	10.7	3.3	2.1	41.8	3.0	9.8	32.5	5.6	24.6	13.1	9.4	35.5	24.9	12.4	10.3	23.3	8.6	24.3	28.0	11.6	20.1	16.7	10.6	13.0	16.9	14.4	14.2	14.6	17.4	11.2	10.1	0.0	0.3	0.0	0.0	8.0	0.0	5.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	12.2	0.0	0.0	0.0	0.0
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 39.6"	"Cell type enhanced"	"Detected in single"	21	"Suprabasal keratinocytes: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 3.9;eosinophil: 5.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.6;U-698: 10.3;U-937: 9.6"	"Not detected"	"Not detected"							HPA054060	Uncertain					NA	NA					"HPA054060: AB_2682362"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	3.2	1.5	2.1	3.4	3.0	1.9	2.1	1.1	3.6	4.3	2.6	1.9	15.5	1.4	2.5	2.2	4.5	2.6	2.2	3.5	1.6	1.2	2.8	4.6	2.4	3.1	2.4	2.4	2.1	2.2	1.5	1.7	2.6	2.7	2.5	1.4	1.4	4.5	7.4	2.0	39.6	2.3	1.9	1.2	4.3	1.7	2.1	1.9	5.8	3.3	6.2	4.7	2.2	5.2	0.4	0.3	5.7	0.1	0.2	0.4	0.2	2.8	3.6	0.3	1.3	0.5	0.7	0.3	0.9	0.8	0.7	2.0	1.0	0.7	0.3	1.9	0.8	0.2	3.1	1.2	2.0	0.0	3.2	7.6	0.3	0.7	0.4	0.3	0.8	2.0	0.8	1.9	0.9	0.7	0.4	0.3	0.6	0.4	3.5	0.2	3.3	2.0	2.3	1.2	0.6	2.4	4.9	1.0	2.3	0.3	1.0	0.8	0.4	0.3	0.3	1.1	0.1	0.6	0.9	0.0	1.3	2.4	2.8	1.1	4.0	2.7	10.3	0.3	9.6	1.5	3.9	0.0	5.7	0.3	0.0	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.1	0.2	2.1	3.0	1.1	3.6	1.6	1.2	2.4	2.4	2.7	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	27.3	47.8	28.8	32.3	31.3	27.2	40.4	22.3	41.4	25.3	41.7	27.1	34.4	44.0	26.6	22.3	40.0	32.7	37.6	69.2	25.6	25.8	45.6	68.4	28.6	46.2	33.1	24.4	25.9	75.0	48.3	22.7	23.0	27.3	23.4	37.6	25.4	40.9	33.1	77.3	28.1	36.1	26.2	25.8	28.4	36.9	47.0	21.5	32.5	37.0	55.4	33.9	26.8	23.3	30.6	57.3	21.7	44.2	25.5	38.8	45.4	29.3	55.9	17.9	37.4	26.0	23.9	36.8	21.5	25.1	34.4	32.6	60.2	32.5	66.1	39.8	21.5	19.7	57.6	42.4	41.7	20.6	26.3	64.9	25.2	45.2	72.8	30.9	45.1	23.5	30.5	33.0	37.1	37.0	22.4	40.9	36.7	56.5	26.1	24.9	59.8	43.2	44.1	40.1	36.1	34.7	59.9	32.5	96.1	29.7	28.8	31.4	38.4	18.8	67.2	29.4	15.4	40.0	36.8	26.0	20.6	24.0	25.4	32.8	39.9	41.3	28.8	26.3	56.7	26.9	21.7	44.2	19.5	31.3	42.3	34.8	30.6	29.7	32.7	57.3	27.5	28.5	29.5	9.1	25.5	31.6	34.9	38.8	45.4	28.8	31.3	22.3	41.4	25.6	25.8	33.1	24.4	27.3	21.5	65.5	70.3	105.7	207.8	149.3	93.5	117.0	178.3	137.9	64.8	167.5	82.5	299.6	283.5	183.0	309.9	94.4	289.0	23.3	252.4	240.7	112.6	188.4	103.9	224.8	230.1	69.9	142.6	95.8	162.5	472.6	101.2	129.8	131.6	183.1	194.4	129.6	169.5	172.7	105.0	374.4	91.2	84.1	142.8	184.3	182.3	136.4	240.1	147.2	348.8	236.5
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62592177	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.9	12.1	10.7	9.9	13.6	7.8	12.9	13.5	13.3	10.5	8.7	15.9	13.0	12.9	11.5	10.8	10.0	16.9	13.7	10.7	13.6	8.3	12.2	22.7	9.6	18.1	15.5	9.5	14.5	26.2	15.5	16.2	12.3	13.0	13.9	6.2	11.9	16.4	11.9	20.5	13.9	11.7	10.2	11.4	14.6	12.5	18.6	13.2	17.1	14.0	8.8	13.6	11.5	9.8	13.1	9.4	6.6	7.3	9.8	16.0	7.2	7.3	9.2	6.4	8.9	7.8	4.5	8.3	7.9	4.8	6.7	5.8	8.2	14.4	11.7	18.2	3.8	8.4	13.8	11.7	9.2	3.4	9.0	6.2	12.0	9.4	7.8	8.7	8.5	5.5	6.3	9.9	8.3	12.8	6.3	6.4	15.2	18.0	12.1	5.6	16.0	12.0	18.1	7.3	4.8	11.3	13.5	10.2	28.4	6.2	4.2	10.6	14.9	6.0	11.4	9.8	5.6	15.9	8.3	5.7	7.6	6.8	8.8	6.0	21.1	18.5	14.4	8.9	6.7	6.2	5.9	5.9	6.6	10.5	7.3	14.6	9.8	9.9	8.4	7.8	13.1	16.0	12.5	3.6	9.8	5.3	9.4	8.9	7.2	10.7	13.6	13.5	13.3	13.6	8.3	15.5	9.5	13.0	13.2	0.0	7.9	8.1	4.8	2.4	7.4	3.2	10.2	9.4	2.3	10.4	5.9	10.6	5.0	7.3	25.9	13.4	5.6	0.0	6.4	6.5	3.8	6.1	2.3	16.2	5.0	1.6	6.9	12.3	4.0	12.8	6.6	3.1	10.1	2.8	6.0	9.3	5.4	3.5	3.2	4.9	8.7	0.0	1.4	9.2	14.8	1.9	11.7	6.9	6.0	2.8
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 272.3;Urothelial cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 144.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.2	103.7	12.1	11.3	58.1	32.6	42.0	41.4	26.2	18.7	19.4	10.9	33.2	16.7	19.3	144.9	70.2	7.8	23.8	15.9	22.2	8.1	10.3	14.1	81.4	46.1	93.3	21.9	15.4	18.5	16.4	41.4	13.2	57.6	64.1	23.0	19.3	7.9	28.0	10.7	22.4	10.0	11.6	44.8	106.9	22.3	8.4	14.5	21.8	12.3	18.8	11.4	33.5	53.0	33.0	23.9	12.5	13.0	85.6	9.2	19.1	20.6	33.9	8.7	17.0	25.1	19.3	12.2	54.4	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9	59.6	55.0	27.6	272.3	92.4	28.0	55.7	38.2	104.4	96.7	15.7	21.6	22.9	34.9	73.1	34.3	40.9	44.4	23.3	68.7	28.0	34.6	217.3	50.9	45.7	36.8	27.0	19.7	50.3	37.2	13.4	63.0	64.0	18.6	55.9	17.9	23.3	183.4	20.3	27.6	28.5	19.7	0.0	58.8	11.6	28.8	63.7	42.9	23.5	24.1	489.6
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA		410000	"Vesicles, Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.4	13.3	1.2	5.2	2.4	3.4	3.0	6.2	7.3	11.2	8.3	12.4	6.7	3.6	15.1	6.5	11.6	11.4	6.2	8.5	4.3	6.8	15.3	6.0	10.6	7.3	4.6	6.7	2.9	3.3	6.5	5.7	4.9	4.6	31.8	0.7	33.2	6.1	8.7	15.6	2.3	10.0	6.1	15.9	9.5	3.4	29.6	3.3	6.8	7.0	6.6	5.8	10.7	13.9	7.1	2.1	11.4	9.1	17.7	8.2	49.4	6.8	13.0	6.1	4.4	2.2	7.9	5.1	10.3	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8	14.9	27.1	5.2	19.2	3.8	20.0	13.6	17.8	13.4	10.3	19.2	9.8	51.6	49.7	18.7	21.0	11.3	13.5	0.0	27.8	19.6	12.5	19.5	1.1	47.4	23.3	9.5	1.2	10.4	20.5	14.1	14.4	12.1	5.0	25.2	12.1	19.0	19.9	14.0	8.5	44.0	9.5	6.5	9.1	8.6	12.8	4.5	35.1	11.7	14.7	12.7
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827531-165911618	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.5	7.1	6.5	11.1	8.6	11.6	17.5	16.9	9.6	9.3	18.4	8.9	11.0	15.3	10.1	15.3	20.5	8.8	9.0	9.6	6.4	6.6	6.6	14.6	11.1	10.3	10.5	6.6	7.5	17.6	7.9	9.4	65.8	11.2	8.1	19.9	5.0	16.1	9.9	20.9	15.0	24.8	10.0	8.2	7.7	13.2	7.2	7.9	13.1	6.4	12.4	12.3	9.0	11.1	3.4	14.7	0.8	5.6	3.4	3.9	2.0	25.2	26.3	14.2	12.7	7.3	12.2	23.1	27.9	20.6	29.8	34.0	24.9	27.8	12.5	19.9	17.3	12.1	20.8	26.6	32.8	26.7	22.9	22.4	14.5	22.6	25.6	18.2	28.3	11.1	11.5	16.9	56.2	35.0	7.2	19.6	24.1	38.3	18.0	26.7	18.3	25.1	18.2	38.9	35.2	25.5	11.5	15.6	42.5	13.8	16.5	21.4	25.3	19.9	39.4	19.3	28.3	24.3	27.0	20.4	16.7	23.3	18.9	29.5	24.2	36.0	46.3	14.4	18.8	12.7	0.8	5.6	0.1	1.8	3.7	3.9	3.4	1.7	2.4	14.7	3.4	0.0	1.4	0.2	3.4	3.2	14.0	2.2	2.0	6.5	8.6	16.9	9.6	6.4	6.6	10.5	6.6	11.2	7.9	0.0	1.4	3.0	24.7	20.4	4.3	4.1	12.7	1.4	4.5	8.7	0.0	1.2	6.6	15.0	94.9	15.3	22.2	0.0	19.1	46.9	11.0	10.1	0.0	4.9	11.9	0.0	6.4	4.9	3.5	31.3	6.1	7.1	10.1	17.2	13.7	4.0	38.8	14.4	3.2	5.8	4.2	0.0	9.0	5.2	11.5	26.0	22.1	4.8	18.3	20.9
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 206.2;Macrophages: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.9	0.8	1.6	2.7	1.2	8.1	3.2	4.5	4.1	5.1	3.3	3.2	0.0	1.2	2.6	26.4	4.6	1.5	13.1	2.7	1.3	1.4	0.2	1.9	1.3	2.4	0.2	0.5	1.6	6.4	1.9	103.9	1.9	2.7	0.2	0.4	3.9	2.2	0.7	0.0	1.1	3.1	1.1	6.9	0.0	1.7	1.7	9.5	3.4	0.7	0.7	3.3	0.9	24.1	8.9	0.8	0.2	3.8	9.7	8.3	2.6	8.2	7.5	10.0	1.1	9.8	1.0	23.6	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8	17.9	64.1	14.6	17.3	41.6	27.8	10.4	22.9	8.1	13.6	10.4	31.4	6.0	59.7	36.9	0.6	58.5	53.1	0.0	35.8	206.2	39.5	10.1	24.4	15.1	111.9	15.9	12.5	78.5	137.0	1.5	4.9	205.8	82.7	43.3	11.6	13.5	73.7	52.6	2.1	15.4	28.8	6.5	33.0	0.0	3.0	26.1	65.8	46.7	13.3	29.6
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 11.6;Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.9	0.0	0.7	0.8	0.9	0.0	0.0	0.0	0.1	1.1	0.6	1.2	1.4	0.3	0.0	0.3	0.6	0.6	0.4	0.4	0.5	0.0	0.4	0.8	0.1	0.0	0.2	0.2	0.0	0.0	1.2	0.1	0.4	0.3	1.2	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.3	9.8	24.2	16.3	9.5	12.2	16.8	9.2	13.5	13.4	15.6	10.1	5.4	22.1	10.9	12.8	21.8	8.6	18.1	9.8	17.2	18.0	16.5	23.3	12.7	21.0	15.8	25.2	13.3	14.4	21.7	14.4	17.9	17.1	9.3	15.5	18.9	11.1	11.2	0.1	25.1	18.0	17.5	5.3	12.5	22.3	24.6	17.3	14.5	8.6	13.0	12.9	14.2	6.1	13.8	28.7	8.4	13.2	7.8	10.5	14.2	9.6	11.2	24.3	31.9	31.8	6.9	13.8	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1	56.6	47.0	71.8	47.7	40.9	133.4	0.0	45.9	66.9	56.9	0.0	229.7	39.6	0.0	0.0	48.0	31.6	5.9	0.0	0.0	15.9	34.0	45.0	55.6	29.2	14.9	198.6	35.3	38.1	14.9	22.9	59.2	16.4	16.9	0.0	15.8	50.0	0.0	12.2	57.3	0.0	193.4	19.4	28.8	108.0	77.6	44.5	30.9	55.4	16.1	36.0
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.9	10.8	6.4	9.3	16.5	25.1	7.9	13.6	13.3	6.0	7.0	4.9	8.9	14.2	12.4	9.0	6.2	17.6	7.6	7.7	9.0	16.6	4.1	10.2	11.5	9.1	14.0	11.6	14.9	16.6	16.1	9.6	11.4	9.5	10.1	7.9	9.6	15.4	16.8	10.7	9.7	7.0	5.2	17.2	7.3	4.9	11.2	6.5	10.7	19.6	4.7	3.7	8.3	11.0	4.7	8.2	4.1	5.3	15.5	5.8	7.0	10.2	9.3	17.8	13.9	10.6	13.8	7.0	7.6	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7	59.6	30.7	5.3	28.7	28.0	13.1	0.0	12.7	26.8	37.5	0.0	17.7	18.4	0.0	0.0	77.5	14.4	23.4	0.0	0.0	14.3	9.9	42.1	45.1	45.3	20.1	17.5	16.0	17.2	62.4	17.6	15.8	40.3	30.4	0.0	18.3	11.4	0.0	20.7	12.4	0.0	14.9	12.9	10.3	19.8	7.8	35.4	77.3	27.7	17.7	54.5
ZNRD1	"HTEX-6, hZR14, RPA12, tctex-6"	ENSG00000066379	"Zinc ribbon domain containing 1"	Q9P1U0	6	30058899-30064909	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	11.7	13.5	6.7	14.1	7.2	8.7	17.1	7.4	8.9	12.3	15.3	6.8	9.1	13.2	12.5	10.2	15.4	13.0	10.4	11.0	6.4	6.3	13.4	12.2	14.8	18.8	8.3	6.1	13.6	22.0	10.2	9.4	11.4	6.2	12.5	14.5	9.7	14.7	10.2	13.5	11.2	14.2	9.1	6.3	17.5	12.7	22.9	6.8	37.0	15.0	15.3	18.9	12.2	15.0	8.2	8.4	6.4	5.9	8.1	13.0	7.9	4.1	0.9	4.6	6.5	2.2	2.7	1.7	1.6	2.4	2.9	2.6	4.6	2.9	3.3	1.4	2.6	4.9	3.5	7.6	6.2	3.1	2.3	7.7	7.8	2.1	6.8	9.3	8.2	3.6	5.4	3.6	4.6	15.8	1.7	8.0	16.8	13.1	2.1	1.9	5.5	7.1	17.8	0.0	9.2	5.4	8.7	4.3	6.4	2.5	6.9	1.6	3.1	2.8	4.4	2.6	2.2	3.3	6.8	1.7	3.4	3.0	0.0	5.1	5.2	9.8	10.6	1.2	13.3	4.5	6.2	5.9	5.7	12.5	5.6	13.0	7.3	10.8	11.5	5.6	8.2	9.8	10.2	6.4	8.1	5.2	8.4	10.9	7.9	6.7	7.2	7.4	8.9	6.4	6.3	8.3	6.1	6.2	6.8	20.8	16.8	48.4	63.0	69.8	13.3	13.3	20.4	16.0	22.7	21.0	2.0	21.3	43.1	28.3	106.8	37.6	47.7	0.0	39.7	37.2	41.2	27.6	31.1	25.8	31.4	11.1	42.2	28.8	38.9	11.9	36.8	27.6	28.7	33.3	41.2	14.0	40.2	59.6	23.0	47.3	13.3	19.4	39.1	52.1	5.9	60.3	14.8	62.3	48.4	68.8
